CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: serotonergic agonist
Accession: CHEBI:35941
browse the term
Definition: An agent that has an affinity for serotonin receptors and is able to mimic the effects of serotonin by stimulating the physiologic activity at the cell receptors. Serotonin agonists are used as antidepressants, anxiolytics, and in the treatment of migraine disorders.
Synonyms: related_synonym: 5-HT agonist; 5-hydroxytryptamine agonist; serotonergic agonists; serotonin agonist; serotonin agonists
G
Slc22a2
solute carrier family 22 member 2
multiple interactions
ISO
Dexfenfluramine inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium]
CTD
PMID:21599003
NCBI chr 1:50,668,817...50,711,019
Ensembl chr 1:50,668,817...50,711,019
G
Slc6a4
solute carrier family 6 member 4
affects activity
ISO
Dexfenfluramine affects the activity of SLC6A4 protein
CTD
PMID:18506000
NCBI chr10:62,322,688...62,357,060
Ensembl chr10:62,324,254...62,357,056
G
Acat2
acetyl-CoA acetyltransferase 2
increases expression
EXP
1-(3-trifluoromethylphenyl)piperazine results in increased expression of ACAT2 mRNA
CTD
PMID:26821219
NCBI chr 1:50,100,840...50,118,886
Ensembl chr 1:50,100,817...50,135,095
G
Bhmt
betaine-homocysteine S-methyltransferase
decreases expression
EXP
1-(3-trifluoromethylphenyl)piperazine results in decreased expression of BHMT mRNA
CTD
PMID:26821219
NCBI chr 2:26,594,852...26,614,429
Ensembl chr 2:26,594,854...26,614,715
G
Cyp51
cytochrome P450, family 51
increases expression
EXP
1-(3-trifluoromethylphenyl)piperazine results in increased expression of CYP51 mRNA
CTD
PMID:26821219
NCBI chr 4:30,991,693...31,010,147
Ensembl chr 4:30,991,613...31,010,450
G
Cyp8b1
cytochrome P450 family 8 subfamily B member 1
decreases expression
EXP
1-(3-trifluoromethylphenyl)piperazine results in decreased expression of CYP8B1 mRNA
CTD
PMID:26821219
NCBI chr 8:130,455,622...130,457,592
Ensembl chr 8:130,442,503...130,457,689
G
Esr1
estrogen receptor 1
multiple interactions
ISO
1-(3-trifluoromethylphenyl)piperazine inhibits the reaction [Estradiol binds to ESR1 protein]
CTD
PMID:23026265
NCBI chr 1:43,511,685...43,904,454
Ensembl chr 1:43,644,392...43,900,354
G
Fads1
fatty acid desaturase 1
increases expression
EXP
1-(3-trifluoromethylphenyl)piperazine results in increased expression of FADS1 mRNA
CTD
PMID:26821219
NCBI chr 1:216,252,605...216,267,618
Ensembl chr 1:216,252,602...216,267,615
G
Fasn
fatty acid synthase
increases expression
EXP
1-(3-trifluoromethylphenyl)piperazine results in increased expression of FASN mRNA
CTD
PMID:26821219
NCBI chr10:106,570,415...106,588,581
Ensembl chr10:106,570,413...106,588,583
G
Fdft1
farnesyl diphosphate farnesyl transferase 1
increases expression
EXP
1-(3-trifluoromethylphenyl)piperazine results in increased expression of FDFT1 mRNA
CTD
PMID:26821219
NCBI chr15:41,588,114...41,616,168
Ensembl chr15:41,588,117...41,616,168
G
Fdps
farnesyl diphosphate synthase
increases expression
EXP
1-(3-trifluoromethylphenyl)piperazine results in increased expression of FDPS mRNA
CTD
PMID:26821219
NCBI chr 2:176,795,192...176,804,816
Ensembl chr 2:176,795,192...176,807,136
G
Gabra1
gamma-aminobutyric acid type A receptor subunit alpha 1
multiple interactions
ISO
1-(3-trifluoromethylphenyl)piperazine inhibits the reaction [gamma-Aminobutyric Acid results in increased activity of [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein]]
CTD
PMID:26344803
NCBI chr10:27,096,731...27,152,563
Ensembl chr10:27,096,740...27,152,442
G
Gabrb2
gamma-aminobutyric acid type A receptor subunit beta 2
multiple interactions
ISO
1-(3-trifluoromethylphenyl)piperazine inhibits the reaction [gamma-Aminobutyric Acid results in increased activity of [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein]]
CTD
PMID:26344803
NCBI chr10:27,438,127...27,657,680
Ensembl chr10:27,438,238...27,655,171
G
Gabrg2
gamma-aminobutyric acid type A receptor subunit gamma 2
multiple interactions
ISO
1-(3-trifluoromethylphenyl)piperazine inhibits the reaction [gamma-Aminobutyric Acid results in increased activity of [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein]]
CTD
PMID:26344803
NCBI chr10:26,876,926...26,965,523
Ensembl chr10:26,876,926...26,965,523
G
Gpnmb
glycoprotein nmb
increases expression
EXP
1-(3-trifluoromethylphenyl)piperazine results in increased expression of GPNMB mRNA
CTD
PMID:26821219
NCBI chr 4:79,341,128...79,362,366
Ensembl chr 4:79,341,021...79,380,240
G
Hmgcr
3-hydroxy-3-methylglutaryl-CoA reductase
increases expression
EXP
1-(3-trifluoromethylphenyl)piperazine results in increased expression of HMGCR mRNA
CTD
PMID:26821219
NCBI chr 2:29,732,163...29,754,276
Ensembl chr 2:29,720,553...29,754,533
G
Hmgcs1
3-hydroxy-3-methylglutaryl-CoA synthase 1
increases expression
EXP
1-(3-trifluoromethylphenyl)piperazine results in increased expression of HMGCS1 mRNA
CTD
PMID:26821219
NCBI chr 2:53,379,457...53,399,807
Ensembl chr 2:53,382,643...53,399,802
G
Idi1
isopentenyl-diphosphate delta isomerase 1
increases expression
EXP
1-(3-trifluoromethylphenyl)piperazine results in increased expression of IDI1 mRNA
CTD
PMID:26821219
NCBI chr17:66,539,761...66,547,524
Ensembl chr17:66,539,763...66,547,524
G
Msmo1
methylsterol monooxygenase 1
increases expression
EXP
1-(3-trifluoromethylphenyl)piperazine results in increased expression of MSMO1 mRNA
CTD
PMID:26821219
NCBI chr16:29,747,113...29,764,360
Ensembl chr16:29,747,137...29,764,445
G
Pcsk9
proprotein convertase subtilisin/kexin type 9
increases expression
EXP
1-(3-trifluoromethylphenyl)piperazine results in increased expression of PCSK9 mRNA
CTD
PMID:26821219
NCBI chr 5:126,440,102...126,462,507
Ensembl chr 5:126,440,102...126,462,507
G
Pgr
progesterone receptor
increases expression
ISO
1-(3-trifluoromethylphenyl)piperazine results in increased expression of PGR mRNA
CTD
PMID:23026265
NCBI chr 8:14,354,398...14,413,271
Ensembl chr 8:14,354,398...14,413,271
G
Rragd
Ras-related GTP binding D
increases expression
EXP
1-(3-trifluoromethylphenyl)piperazine results in increased expression of RRAGD mRNA
CTD
PMID:26821219
NCBI chr 5:52,170,234...52,205,700
Ensembl chr 5:52,169,783...52,209,000
G
Sqle
squalene epoxidase
increases expression
EXP
1-(3-trifluoromethylphenyl)piperazine results in increased expression of SQLE mRNA
CTD
PMID:26821219
NCBI chr 7:92,758,175...92,773,049
Ensembl chr 7:92,757,409...92,773,050
G
Sult2a6
sulfotransferase family 2A, dehydroepiandrosterone (DHEA)-preferring, member 6
decreases expression
EXP
1-(3-trifluoromethylphenyl)piperazine results in decreased expression of SULT2A6 mRNA
CTD
PMID:26821219
NCBI chr 1:84,046,685...84,097,808
Ensembl chr 1:84,046,685...84,097,808
G
Tff1
trefoil factor 1
increases expression
ISO
1-(3-trifluoromethylphenyl)piperazine results in increased expression of TFF1 mRNA
CTD
PMID:23026265
NCBI chr20:9,237,095...9,240,956
Ensembl chr20:9,237,095...9,240,956
G
Cyp2d4
cytochrome P450, family 2, subfamily d, polypeptide 4
affects metabolic processing multiple interactions
ISO
CYP2D6 protein affects the metabolism of 1-(3-chlorophenyl)piperazine Quinidine inhibits the reaction [CYP2D6 protein affects the metabolism of 1-(3-chlorophenyl)piperazine]
CTD
PMID:18238857
NCBI chr 7:115,762,662...115,771,832
Ensembl chr 7:115,761,696...115,771,837
G
Cyp3a2
cytochrome P450, family 3, subfamily a, polypeptide 2
multiple interactions
ISO
1-(3-chlorophenyl)piperazine promotes the reaction [NR1I2 protein results in increased expression of CYP3A4 mRNA]; N-Methyl-3,4-methylenedioxyamphetamine inhibits the reaction [1-(3-chlorophenyl)piperazine promotes the reaction [NR1I2 protein results in increased expression of CYP3A4 mRNA]]
CTD
PMID:21402137
NCBI chr12:14,321,771...14,343,886
Ensembl chr12:14,321,771...14,343,857
G
Fos
Fos proto-oncogene, AP-1 transcription factor subunit
increases expression multiple interactions
EXP ISO
1-(3-chlorophenyl)piperazine results in increased expression of FOS protein 8-(5-(5-amino-2,4-dimethoxyphenyl)-5-oxopentyl)-1,3,8-triazaspiro(4.5)decane-2,4-dione inhibits the reaction [1-(3-chlorophenyl)piperazine results in increased expression of FOS protein]
CTD
PMID:11298663 PMID:28186389
NCBI chr 6:110,852,188...110,855,054
Ensembl chr 6:110,852,190...110,855,598
G
Gabbr2
gamma-aminobutyric acid type B receptor subunit 2
multiple interactions
ISO
1-(3-chlorophenyl)piperazine affects the reaction [gamma-Aminobutyric Acid results in increased activity of [GABRA1 protein co-treated with GABBR2 protein co-treated with GABRG2 protein]]
CTD
PMID:21729720
NCBI chr 5:65,743,073...66,083,695
Ensembl chr 5:65,743,073...66,083,695
G
Gabra1
gamma-aminobutyric acid type A receptor subunit alpha 1
multiple interactions
ISO
1-(3-chlorophenyl)piperazine affects the reaction [gamma-Aminobutyric Acid results in increased activity of [GABRA1 protein co-treated with GABBR2 protein co-treated with GABRG2 protein]]; 1-(3-chlorophenyl)piperazine inhibits the reaction [gamma-Aminobutyric Acid results in increased activity of [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein]]; 1-(3-chlorophenyl)piperazine promotes the reaction [3,4-Methylenedioxyamphetamine results in decreased activity of [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein]]; 1-(3-chlorophenyl)piperazine promotes the reaction [Cocaine results in decreased activity of [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein]]; 1-(3-chlorophenyl)piperazine results in decreased activity of [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein]; 3,4-Methylenedioxyamphetamine promotes the reaction [1-(3-chlorophenyl)piperazine results in decreased activity of [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein]]; Cocaine promotes the reaction [1-(3-chlorophenyl)piperazine results in decreased activity of [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein]]
CTD
PMID:21729720 PMID:23266428 PMID:26344803
NCBI chr10:27,096,731...27,152,563
Ensembl chr10:27,096,740...27,152,442
G
Gabrb2
gamma-aminobutyric acid type A receptor subunit beta 2
multiple interactions
ISO
1-(3-chlorophenyl)piperazine inhibits the reaction [gamma-Aminobutyric Acid results in increased activity of [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein]]; 1-(3-chlorophenyl)piperazine promotes the reaction [3,4-Methylenedioxyamphetamine results in decreased activity of [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein]]; 1-(3-chlorophenyl)piperazine promotes the reaction [Cocaine results in decreased activity of [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein]]; 1-(3-chlorophenyl)piperazine results in decreased activity of [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein]; 3,4-Methylenedioxyamphetamine promotes the reaction [1-(3-chlorophenyl)piperazine results in decreased activity of [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein]]; Cocaine promotes the reaction [1-(3-chlorophenyl)piperazine results in decreased activity of [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein]]
CTD
PMID:23266428 PMID:26344803
NCBI chr10:27,438,127...27,657,680
Ensembl chr10:27,438,238...27,655,171
G
Gabrg2
gamma-aminobutyric acid type A receptor subunit gamma 2
multiple interactions
ISO
1-(3-chlorophenyl)piperazine affects the reaction [gamma-Aminobutyric Acid results in increased activity of [GABRA1 protein co-treated with GABBR2 protein co-treated with GABRG2 protein]]; 1-(3-chlorophenyl)piperazine inhibits the reaction [gamma-Aminobutyric Acid results in increased activity of [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein]]; 1-(3-chlorophenyl)piperazine promotes the reaction [3,4-Methylenedioxyamphetamine results in decreased activity of [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein]]; 1-(3-chlorophenyl)piperazine promotes the reaction [Cocaine results in decreased activity of [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein]]; 1-(3-chlorophenyl)piperazine results in decreased activity of [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein]; 3,4-Methylenedioxyamphetamine promotes the reaction [1-(3-chlorophenyl)piperazine results in decreased activity of [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein]]; Cocaine promotes the reaction [1-(3-chlorophenyl)piperazine results in decreased activity of [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein]]
CTD
PMID:21729720 PMID:23266428 PMID:26344803
NCBI chr10:26,876,926...26,965,523
Ensembl chr10:26,876,926...26,965,523
G
Htr1a
5-hydroxytryptamine receptor 1A
multiple interactions
EXP
[1-((4-fluorobenzoylamino)ethyl)-4-(7-methoxy-1-naphthyl)piperazine hydrochloride binds to and results in increased activity of HTR1A protein] which results in decreased susceptibility to 1-(3-chlorophenyl)piperazine; [8-Hydroxy-2-(di-n-propylamino)tetralin binds to and results in increased activity of HTR1A protein] which results in decreased susceptibility to 1-(3-chlorophenyl)piperazine
CTD
PMID:8539317
NCBI chr 2:38,427,169...38,431,733
Ensembl chr 2:38,427,083...38,540,760
G
Htr2a
5-hydroxytryptamine receptor 2A
increases response to substance multiple interactions affects response to substance
ISO
HTR2A gene SNP results in increased susceptibility to 1-(3-chlorophenyl)piperazine 1-(3-chlorophenyl)piperazine binds to and results in increased activity of HTR2A protein HTR2A protein affects the susceptibility to 1-(3-chlorophenyl)piperazine
CTD
PMID:16314884
NCBI chr15:56,360,647...56,428,703
Ensembl chr15:56,359,596...56,431,619
G
Htr2c
5-hydroxytryptamine receptor 2C
multiple interactions
ISO
[1-(3-chlorophenyl)piperazine binds to and results in increased activity of HTR2C protein] which results in increased susceptibility to Cocaine
CTD
PMID:10541732
NCBI chr X:115,453,190...115,682,325
Ensembl chr X:115,452,842...115,682,324
G
Lep
leptin
multiple interactions
ISO
1-(3-chlorophenyl)piperazine inhibits the reaction [Corticosterone results in decreased expression of LEP protein]; 8-(5-(5-amino-2,4-dimethoxyphenyl)-5-oxopentyl)-1,3,8-triazaspiro(4.5)decane-2,4-dione inhibits the reaction [1-(3-chlorophenyl)piperazine inhibits the reaction [Corticosterone results in decreased expression of LEP protein]]
CTD
PMID:28186389
NCBI chr 4:58,626,529...58,640,663
Ensembl chr 4:58,626,523...58,640,661
G
Nr1i2
nuclear receptor subfamily 1, group I, member 2
multiple interactions
ISO
1-(3-chlorophenyl)piperazine promotes the reaction [NR1I2 protein results in increased expression of CYP3A4 mRNA]; N-Methyl-3,4-methylenedioxyamphetamine inhibits the reaction [1-(3-chlorophenyl)piperazine promotes the reaction [NR1I2 protein results in increased expression of CYP3A4 mRNA]]
CTD
PMID:21402137
NCBI chr11:75,965,717...76,006,733
Ensembl chr11:75,965,632...76,002,380
G
Plcb1
phospholipase C beta 1
increases expression
EXP
1-(3-chlorophenyl)piperazine results in increased expression of PLCB1 mRNA; 1-(3-chlorophenyl)piperazine results in increased expression of PLCB1 protein
CTD
PMID:12527476
NCBI chr 3:142,512,765...143,224,042
Ensembl chr 3:142,513,033...143,225,646
G
Prl
prolactin
multiple interactions increases expression
ISO
Cocaine inhibits the reaction [1-(3-chlorophenyl)piperazine results in increased expression of PRL protein]
CTD
PMID:9598218 PMID:16418827
NCBI chr17:38,287,355...38,298,234
Ensembl chr17:38,288,162...38,298,217
G
Slc6a4
solute carrier family 6 member 4
affects response to substance
ISO
SLC6A4 protein affects the susceptibility to 1-(3-chlorophenyl)piperazine
CTD
PMID:25522398
NCBI chr10:62,322,688...62,357,060
Ensembl chr10:62,324,254...62,357,056
G
Aass
aminoadipate-semialdehyde synthase
decreases expression
EXP
N-benzylpiperazine results in decreased expression of AASS mRNA
CTD
PMID:26821219
NCBI chr 4:52,572,146...52,628,811
Ensembl chr 4:52,572,147...52,657,600
G
Acat2
acetyl-CoA acetyltransferase 2
increases expression
EXP
N-benzylpiperazine results in increased expression of ACAT2 mRNA
CTD
PMID:26821219
NCBI chr 1:50,100,840...50,118,886
Ensembl chr 1:50,100,817...50,135,095
G
Acsl3
acyl-CoA synthetase long-chain family member 3
increases expression
EXP
N-benzylpiperazine results in increased expression of ACSL3 mRNA
CTD
PMID:26821219
NCBI chr 9:87,563,601...87,613,078
Ensembl chr 9:87,563,601...87,613,097
G
Acsm5
acyl-CoA synthetase medium-chain family member 5
decreases expression
EXP
N-benzylpiperazine results in decreased expression of ACSM5 mRNA
CTD
PMID:26821219
NCBI chr 1:183,302,241...183,328,175
Ensembl chr 1:183,294,105...183,329,925
G
B4galt1
beta-1,4-galactosyltransferase 1
increases expression
EXP
N-benzylpiperazine results in increased expression of B4GALT1 mRNA
CTD
PMID:26821219
NCBI chr 5:60,731,601...60,778,456
Ensembl chr 5:60,731,602...60,778,445
G
Bbox1
gamma-butyrobetaine hydroxylase 1
decreases expression
EXP
N-benzylpiperazine results in decreased expression of BBOX1 mRNA
CTD
PMID:26821219
NCBI chr 3:117,277,226...117,326,383
Ensembl chr 3:117,277,226...117,326,064
G
Bhmt
betaine-homocysteine S-methyltransferase
decreases expression
EXP
N-benzylpiperazine results in decreased expression of BHMT mRNA
CTD
PMID:26821219
NCBI chr 2:26,594,852...26,614,429
Ensembl chr 2:26,594,854...26,614,715
G
Bhmt2
betaine-homocysteine S-methyltransferase 2
decreases expression
EXP
N-benzylpiperazine results in decreased expression of BHMT2 mRNA
CTD
PMID:26821219
NCBI chr 2:26,630,502...26,647,450
Ensembl chr 2:26,630,510...26,651,326
G
Cables1
Cdk5 and Abl enzyme substrate 1
increases expression
EXP
N-benzylpiperazine results in increased expression of CABLES1 mRNA
CTD
PMID:26821219
NCBI chr18:3,349,681...3,455,956
Ensembl chr18:3,351,652...3,455,956
G
Cat
catalase
increases activity
ISO
1-benzylpiperazine results in increased activity of CAT protein
CTD
PMID:28874085
NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:110,297,342...110,329,526
G
Csrp3
cysteine and glycine rich protein 3
increases expression
EXP
N-benzylpiperazine results in increased expression of CSRP3 mRNA
CTD
PMID:26821219
NCBI chr 1:107,664,338...107,682,916
Ensembl chr 1:107,664,338...107,682,916
G
Cyp2a1
cytochrome P450, family 2, subfamily a, polypeptide 1
decreases expression
EXP
N-benzylpiperazine results in decreased expression of CYP2A1 mRNA
CTD
PMID:26821219
NCBI chr 1:91,359,278...91,372,554
Ensembl chr 1:91,359,272...91,389,730
G
Cyp2e1
cytochrome P450, family 2, subfamily e, polypeptide 1
decreases expression
EXP
N-benzylpiperazine results in decreased expression of CYP2E1 mRNA
CTD
PMID:26821219
NCBI chr 1:205,269,967...205,280,365
Ensembl chr 1:205,267,505...205,293,495
G
Cyp4a1
cytochrome P450, family 4, subfamily a, polypeptide 1
decreases expression
EXP
N-benzylpiperazine results in decreased expression of CYP4A1 mRNA
CTD
PMID:26821219
NCBI chr 5:134,360,096...134,374,233
Ensembl chr 5:134,360,111...134,374,231
G
Cyp4a3
cytochrome P450, family 4, subfamily a, polypeptide 3
decreases expression
EXP
N-benzylpiperazine results in decreased expression of CYP4A3 mRNA
CTD
PMID:26821219
NCBI chr 5:134,334,396...134,352,268
Ensembl chr 5:134,334,701...134,352,236
G
Cyp4f4
cytochrome P450, family 4, subfamily f, polypeptide 4
decreases expression
EXP
N-benzylpiperazine results in decreased expression of CYP4F4 mRNA
CTD
PMID:26821219
NCBI chr 7:12,367,711...12,384,010
Ensembl chr 7:12,367,660...12,384,010
G
Cyp51
cytochrome P450, family 51
increases expression
EXP
N-benzylpiperazine results in increased expression of CYP51 mRNA
CTD
PMID:26821219
NCBI chr 4:30,991,693...31,010,147
Ensembl chr 4:30,991,613...31,010,450
G
Cyp8b1
cytochrome P450 family 8 subfamily B member 1
decreases expression
EXP
N-benzylpiperazine results in decreased expression of CYP8B1 mRNA
CTD
PMID:26821219
NCBI chr 8:130,455,622...130,457,592
Ensembl chr 8:130,442,503...130,457,689
G
Dpyd
dihydropyrimidine dehydrogenase
decreases expression
EXP
N-benzylpiperazine results in decreased expression of DPYD mRNA
CTD
PMID:26821219
NCBI chr 2:209,293,902...210,159,777
Ensembl chr 2:209,293,929...210,159,778
G
Dpysl2
dihydropyrimidinase-like 2
increases expression
EXP
N-benzylpiperazine results in increased expression of DPYSL2 mRNA
CTD
PMID:26821219
NCBI chr15:45,181,041...45,287,065
Ensembl chr15:45,181,041...45,287,065
G
Eepd1
endonuclease/exonuclease/phosphatase family domain containing 1
increases expression
EXP
N-benzylpiperazine results in increased expression of EEPD1 mRNA
CTD
PMID:26821219
NCBI chr 8:32,233,834...32,340,148
Ensembl chr 8:32,233,070...32,340,147
G
Ehhadh
enoyl-CoA hydratase and 3-hydroxyacyl CoA dehydrogenase
decreases expression
EXP
N-benzylpiperazine results in decreased expression of EHHADH mRNA
CTD
PMID:26821219
NCBI chr11:92,746,409...92,779,647
Ensembl chr11:92,746,420...92,779,662
G
Fads1
fatty acid desaturase 1
increases expression
EXP
N-benzylpiperazine results in increased expression of FADS1 mRNA
CTD
PMID:26821219
NCBI chr 1:216,252,605...216,267,618
Ensembl chr 1:216,252,602...216,267,615
G
Fasn
fatty acid synthase
increases expression
EXP
N-benzylpiperazine results in increased expression of FASN mRNA
CTD
PMID:26821219
NCBI chr10:106,570,415...106,588,581
Ensembl chr10:106,570,413...106,588,583
G
Fbp1
fructose-bisphosphatase 1
decreases expression
EXP
N-benzylpiperazine results in decreased expression of FBP1 mRNA
CTD
PMID:26821219
NCBI chr17:2,212,941...2,235,749
Ensembl chr17:2,213,492...2,235,746
G
Fdft1
farnesyl diphosphate farnesyl transferase 1
increases expression
EXP
N-benzylpiperazine results in increased expression of FDFT1 mRNA
CTD
PMID:26821219
NCBI chr15:41,588,114...41,616,168
Ensembl chr15:41,588,117...41,616,168
G
Fdps
farnesyl diphosphate synthase
increases expression
EXP
N-benzylpiperazine results in increased expression of FDPS mRNA
CTD
PMID:26821219
NCBI chr 2:176,795,192...176,804,816
Ensembl chr 2:176,795,192...176,807,136
G
Flcn
folliculin
increases expression
EXP
N-benzylpiperazine results in increased expression of FLCN mRNA
CTD
PMID:26821219
NCBI chr10:45,088,164...45,107,581
Ensembl chr10:45,088,167...45,107,309
G
Ftcd
formimidoyltransferase cyclodeaminase
decreases expression
EXP
N-benzylpiperazine results in decreased expression of FTCD mRNA
CTD
PMID:26821219
NCBI chr20:12,054,710...12,068,219
Ensembl chr20:12,054,711...12,068,237
G
G6pc1
glucose-6-phosphatase catalytic subunit 1
decreases expression
EXP
N-benzylpiperazine results in decreased expression of G6PC1 mRNA
CTD
PMID:26821219
NCBI chr10:86,807,659...86,819,023
Ensembl chr10:86,757,899...86,818,033
G
Gabra1
gamma-aminobutyric acid type A receptor subunit alpha 1
multiple interactions
ISO
1-benzylpiperazine analog inhibits the reaction [gamma-Aminobutyric Acid results in increased activity of [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein]]; 1-benzylpiperazine inhibits the reaction [gamma-Aminobutyric Acid results in increased activity of [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein]]
CTD
PMID:26344803
NCBI chr10:27,096,731...27,152,563
Ensembl chr10:27,096,740...27,152,442
G
Gabrb2
gamma-aminobutyric acid type A receptor subunit beta 2
multiple interactions
ISO
1-benzylpiperazine analog inhibits the reaction [gamma-Aminobutyric Acid results in increased activity of [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein]]; 1-benzylpiperazine inhibits the reaction [gamma-Aminobutyric Acid results in increased activity of [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein]]
CTD
PMID:26344803
NCBI chr10:27,438,127...27,657,680
Ensembl chr10:27,438,238...27,655,171
G
Gabrg2
gamma-aminobutyric acid type A receptor subunit gamma 2
multiple interactions
ISO
1-benzylpiperazine analog inhibits the reaction [gamma-Aminobutyric Acid results in increased activity of [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein]]; 1-benzylpiperazine inhibits the reaction [gamma-Aminobutyric Acid results in increased activity of [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein]]
CTD
PMID:26344803
NCBI chr10:26,876,926...26,965,523
Ensembl chr10:26,876,926...26,965,523
G
Gpnmb
glycoprotein nmb
increases expression
EXP
N-benzylpiperazine results in increased expression of GPNMB mRNA
CTD
PMID:26821219
NCBI chr 4:79,341,128...79,362,366
Ensembl chr 4:79,341,021...79,380,240
G
Gstt3
glutathione S-transferase, theta 3
decreases expression
EXP
N-benzylpiperazine results in decreased expression of GSTT3 mRNA
CTD
PMID:26821219
NCBI chr20:12,873,618...12,881,974
Ensembl chr20:12,874,374...12,881,973
G
Gys2
glycogen synthase 2
decreases expression
EXP
N-benzylpiperazine results in decreased expression of GYS2 mRNA
CTD
PMID:26821219
NCBI chr 4:177,096,063...177,137,236
Ensembl chr 4:177,096,063...177,137,236
G
Hao2
hydroxyacid oxidase 2
decreases expression
EXP
N-benzylpiperazine results in decreased expression of HAO2 mRNA
CTD
PMID:26821219
NCBI chr 2:188,888,848...188,921,567
Ensembl chr 2:188,889,212...188,913,133
G
Hmgcr
3-hydroxy-3-methylglutaryl-CoA reductase
increases expression
EXP
N-benzylpiperazine results in increased expression of HMGCR mRNA
CTD
PMID:26821219
NCBI chr 2:29,732,163...29,754,276
Ensembl chr 2:29,720,553...29,754,533
G
Hmgcs1
3-hydroxy-3-methylglutaryl-CoA synthase 1
increases expression
EXP
N-benzylpiperazine results in increased expression of HMGCS1 mRNA
CTD
PMID:26821219
NCBI chr 2:53,379,457...53,399,807
Ensembl chr 2:53,382,643...53,399,802
G
Hmgcs2
3-hydroxy-3-methylglutaryl-CoA synthase 2
decreases expression
EXP
N-benzylpiperazine results in decreased expression of HMGCS2 mRNA
CTD
PMID:26821219
NCBI chr 2:188,564,348...188,590,872
Ensembl chr 2:188,547,767...188,592,242
G
Idi1
isopentenyl-diphosphate delta isomerase 1
increases expression
EXP
N-benzylpiperazine results in increased expression of IDI1 mRNA
CTD
PMID:26821219
NCBI chr17:66,539,761...66,547,524
Ensembl chr17:66,539,763...66,547,524
G
Il1r2
interleukin 1 receptor type 2
increases expression
EXP
N-benzylpiperazine results in increased expression of IL1R2 mRNA
CTD
PMID:26821219
NCBI chr 9:49,879,928...49,920,374
Ensembl chr 9:49,877,266...49,920,374
G
Insig1
insulin induced gene 1
increases expression
EXP
N-benzylpiperazine results in increased expression of INSIG1 mRNA
CTD
PMID:26821219
NCBI chr 4:8,049,339...8,057,812
Ensembl chr 4:8,049,556...8,057,778
G
Kynu
kynureninase
decreases expression
EXP
N-benzylpiperazine results in decreased expression of KYNU mRNA
CTD
PMID:26821219
NCBI chr 3:48,188,286...48,338,996
Ensembl chr 3:48,188,182...48,339,014
G
Mcm6
minichromosome maintenance complex component 6
increases expression
EXP
N-benzylpiperazine results in increased expression of MCM6 mRNA
CTD
PMID:26821219
NCBI chr13:42,379,161...42,404,352
Ensembl chr13:42,379,162...42,465,467
G
Mdh1
malate dehydrogenase 1
decreases expression
EXP
N-benzylpiperazine results in decreased expression of MDH1 mRNA
CTD
PMID:26821219
NCBI chr14:99,831,934...99,847,227
Ensembl chr14:99,831,615...99,847,232
G
Msmo1
methylsterol monooxygenase 1
increases expression
EXP
N-benzylpiperazine results in increased expression of MSMO1 mRNA
CTD
PMID:26821219
NCBI chr16:29,747,113...29,764,360
Ensembl chr16:29,747,137...29,764,445
G
Ndrg1
N-myc downstream regulated 1
increases expression
EXP
N-benzylpiperazine results in increased expression of NDRG1 mRNA
CTD
PMID:26821219
NCBI chr 7:100,573,526...100,614,902
Ensembl chr 7:100,573,523...100,614,913
G
Nr1i3
nuclear receptor subfamily 1, group I, member 3
decreases expression
EXP
N-benzylpiperazine results in decreased expression of NR1I3 mRNA
CTD
PMID:26821219
NCBI chr13:86,165,327...86,170,362
Ensembl chr13:86,165,349...86,170,370
G
Nrg1
neuregulin 1
increases expression
EXP
N-benzylpiperazine results in increased expression of NRG1 mRNA
CTD
PMID:26821219
NCBI chr16:65,954,084...67,007,484
Ensembl chr16:65,953,865...66,999,849
G
Pcsk9
proprotein convertase subtilisin/kexin type 9
increases expression
EXP
N-benzylpiperazine results in increased expression of PCSK9 mRNA
CTD
PMID:26821219
NCBI chr 5:126,440,102...126,462,507
Ensembl chr 5:126,440,102...126,462,507
G
Pdp2
pyruvate dehydrogenase phosphatase catalytic subunit 2
increases expression
EXP
N-benzylpiperazine results in increased expression of PDP2 mRNA
CTD
PMID:26821219
NCBI chr19:392,858...400,529
Ensembl chr19:392,183...400,902
G
Pea15
proliferation and apoptosis adaptor protein 15
increases expression
EXP
N-benzylpiperazine results in increased expression of PEA15 mRNA
CTD
PMID:26821219
NCBI chr13:87,190,189...87,199,811
Ensembl chr13:87,187,295...87,199,859
G
Pgr
progesterone receptor
increases expression
ISO
1-benzylpiperazine results in increased expression of PGR mRNA
CTD
PMID:23026265
NCBI chr 8:14,354,398...14,413,271
Ensembl chr 8:14,354,398...14,413,271
G
Rab30
RAB30, member RAS oncogene family
increases expression
EXP
N-benzylpiperazine results in increased expression of RAB30 mRNA
CTD
PMID:26821219
NCBI chr 1:156,216,137...156,310,778
Ensembl chr 1:156,216,137...156,310,778
G
Rab32
RAB32, member RAS oncogene family
increases expression
EXP
N-benzylpiperazine results in increased expression of RAB32 mRNA
CTD
PMID:26821219
NCBI chr 1:6,766,448...6,781,258
Ensembl chr 1:6,766,455...6,781,258
G
Rhoq
ras homolog family member Q
increases expression
EXP
N-benzylpiperazine results in increased expression of RHOQ mRNA
CTD
PMID:26821219
NCBI chr 6:13,368,499...13,403,929
Ensembl chr 1:115,757,909...115,759,467
G
Rnf145
ring finger protein 145
increases expression
EXP
N-benzylpiperazine results in increased expression of RNF145 mRNA
CTD
PMID:26821219
NCBI chr10:29,507,779...29,552,153
Ensembl chr10:29,507,772...29,552,151
G
Rragd
Ras-related GTP binding D
increases expression
EXP
N-benzylpiperazine results in increased expression of RRAGD mRNA
CTD
PMID:26821219
NCBI chr 5:52,170,234...52,205,700
Ensembl chr 5:52,169,783...52,209,000
G
Slc10a1
solute carrier family 10 member 1
decreases expression
EXP
N-benzylpiperazine results in decreased expression of SLC10A1 mRNA
CTD
PMID:26821219
NCBI chr 6:106,344,319...106,357,944
Ensembl chr 6:106,344,319...106,357,944
G
Slc38a7
solute carrier family 38, member 7
increases expression
EXP
N-benzylpiperazine results in increased expression of SLC38A7 mRNA
CTD
PMID:26821219
NCBI chr19:9,215,336...9,231,592
Ensembl chr19:9,215,383...9,231,589
G
Slc39a10
solute carrier family 39 member 10
increases expression
EXP
N-benzylpiperazine results in increased expression of SLC39A10 mRNA
CTD
PMID:26821219
NCBI chr 9:62,331,281...62,454,754
Ensembl chr 9:62,370,598...62,454,747
G
Slc6a6
solute carrier family 6 member 6
increases expression
EXP
N-benzylpiperazine results in increased expression of SLC6A6 mRNA
CTD
PMID:26821219
NCBI chr 4:125,752,340...125,826,033
Ensembl chr 4:125,752,372...125,826,032
G
Slco1a4
solute carrier organic anion transporter family, member 1a4
decreases expression
EXP
N-benzylpiperazine results in decreased expression of SLCO1A2 mRNA
CTD
PMID:26821219
NCBI chr 4:176,441,104...176,495,846
Ensembl chr 4:176,441,104...176,495,816
G
Sod1
superoxide dismutase 1
increases activity
ISO
1-benzylpiperazine results in increased activity of SOD1 protein
CTD
PMID:28874085
NCBI chr11:42,942,742...42,948,399
Ensembl chr11:42,942,678...42,948,399
G
Sptlc2
serine palmitoyltransferase, long chain base subunit 2
increases expression
EXP
N-benzylpiperazine results in increased expression of SPTLC2 mRNA
CTD
PMID:26821219
NCBI chr 6:112,679,623...112,762,470
Ensembl chr 6:112,679,623...112,762,640
G
Sqle
squalene epoxidase
increases expression
EXP
N-benzylpiperazine results in increased expression of SQLE mRNA
CTD
PMID:26821219
NCBI chr 7:92,758,175...92,773,049
Ensembl chr 7:92,757,409...92,773,050
G
Srebf1
sterol regulatory element binding transcription factor 1
increases expression
EXP
N-benzylpiperazine results in increased expression of SREBF1 mRNA
CTD
PMID:26821219
NCBI chr10:45,507,152...45,529,164
Ensembl chr10:45,507,152...45,529,164
G
Stard4
StAR-related lipid transfer domain containing 4
increases expression
EXP
N-benzylpiperazine results in increased expression of STARD4 mRNA
CTD
PMID:26821219
NCBI chr18:25,088,831...25,104,172
Ensembl chr18:25,091,255...25,104,172
G
Stk10
serine/threonine kinase 10
increases expression
EXP
N-benzylpiperazine results in increased expression of STK10 mRNA
CTD
PMID:26821219
NCBI chr10:17,622,149...17,716,337
Ensembl chr10:17,622,162...17,716,332
G
Stx3
syntaxin 3
increases expression
EXP
N-benzylpiperazine results in increased expression of STX3 mRNA
CTD
PMID:26821219
NCBI chr 1:217,940,697...218,114,865
Ensembl chr 1:217,909,169...218,110,466
G
Sult2a6
sulfotransferase family 2A, dehydroepiandrosterone (DHEA)-preferring, member 6
decreases expression
EXP
N-benzylpiperazine results in decreased expression of SULT2A6 mRNA
CTD
PMID:26821219
NCBI chr 1:84,046,685...84,097,808
Ensembl chr 1:84,046,685...84,097,808
G
Tecpr1
tectonin beta-propeller repeat containing 1
increases expression
EXP
N-benzylpiperazine results in increased expression of TECPR1 mRNA
CTD
PMID:26821219
NCBI chr12:15,504,456...15,534,541
Ensembl chr12:15,505,343...15,534,116
G
Tff1
trefoil factor 1
increases expression
ISO
1-benzylpiperazine results in increased expression of TFF1 mRNA
CTD
PMID:23026265
NCBI chr20:9,237,095...9,240,956
Ensembl chr20:9,237,095...9,240,956
G
Tm4sf4
transmembrane 4 L six family member 4
decreases expression
EXP
N-benzylpiperazine results in decreased expression of TM4SF4 mRNA
CTD
PMID:26821219
NCBI chr 2:143,720,220...143,771,283
Ensembl chr 2:143,720,267...143,771,227
G
Trim59
tripartite motif-containing 59
increases expression
EXP
N-benzylpiperazine results in increased expression of TRIM59 mRNA
CTD
PMID:26821219
NCBI chr 2:155,579,183...155,593,450
Ensembl chr 2:155,567,115...155,598,645
G
Ttc36
tetratricopeptide repeat domain 36
decreases expression
EXP
N-benzylpiperazine results in decreased expression of TTC36 mRNA
CTD
PMID:26821219
NCBI chr 8:54,009,522...54,013,129
Ensembl chr 8:54,009,522...54,013,129
G
Urad
ureidoimidazoline (2-oxo-4-hydroxy-4-carboxy-5-) decarboxylase
decreases expression
EXP
N-benzylpiperazine results in decreased expression of URAD mRNA
CTD
PMID:26821219
NCBI chr12:12,745,388...12,755,034
Ensembl chr12:12,745,450...12,755,749
G
Usp2
ubiquitin specific peptidase 2
decreases expression
EXP
N-benzylpiperazine results in decreased expression of USP2 mRNA
CTD
PMID:26821219
NCBI chr 8:53,308,264...53,336,800
Ensembl chr 8:53,308,303...53,336,794
G
Wfdc2
WAP four-disulfide core domain 2
increases expression
EXP
N-benzylpiperazine results in increased expression of WFDC2 mRNA
CTD
PMID:26821219
NCBI chr 3:173,706,091...173,735,055
Ensembl chr 3:173,706,460...173,712,161
G
Htr3a
5-hydroxytryptamine receptor 3A
multiple interactions
ISO
2-methyl-5-HT binds to and results in increased activity of HTR3A protein
CTD
PMID:15802305
NCBI chr 8:58,138,514...58,150,960
Ensembl chr 8:58,138,226...58,150,884
G
Il1b
interleukin 1 beta
multiple interactions
ISO
2-methyl-5-HT promotes the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]
CTD
PMID:15802305
NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:137,030,205...137,036,601
G
Il6
interleukin 6
multiple interactions
ISO
2-methyl-5-HT promotes the reaction [Lipopolysaccharides results in increased secretion of IL6 protein]
CTD
PMID:15802305
NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,889,999...5,894,610
G
Calca
calcitonin-related polypeptide alpha
decreases expression
EXP
CGS 12066B results in decreased expression of CALCA mRNA
CTD
PMID:14715155
NCBI chr 1:178,312,636...178,317,588
Ensembl chr 1:178,312,638...178,317,529
G
Htr1b
5-hydroxytryptamine receptor 1B
affects binding
EXP
CGS 12066B binds to HTR1B protein
CTD
PMID:11888550
NCBI chr 8:91,395,405...91,414,815
Ensembl chr 8:91,052,432...91,418,583
G
Htr1a
5-hydroxytryptamine receptor 1A
multiple interactions
EXP
[1-((4-fluorobenzoylamino)ethyl)-4-(7-methoxy-1-naphthyl)piperazine hydrochloride binds to and results in increased activity of HTR1A protein] which results in decreased susceptibility to 1-(3-chlorophenyl)piperazine; [1-((4-fluorobenzoylamino)ethyl)-4-(7-methoxy-1-naphthyl)piperazine hydrochloride binds to and results in increased activity of HTR1A protein] which results in decreased susceptibility to Apomorphine; [1-((4-fluorobenzoylamino)ethyl)-4-(7-methoxy-1-naphthyl)piperazine hydrochloride binds to and results in increased activity of HTR1A protein] which results in decreased susceptibility to Physostigmine; tertatolol inhibits the reaction [[1-((4-fluorobenzoylamino)ethyl)-4-(7-methoxy-1-naphthyl)piperazine hydrochloride binds to and results in increased activity of HTR1A protein] which results in decreased susceptibility to Apomorphine]; tertatolol inhibits the reaction [[1-((4-fluorobenzoylamino)ethyl)-4-(7-methoxy-1-naphthyl)piperazine hydrochloride binds to and results in increased activity of HTR1A protein] which results in decreased susceptibility to Physostigmine]
CTD
PMID:8539317
NCBI chr 2:38,427,169...38,431,733
Ensembl chr 2:38,427,083...38,540,760
G
Cyp2d4
cytochrome P450, family 2, subfamily d, polypeptide 4
multiple interactions
ISO
CYP2D6 protein binds to and results in decreased methylation of 5-Methoxytryptamine
CTD
PMID:12777961
NCBI chr 7:115,762,662...115,771,832
Ensembl chr 7:115,761,696...115,771,837
G
Htr7
5-hydroxytryptamine receptor 7
multiple interactions
ISO
[5-Methoxytryptamine binds to and results in increased activity of HTR7 protein] which results in increased abundance of Cyclic AMP
CTD
PMID:14578406
NCBI chr 1:243,049,064...243,173,636
Ensembl chr 1:243,049,081...243,173,230
G
Kmo
kynurenine 3-monooxygenase
increases expression
EXP
5-Methoxytryptamine results in increased expression of KMO mRNA
CTD
PMID:32243540
NCBI chr13:90,089,340...90,121,108
Ensembl chr13:90,089,463...90,125,151
G
Ppp1r1b
protein phosphatase 1, regulatory (inhibitor) subunit 1B
decreases phosphorylation increases phosphorylation
ISO
5-Methoxytryptamine results in decreased phosphorylation of PPP1R1B protein 5-Methoxytryptamine results in increased phosphorylation of PPP1R1B protein
CTD
PMID:11880652
NCBI chr10:83,843,948...83,853,063
Ensembl chr10:83,844,036...83,853,063
G
Sod2
superoxide dismutase 2
decreases expression
EXP
5-Methoxytryptamine results in decreased expression of SOD2 mRNA
CTD
PMID:32243540
NCBI chr 1:50,043,323...50,050,168
Ensembl chr 1:50,043,325...50,050,168
G
Taar1
trace-amine-associated receptor 1
increases activity multiple interactions
ISO
5-Methoxytryptamine results in increased activity of TAAR1 protein [5-Methoxytryptamine results in increased activity of TAAR1 protein] which results in increased abundance of Cyclic AMP
CTD
PMID:19725810
NCBI chr 1:23,336,978...23,337,976
Ensembl chr 1:23,335,165...23,353,981
G
Tph1
tryptophan hydroxylase 1
decreases expression
EXP
5-Methoxytryptamine results in decreased expression of TPH1 mRNA
CTD
PMID:32243540
NCBI chr 1:106,293,695...106,314,628
Ensembl chr 1:106,085,953...106,312,484
G
Cyp1a2
cytochrome P450, family 1, subfamily a, polypeptide 2
multiple interactions decreases activity
ISO
[5-methyltryptamine analog results in decreased activity of CYP1A2 protein] which results in decreased metabolism of Phenacetin
CTD
PMID:26599973
NCBI chr 8:66,971,261...66,978,149
Ensembl chr 8:66,971,261...66,978,149
G
Cyp2b3
cytochrome P450, family 2, subfamily b, polypeptide 3
multiple interactions decreases activity
ISO
[5-methyltryptamine analog results in decreased activity of CYP2B6 protein] which results in decreased metabolism of Bupropion
CTD
PMID:26599973
NCBI chr 1:90,780,468...90,859,852
G
Cyp2c6
cytochrome P450, family 2, subfamily C, polypeptide 6
decreases activity multiple interactions
ISO
5-methyltryptamine analog results in decreased activity of CYP2C19 protein [5-methyltryptamine analog results in decreased activity of CYP2C19 protein] which results in decreased metabolism of Omeprazole
CTD
PMID:26599973
NCBI chr 1:247,879,058...247,916,804
Ensembl chr 1:247,879,078...247,916,798
G
Cyp2d4
cytochrome P450, family 2, subfamily d, polypeptide 4
multiple interactions decreases activity
ISO
[5-methyltryptamine analog results in decreased activity of CYP2D6 protein] which results in decreased metabolism of Dextromethorphan
CTD
PMID:26599973
NCBI chr 7:115,762,662...115,771,832
Ensembl chr 7:115,761,696...115,771,837
G
Cyp2e1
cytochrome P450, family 2, subfamily e, polypeptide 1
decreases activity multiple interactions
ISO
5-methyltryptamine analog results in decreased activity of CYP2E1 protein [5-methyltryptamine analog results in decreased activity of CYP2E1 protein] which results in decreased metabolism of Chlorzoxazone
CTD
PMID:26599973
NCBI chr 1:205,269,967...205,280,365
Ensembl chr 1:205,267,505...205,293,495
G
Maoa
monoamine oxidase A
decreases activity
ISO
5-methyltryptamine results in decreased activity of MAOA protein
CTD
PMID:28302559
NCBI chr X:8,615,239...8,681,372
Ensembl chr X:8,615,239...8,682,631
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
decreases methylation increases metabolic processing increases hydroxylation
ISO
CYP1A1 protein results in decreased methylation of almotriptan CYP1A1 protein results in increased metabolism of almotriptan CYP1A1 protein results in increased hydroxylation of almotriptan
CTD
PMID:12642466
NCBI chr 8:66,991,940...66,998,014
Ensembl chr 8:66,991,970...66,998,012
G
Cyp1a2
cytochrome P450, family 1, subfamily a, polypeptide 2
decreases methylation
ISO
CYP1A2 protein results in decreased methylation of almotriptan
CTD
PMID:12642466
NCBI chr 8:66,971,261...66,978,149
Ensembl chr 8:66,971,261...66,978,149
G
Cyp2c6
cytochrome P450, family 2, subfamily C, polypeptide 6
decreases methylation
ISO
CYP2C19 protein results in decreased methylation of almotriptan
CTD
PMID:12642466
NCBI chr 1:247,879,058...247,916,804
Ensembl chr 1:247,879,078...247,916,798
G
Cyp2c79
cytochrome P450, family 2, subfamily c, polypeptide 79
decreases methylation
ISO
CYP2C8 protein results in decreased methylation of almotriptan
CTD
PMID:12642466
G
Cyp2d4
cytochrome P450, family 2, subfamily d, polypeptide 4
decreases methylation increases hydroxylation
ISO
CYP2D6 protein results in decreased methylation of almotriptan CYP2D6 protein results in increased hydroxylation of almotriptan
CTD
PMID:12642466
NCBI chr 7:115,762,662...115,771,832
Ensembl chr 7:115,761,696...115,771,837
G
Cyp3a2
cytochrome P450, family 3, subfamily a, polypeptide 2
increases hydroxylation decreases methylation
ISO
CYP3A4 protein results in increased hydroxylation of almotriptan CYP3A4 protein results in decreased methylation of almotriptan
CTD
PMID:12642466
NCBI chr12:14,321,771...14,343,886
Ensembl chr12:14,321,771...14,343,857
G
Fmo3
flavin containing dimethylaniline monoxygenase 3
increases oxidation
ISO
FMO3 protein results in increased oxidation of almotriptan
CTD
PMID:12642466
NCBI chr13:77,838,899...77,868,869
Ensembl chr13:77,842,602...77,861,256
G
Htr1b
5-hydroxytryptamine receptor 1B
multiple interactions
ISO
HTR1B affects the reaction [almotriptan inhibits the reaction [Colforsin results in increased abundance of Cyclic AMP]]
CTD
PMID:11134654
NCBI chr 8:91,395,405...91,414,815
Ensembl chr 8:91,052,432...91,418,583
G
Maoa
monoamine oxidase A
increases metabolic processing
ISO
MAOA protein results in increased metabolism of almotriptan
CTD
PMID:12642466
NCBI chr X:8,615,239...8,681,372
Ensembl chr X:8,615,239...8,682,631
G
Il6
interleukin 6
multiple interactions
ISO
alpha-methylserotonin results in increased expression of and results in increased secretion of IL6 protein
CTD
PMID:11076827
NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,889,999...5,894,610
G
Acadl
acyl-CoA dehydrogenase, long chain
decreases expression
EXP
Aripiprazole results in decreased expression of ACADL mRNA
CTD
PMID:17868501
NCBI chr 9:75,783,689...75,822,077
Ensembl chr 9:75,783,689...75,822,164
G
Adora2a
adenosine A2a receptor
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of ADORA2A mRNA
CTD
PMID:31476115
NCBI chr20:13,315,270...13,332,802
Ensembl chr20:13,315,270...13,332,802
G
Arpc1b
actin related protein 2/3 complex, subunit 1B
decreases expression
EXP
Aripiprazole results in decreased expression of ARPC1B mRNA
CTD
PMID:17868501
NCBI chr12:14,595,939...14,609,501
Ensembl chr12:14,595,678...14,609,504
G
Bax
BCL2 associated X, apoptosis regulator
increases expression
ISO
Aripiprazole results in increased expression of BAX mRNA
CTD
PMID:39971107
NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:105,076,473...105,086,429
G
Bcl10
BCL10, immune signaling adaptor
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of BCL10 mRNA
CTD
PMID:31476115
NCBI chr 2:237,501,181...237,510,821
Ensembl chr 2:237,501,134...237,511,829
G
Bcl2l1
Bcl2-like 1
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of BCL2L1 mRNA
CTD
PMID:31476115
NCBI chr 3:161,713,777...161,764,844
Ensembl chr 3:161,745,540...161,764,907 Ensembl chr 1:161,745,540...161,764,907
G
Bcl6
BCL6, transcription repressor
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in decreased expression of BCL6 mRNA
CTD
PMID:31476115
NCBI chr11:90,358,753...90,382,049
Ensembl chr11:90,358,753...90,382,047
G
Bid
BH3 interacting domain death agonist
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of BID mRNA
CTD
PMID:31476115
NCBI chr 4:155,785,366...155,808,775
Ensembl chr 4:155,785,377...155,808,275
G
C1r
complement C1r
multiple interactions
ISO
Aripiprazole promotes the reaction [Ozone results in decreased expression of C1R mRNA]
CTD
PMID:31476115
NCBI chr 4:159,099,013...159,109,770
Ensembl chr 4:159,098,918...159,109,714
G
C2
complement C2
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of C2 mRNA
CTD
PMID:31476115
NCBI chr20:3,944,722...3,975,006
Ensembl chr20:3,955,776...3,981,740
G
Casp3
caspase 3
increases expression
ISO
Aripiprazole results in increased expression of CASP3 mRNA
CTD
PMID:39971107
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:52,395,540...52,413,732
G
Cbx7
chromobox 7
decreases expression increases expression
EXP
Aripiprazole results in decreased expression of CBX7 mRNA Aripiprazole results in increased expression of CBX7 mRNA
CTD
PMID:17868501
NCBI chr 7:113,341,030...113,358,716
Ensembl chr 7:113,341,030...113,358,346
G
Ccl19
C-C motif chemokine ligand 19
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of CCL19 mRNA
CTD
PMID:31476115
NCBI chr 5:61,759,220...61,761,164
Ensembl chr 5:61,759,220...61,772,022
G
Ccl2
C-C motif chemokine ligand 2
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of CCL2 mRNA
CTD
PMID:31476115
NCBI chr10:67,503,077...67,504,875
Ensembl chr10:67,503,077...67,504,875
G
Ccl20
C-C motif chemokine ligand 20
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of CCL20 mRNA
CTD
PMID:31476115
NCBI chr 9:91,837,139...91,839,736
Ensembl chr 9:91,836,946...91,839,736
G
Ccl22
C-C motif chemokine ligand 22
multiple interactions
ISO
Aripiprazole inhibits the reaction [Ozone results in increased expression of CCL22 mRNA]
CTD
PMID:31476115
NCBI chr19:10,263,589...10,270,359
Ensembl chr19:10,263,589...10,270,359
G
Ccl3
C-C motif chemokine ligand 3
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of CCL3 mRNA
CTD
PMID:31476115
NCBI chr10:68,948,889...68,950,439
Ensembl chr10:68,948,889...68,950,439
G
Ccl4
C-C motif chemokine ligand 4
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of CCL4 mRNA
CTD
PMID:31476115
NCBI chr10:68,963,893...68,965,728
Ensembl chr10:68,950,289...68,965,722
G
Ccl5
C-C motif chemokine ligand 5
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of CCL5 mRNA
CTD
PMID:31476115
NCBI chr10:68,820,330...68,824,906
Ensembl chr10:68,738,651...68,824,884
G
Ccr3
C-C motif chemokine receptor 3
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of CCR3 mRNA
CTD
PMID:31476115
NCBI chr 8:132,463,533...132,511,601
Ensembl chr 8:132,463,788...132,511,593
G
Cd274
CD274 molecule
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of CD274 mRNA
CTD
PMID:31476115
NCBI chr 1:236,526,215...236,549,956
Ensembl chr 1:236,496,463...236,549,951
G
Cd33
CD33 molecule
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of CD33 mRNA
CTD
PMID:31476115
NCBI chr 1:103,071,985...103,086,687
Ensembl chr 1:103,072,375...103,086,291
G
Cd44
CD44 molecule
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of CD44 mRNA
CTD
PMID:31476115
NCBI chr 3:109,610,824...109,699,776
Ensembl chr 3:109,612,054...109,699,424
G
Cd70
Cd70 molecule
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of CD70 mRNA
CTD
PMID:31476115
NCBI chr 9:2,093,540...2,096,692
Ensembl chr 9:2,086,848...2,096,692
G
Cd83
CD83 molecule
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of CD83 mRNA
CTD
PMID:31476115
NCBI chr17:21,093,281...21,113,223
Ensembl chr17:21,093,281...21,113,047
G
Cdh5
cadherin 5
multiple interactions
ISO
Aripiprazole inhibits the reaction [Ozone results in increased expression of CDH5 mRNA]
CTD
PMID:31476115
NCBI chr19:821,875...860,931
Ensembl chr19:822,464...860,822
G
Cdkn1a
cyclin-dependent kinase inhibitor 1A
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of CDKN1A mRNA
CTD
PMID:31476115
NCBI chr20:7,150,820...7,161,373
Ensembl chr20:7,153,958...7,164,969
G
Cebpb
CCAAT/enhancer binding protein beta
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of CEBPB mRNA
CTD
PMID:31476115
NCBI chr 3:176,817,005...176,818,436
Ensembl chr 3:176,816,859...176,838,072
G
Ces1d
carboxylesterase 1D
multiple interactions
ISO
Aripiprazole inhibits the reaction [CES1 protein results in increased hydrolysis of 4-nitrophenyl acetate]; Aripiprazole inhibits the reaction [CES1 protein results in increased hydrolysis of Methylphenidate]
CTD
PMID:20097249
NCBI chr19:30,046,494...30,085,039
Ensembl chr19:30,046,449...30,085,449
G
Cfb
complement factor B
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of CFB mRNA
CTD
PMID:31476115
NCBI chr20:3,975,271...3,981,138
Ensembl chr20:3,955,776...3,981,740
G
Cldn5
claudin 5
decreases expression
EXP
Aripiprazole results in decreased expression of CLDN5 mRNA
CTD
PMID:17868501
NCBI chr11:95,717,172...95,718,598
Ensembl chr11:95,717,176...95,719,322
G
Cnr1
cannabinoid receptor 1
increases expression
EXP
Aripiprazole results in increased expression of CNR1 mRNA
CTD
PMID:17868501
NCBI chr 5:53,204,867...53,230,396
Ensembl chr 5:53,204,260...53,239,252
G
Comt
catechol-O-methyltransferase
increases expression
EXP
Aripiprazole results in increased expression of COMT mRNA
CTD
PMID:17868501
NCBI chr11:96,072,371...96,091,956
Ensembl chr11:96,072,489...96,092,533
G
Creb1
cAMP responsive element binding protein 1
increases expression
EXP
Aripiprazole results in increased expression of CREB1 mRNA
CTD
PMID:26894264
NCBI chr 9:73,397,333...73,466,339
Ensembl chr 9:73,397,306...73,466,339
G
Creb5
cAMP responsive element binding protein 5
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of CREB5 mRNA
CTD
PMID:31476115
NCBI chr 4:83,723,587...84,124,786
Ensembl chr 4:83,723,194...84,120,793
G
Crebbp
CREB binding protein
decreases expression
EXP
Aripiprazole results in decreased expression of CREBBP mRNA
CTD
PMID:17868501
NCBI chr10:11,842,307...11,968,266
Ensembl chr10:11,822,620...11,968,266
G
Crmp1
collapsin response mediator protein 1
increases expression
EXP
Aripiprazole results in increased expression of CRMP1 mRNA
CTD
PMID:17868501
NCBI chr14:77,734,675...77,780,916
Ensembl chr14:77,734,675...77,780,916
G
Csf1
colony stimulating factor 1
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of CSF1 mRNA
CTD
PMID:31476115
NCBI chr 2:198,065,400...198,084,774
Ensembl chr 2:198,065,405...198,084,468
G
Csf2
colony stimulating factor 2
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of CSF2 mRNA
CTD
PMID:31476115
NCBI chr10:38,887,692...38,889,673
Ensembl chr10:38,887,692...38,890,031
G
Csf3
colony stimulating factor 3
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of CSF3 mRNA
CTD
PMID:31476115
NCBI chr10:84,157,485...84,159,860
Ensembl chr10:84,157,211...84,159,860
G
Cx3cl1
C-X3-C motif chemokine ligand 1
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of CX3CL1 mRNA
CTD
PMID:31476115
NCBI chr19:10,233,326...10,244,856
Ensembl chr19:10,233,329...10,242,999
G
Cxcl1
C-X-C motif chemokine ligand 1
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of CXCL1 mRNA
CTD
PMID:31476115
NCBI chr14:17,477,542...17,479,321
Ensembl chr14:17,477,549...17,479,811
G
Cxcl2
C-X-C motif chemokine ligand 2
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of CXCL2 mRNA
CTD
PMID:31476115
NCBI chr14:17,465,210...17,467,255
Ensembl chr14:17,465,242...17,467,255
G
Cxcl3
C-X-C motif chemokine ligand 3
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of CXCL1 mRNA
CTD
PMID:31476115
NCBI chr14:17,571,900...17,573,624
Ensembl chr14:17,571,900...17,573,624
G
Cxcr5
C-X-C motif chemokine receptor 5
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of CXCR5 mRNA
CTD
PMID:31476115
NCBI chr 8:53,738,878...53,756,813
Ensembl chr 8:53,740,197...53,754,816
G
Cxcr6
C-X-C motif chemokine receptor 6
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of CXCR6 mRNA
CTD
PMID:31476115
NCBI chr 8:132,311,834...132,317,001
Ensembl chr 8:132,306,600...132,322,498
G
Cybb
cytochrome b-245 beta chain
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of CYBB mRNA
CTD
PMID:31476115
NCBI chr X:16,030,596...16,065,065
Ensembl chr X:16,030,596...16,065,065
G
Cyld
CYLD lysine 63 deubiquitinase
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of CYLD mRNA
CTD
PMID:31476115
NCBI chr19:34,487,491...34,547,311
Ensembl chr19:34,488,583...34,547,118
G
Dcx
doublecortin
decreases expression
ISO
Aripiprazole results in decreased expression of DCX mRNA
CTD
PMID:39971107
NCBI chr X:112,227,455...112,370,291
Ensembl chr X:112,227,455...112,304,161
G
Ddr2
discoidin domain receptor tyrosine kinase 2
decreases expression
EXP
Aripiprazole results in decreased expression of DDR2 mRNA
CTD
PMID:17868501
NCBI chr13:84,726,412...84,851,032
Ensembl chr13:84,731,180...84,850,288
G
Ddx50
DExD-box helicase 50
increases expression
EXP
Aripiprazole results in increased expression of DDX50 mRNA
CTD
PMID:17868501
NCBI chr20:31,104,354...31,133,652
Ensembl chr20:31,104,354...31,133,652
G
Dlg4
discs large MAGUK scaffold protein 4
decreases expression
ISO
Aripiprazole results in decreased expression of DLG4 mRNA
CTD
PMID:39971107
NCBI chr10:55,239,397...55,267,780
Ensembl chr10:55,236,869...55,265,839
G
Dnal4
dynein, axonemal, light chain 4
decreases expression
EXP
Aripiprazole results in decreased expression of DNAL4 mRNA
CTD
PMID:17868501
NCBI chr 7:113,192,807...113,205,665
Ensembl chr20:21,722,009...21,723,262 Ensembl chr 7:21,722,009...21,723,262
G
Dnmt3a
DNA methyltransferase 3 alpha
increases expression
EXP
Aripiprazole results in increased expression of DNMT3A mRNA
CTD
PMID:17868501
NCBI chr 6:32,507,316...32,621,678
Ensembl chr 6:32,512,070...32,614,970
G
Drd2
dopamine receptor D2
multiple interactions
EXP ISO
[Aripiprazole binds to and results in increased activity of DRD2 protein] which results in increased susceptibility to Methamphetamine
CTD
PMID:17069544 PMID:17327886
NCBI chr 8:58,605,403...58,669,339
Ensembl chr 8:58,605,403...58,669,339
G
Dusp4
dual specificity phosphatase 4
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of DUSP4 mRNA
CTD
PMID:31476115
NCBI chr16:64,079,893...64,101,396
Ensembl chr16:64,079,893...64,093,700
G
Dusp6
dual specificity phosphatase 6
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of DUSP6 mRNA
CTD
PMID:31476115
NCBI chr 7:35,979,502...35,983,834
Ensembl chr 7:35,977,921...35,983,833
G
Ebi3
Epstein-Barr virus induced 3
multiple interactions
ISO
Aripiprazole promotes the reaction [Ozone results in increased expression of EBI3 mRNA]
CTD
PMID:31476115
NCBI chr 9:861,441...874,731
Ensembl chr 9:870,792...874,973
G
Egr1
early growth response 1
increases expression
EXP
Aripiprazole results in increased expression of EGR1 mRNA; Aripiprazole results in increased expression of EGR1 protein
CTD
PMID:17868501
NCBI chr18:26,737,078...26,740,877
Ensembl chr18:26,736,838...26,740,843
G
Egr2
early growth response 2
increases expression
EXP
Aripiprazole results in increased expression of EGR2 mRNA
CTD
PMID:17868501
NCBI chr20:21,050,149...21,055,201
Ensembl chr20:21,050,149...21,057,748
G
Egr4
early growth response 4
increases expression
EXP
Aripiprazole results in increased expression of EGR4 mRNA
CTD
PMID:17868501
NCBI chr 4:119,605,358...119,607,817
Ensembl chr 4:119,605,357...119,608,368
G
Elane
elastase, neutrophil expressed
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of ELANE mRNA
CTD
PMID:31476115
NCBI chr 7:10,467,877...10,469,725
Ensembl chr 7:10,467,877...10,469,725
G
Elavl2
ELAV like RNA binding protein 2
increases expression
EXP
Aripiprazole results in increased expression of ELAVL2 mRNA
CTD
PMID:17868501
NCBI chr 5:111,076,705...111,202,341
Ensembl chr 5:111,076,705...111,224,918
G
Ets1
ETS proto-oncogene 1, transcription factor
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of ETS1 mRNA
CTD
PMID:31476115
NCBI chr 8:39,303,936...39,426,022
Ensembl chr 8:39,303,925...39,426,021
G
Exoc2
exocyst complex component 2
increases expression
EXP
Aripiprazole results in increased expression of EXOC2 mRNA
CTD
PMID:17868501
NCBI chr17:33,714,949...33,906,901
Ensembl chr17:33,715,008...33,901,944
G
F2rl1
F2R like trypsin receptor 1
multiple interactions
ISO
Aripiprazole inhibits the reaction [Ozone results in increased expression of F2RL1 mRNA]
CTD
PMID:31476115
NCBI chr 2:28,507,003...28,519,954
Ensembl chr 2:28,507,003...28,519,954
G
Fez1
fasciculation and elongation protein zeta 1
multiple interactions increases expression
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of FEZ1 mRNA Aripiprazole results in increased expression of FEZ1 mRNA
CTD
PMID:31476115
NCBI chr 8:44,733,288...44,778,519
Ensembl chr 8:44,733,300...44,784,097
G
Fn1
fibronectin 1
decreases expression
ISO
Aripiprazole results in decreased expression of FN1 mRNA
CTD
PMID:31476115
NCBI chr 9:80,645,507...80,714,200
Ensembl chr 9:80,645,507...80,714,137
G
Gabrb1
gamma-aminobutyric acid type A receptor subunit beta1
increases expression
EXP
Aripiprazole results in increased expression of GABRB1 mRNA
CTD
PMID:26894264
NCBI chr14:36,434,339...36,917,920
Ensembl chr14:36,434,352...36,902,893
G
Hbegf
heparin-binding EGF-like growth factor
decreases expression
EXP
Aripiprazole results in decreased expression of HBEGF mRNA
CTD
PMID:17868501
NCBI chr18:28,380,337...28,390,220
Ensembl chr18:28,380,337...28,390,220
G
Htr1a
5-hydroxytryptamine receptor 1A
multiple interactions
ISO
Aripiprazole binds to and affects the activity of HTR1A protein; Aripiprazole binds to and results in increased activity of HTR1A protein
CTD
PMID:17069544 PMID:21823597
NCBI chr 2:38,427,169...38,431,733
Ensembl chr 2:38,427,083...38,540,760
G
Htr2a
5-hydroxytryptamine receptor 2A
multiple interactions decreases response to substance affects response to substance
ISO
Aripiprazole binds to and results in decreased activity of HTR2A protein; Aripiprazole binds to and results in increased activity of HTR2A protein; Aripiprazole inhibits the reaction [Ketanserin binds to HTR2A protein] HTR2A gene SNP results in decreased susceptibility to Aripiprazole HTR2A protein affects the susceptibility to Aripiprazole
CTD
PMID:16314884 PMID:21823597
NCBI chr15:56,360,647...56,428,703
Ensembl chr15:56,359,596...56,431,619
G
Htr2c
5-hydroxytryptamine receptor 2C
multiple interactions
ISO
Aripiprazole binds to and affects the activity of HTR2C protein
CTD
PMID:21823597
NCBI chr X:115,453,190...115,682,325
Ensembl chr X:115,452,842...115,682,324
G
Icam1
intercellular adhesion molecule 1
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of ICAM1 mRNA
CTD
PMID:31476115
NCBI chr 8:27,829,688...27,841,618
Ensembl chr 8:27,829,161...27,841,617
G
Icam4
intercellular adhesion molecule 4, Landsteiner-Wiener blood group
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of ICAM4 mRNA
CTD
PMID:31476115
NCBI chr 8:27,842,255...27,843,351
Ensembl chr 8:27,842,255...27,844,371
G
Icoslg
inducible T-cell co-stimulator ligand
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of ICOSLG mRNA
CTD
PMID:31476115
NCBI chr20:10,600,078...10,610,385
Ensembl chr20:10,600,078...10,610,365
G
Ifnb1
interferon beta 1
increases expression multiple interactions
ISO
Aripiprazole results in increased expression of IFNB1 mRNA Aripiprazole promotes the reaction [Ozone results in increased expression of IFNB1 mRNA]
CTD
PMID:31476115
NCBI chr 5:108,066,650...108,067,487
Ensembl chr 5:108,066,650...108,067,487
G
Ifng
interferon gamma
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in decreased expression of IFNG mRNA
CTD
PMID:31476115
NCBI chr 7:55,789,180...55,793,216
Ensembl chr 7:55,761,736...55,793,216
G
Ifngr1
interferon gamma receptor 1
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of IFNGR1 mRNA
CTD
PMID:31476115
NCBI chr 1:16,152,811...16,171,439
Ensembl chr 1:16,152,879...16,171,437
G
Ikbke
inhibitor of nuclear factor kappa B kinase subunit epsilon
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of IKBKE mRNA
CTD
PMID:31476115
NCBI chr13:45,264,404...45,290,737
Ensembl chr13:45,264,412...45,289,396
G
Il11
interleukin 11
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of IL11 mRNA
CTD
PMID:31476115
NCBI chr 1:78,098,622...78,104,915
Ensembl chr 1:78,096,930...78,104,915
G
Il1a
interleukin 1 alpha
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of IL1A mRNA
CTD
PMID:31476115
NCBI chr 3:136,979,804...136,990,236
Ensembl chr 3:136,979,805...136,998,013
G
Il1b
interleukin 1 beta
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of IL1B mRNA
CTD
PMID:31476115
NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:137,030,205...137,036,601
G
Il1r2
interleukin 1 receptor type 2
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of IL1R2 mRNA
CTD
PMID:31476115
NCBI chr 9:49,879,928...49,920,374
Ensembl chr 9:49,877,266...49,920,374
G
Il1rap
interleukin 1 receptor accessory protein
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of IL1RAP mRNA
CTD
PMID:31476115
NCBI chr11:87,567,813...87,704,346
Ensembl chr11:87,575,116...87,704,342
G
Il1rapl2
interleukin 1 receptor accessory protein-like 2
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of IL1RAPL2 mRNA
CTD
PMID:31476115
NCBI chr X:105,547,403...107,080,369
Ensembl chr X:105,754,490...107,065,223
G
Il1rl1
interleukin 1 receptor-like 1
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of IL1RL1 mRNA
CTD
PMID:31476115
NCBI chr 9:50,157,326...50,222,888
Ensembl chr 9:50,204,551...50,222,891
G
Il23a
interleukin 23 subunit alpha
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of IL23A mRNA
CTD
PMID:31476115
NCBI chr 7:1,306,320...1,308,434
Ensembl chr 7:1,306,320...1,308,434
G
Il24
interleukin 24
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of IL24 mRNA
CTD
PMID:31476115
NCBI chr13:44,905,362...44,910,760
Ensembl chr13:44,905,363...44,910,760
G
Il2rg
interleukin 2 receptor subunit gamma
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in decreased expression of IL2RG mRNA
CTD
PMID:31476115
NCBI chr X:70,435,340...70,439,052
Ensembl chr X:70,435,343...70,439,161
G
Il4r
interleukin 4 receptor
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of IL4R mRNA
CTD
PMID:31476115
NCBI chr 1:189,545,739...189,570,639
Ensembl chr 1:189,544,988...189,570,636
G
Il5
interleukin 5
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of IL5 mRNA
CTD
PMID:31476115
NCBI chr10:38,375,132...38,378,003
Ensembl chr10:38,375,132...38,378,003
G
Il6
interleukin 6
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of IL6 mRNA; Aripiprazole promotes the reaction [Ozone results in increased expression of IL6 mRNA]
CTD
PMID:31476115
NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,889,999...5,894,610
G
Il7r
interleukin 7 receptor
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of IL7R mRNA
CTD
PMID:31476115
NCBI chr 2:60,179,561...60,204,937
Ensembl chr 2:60,181,382...60,211,027
G
Inpp5d
inositol polyphosphate-5-phosphatase D
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of INPP5D mRNA
CTD
PMID:31476115
NCBI chr 9:95,735,533...95,840,584
Ensembl chr 9:95,735,530...95,840,589
G
Irak2
interleukin-1 receptor-associated kinase 2
multiple interactions
ISO
Aripiprazole promotes the reaction [Ozone results in increased expression of IRAK2 mRNA]
CTD
PMID:31476115
NCBI chr 4:148,341,704...148,398,211
Ensembl chr 4:148,341,719...148,398,210
G
Irf8
interferon regulatory factor 8
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in decreased expression of IRF8 mRNA
CTD
PMID:31476115
NCBI chr19:65,699,284...65,721,066
Ensembl chr19:65,699,284...65,721,062
G
Isg20
interferon stimulated exonuclease gene 20
increases expression multiple interactions
ISO
Aripiprazole results in increased expression of ISG20 mRNA [Aripiprazole co-treated with Ozone] results in increased expression of ISG20 mRNA
CTD
PMID:31476115
NCBI chr 1:142,234,729...142,246,403
Ensembl chr 1:142,236,137...142,246,401
G
Itga2
integrin subunit alpha 2
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of ITGA2 mRNA
CTD
PMID:31476115
NCBI chr 2:48,253,412...48,354,509
Ensembl chr 2:48,253,412...48,354,509
G
Itga5
integrin subunit alpha 5
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of ITGA5 mRNA
CTD
PMID:31476115
NCBI chr 7:136,358,097...136,381,305
Ensembl chr 7:136,358,097...136,381,305
G
Kcnh2
potassium voltage-gated channel subfamily H member 2
multiple interactions decreases activity
ISO
Aripiprazole inhibits the reaction [KCNH2 protein results in increased transport of Thallium] Aripiprazole results in decreased activity of KCNH2 protein
CTD
PMID:21158687 PMID:28551711
NCBI chr 4:11,719,357...11,751,424
Ensembl chr 4:11,692,980...11,751,421
G
Kcnj3
potassium inwardly-rectifying channel, subfamily J, member 3
increases expression
EXP
Aripiprazole results in increased expression of KCNJ3 mRNA
CTD
PMID:17868501
NCBI chr 3:60,353,990...60,518,110
Ensembl chr 3:60,354,146...60,518,104
G
Lif
LIF, interleukin 6 family cytokine
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of LIF mRNA
CTD
PMID:31476115
NCBI chr14:83,354,602...83,364,053
Ensembl chr14:83,358,164...83,364,053
G
Lrrn3
leucine rich repeat neuronal 3
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of LRRN3 mRNA
CTD
PMID:31476115
NCBI chr 6:64,216,164...64,247,293
Ensembl chr 6:64,215,878...64,247,614
G
Lta
lymphotoxin alpha
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of LTA mRNA
CTD
PMID:31476115
NCBI chr20:3,622,291...3,625,852
Ensembl chr20:3,623,527...3,625,533
G
Ltb
lymphotoxin beta
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of LTB mRNA
CTD
PMID:31476115
NCBI chr20:3,632,209...3,634,054
Ensembl chr20:3,632,210...3,634,054
G
Lyn
LYN proto-oncogene, Src family tyrosine kinase
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of LYN mRNA
CTD
PMID:31476115
NCBI chr 5:21,437,127...21,553,097
Ensembl chr 5:21,437,084...21,554,461
G
Maob
monoamine oxidase B
increases expression
EXP
Aripiprazole results in increased expression of MAOB mRNA
CTD
PMID:17868501
NCBI chr X:8,490,405...8,594,065
Ensembl chr X:8,490,344...8,594,375
G
Map2
microtubule-associated protein 2
decreases expression
ISO
Aripiprazole results in decreased expression of MAP2 mRNA
CTD
PMID:39971107
NCBI chr 9:75,173,038...75,431,606
Ensembl chr 9:75,288,262...75,428,459
G
Mapk6
mitogen-activated protein kinase 6
increases expression
EXP
Aripiprazole results in increased expression of MAPK6 mRNA
CTD
PMID:17868501
NCBI chr 8:85,027,141...85,050,236
Ensembl chr 8:85,027,144...85,050,236
G
Mapkapk2
MAPK activated protein kinase 2
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of MAPKAPK2 mRNA
CTD
PMID:31476115
NCBI chr13:45,066,027...45,112,326
Ensembl chr13:45,066,031...45,112,326
G
Nes
nestin
decreases expression
ISO
Aripiprazole results in decreased expression of NES mRNA
CTD
PMID:39971107
NCBI chr 2:175,735,715...175,745,631
Ensembl chr 2:175,736,551...175,746,228
G
Neurod1
neuronal differentiation 1
decreases expression
ISO
Aripiprazole results in decreased expression of NEUROD1 mRNA
CTD
PMID:39971107
NCBI chr 3:84,766,483...84,770,454
Ensembl chr 3:84,764,725...84,770,810
G
Nfkb1
nuclear factor kappa B subunit 1
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of NFKB1 mRNA
CTD
PMID:31476115
NCBI chr 2:226,689,745...226,805,897
Ensembl chr 2:226,689,745...226,783,088
G
Nfkb2
nuclear factor kappa B subunit 2
multiple interactions
ISO
Aripiprazole promotes the reaction [Ozone results in increased expression of NFKB2 mRNA]
CTD
PMID:31476115
NCBI chr 1:255,106,010...255,114,649
Ensembl chr 1:255,107,374...255,114,637
G
Nfkbia
NFKB inhibitor alpha
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of NFKBIA mRNA
CTD
PMID:31476115
NCBI chr 6:78,593,844...78,597,307
Ensembl chr 6:78,593,847...78,597,072
G
Nlrp3
NLR family, pyrin domain containing 3
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of NLRP3 mRNA
CTD
PMID:31476115
NCBI chr10:44,826,299...44,853,373
Ensembl chr10:44,828,014...44,853,394
G
Nod2
nucleotide-binding oligomerization domain containing 2
multiple interactions increases expression
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of NOD2 mRNA Aripiprazole results in increased expression of NOD2 mRNA
CTD
PMID:31476115
NCBI chr19:34,555,832...34,596,281
Ensembl chr19:34,555,832...34,722,846
G
Nos2
nitric oxide synthase 2
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of NOS2A mRNA
CTD
PMID:31476115
NCBI chr10:64,313,335...64,349,221
Ensembl chr10:64,313,335...64,401,880
G
Npdc1
neural proliferation, differentiation and control, 1
decreases expression
EXP
Aripiprazole results in decreased expression of NPDC1 mRNA
CTD
PMID:17868501
NCBI chr 3:28,618,601...28,624,591
G
Nt5e
5' nucleotidase, ecto
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of NT5E mRNA
CTD
PMID:31476115
NCBI chr 8:98,150,925...98,195,646
Ensembl chr 8:98,150,900...98,195,645
G
Ntm
neurotrimin
decreases expression
EXP
Aripiprazole results in decreased expression of NTM mRNA
CTD
PMID:17868501
NCBI chr 8:35,634,929...36,625,081
Ensembl chr 8:35,635,640...36,624,807
G
Olig2
oligodendrocyte transcription factor 2
decreases expression
ISO
Aripiprazole results in decreased expression of OLIG2 mRNA
CTD
PMID:39971107
NCBI chr11:43,961,585...43,964,961
Ensembl chr11:43,958,940...43,968,634
G
Pax6
paired box 6
decreases expression
ISO
Aripiprazole results in decreased expression of PAX6 mRNA
CTD
PMID:39971107
NCBI chr 3:112,590,034...112,611,771
Ensembl chr 3:112,590,391...112,611,763
G
Pdcd1lg2
programmed cell death 1 ligand 2
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of PDCD1LG2 mRNA
CTD
PMID:31476115
NCBI chr 1:236,572,497...236,637,490
Ensembl chr 1:236,565,526...236,637,490
G
Pdgfc
platelet derived growth factor C
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in decreased expression of PDGFC mRNA
CTD
PMID:31476115
NCBI chr 2:168,613,409...168,791,575
Ensembl chr 2:168,614,353...168,791,573
G
Pdp1
pyruvate dehydrogenase phosphatase catalytic subunit 1
increases expression
EXP
Aripiprazole results in increased expression of PDP1 mRNA
CTD
PMID:17868501
NCBI chr 5:30,245,699...30,252,494
Ensembl chr 5:30,242,704...30,253,960
G
Plau
plasminogen activator, urokinase
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of PLAU mRNA
CTD
PMID:31476115
NCBI chr15:3,505,485...3,511,987
Ensembl chr15:3,505,487...3,512,030
G
Plaur
plasminogen activator, urokinase receptor
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of PLAUR mRNA
CTD
PMID:31476115
NCBI chr 1:89,181,363...89,196,308
Ensembl chr 1:89,178,453...89,198,130
G
Pou2f2
POU class 2 homeobox 2
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of POU2F2 mRNA
CTD
PMID:31476115
NCBI chr 1:89,810,153...89,897,560
Ensembl chr 1:89,812,093...89,897,564
G
Prg2
proteoglycan 2, pro eosinophil major basic protein
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of PRG2 mRNA
CTD
PMID:31476115
NCBI chr 3:90,469,192...90,472,759
Ensembl chr 3:90,469,176...90,472,752
G
Prkaca
protein kinase cAMP-activated catalytic subunit alpha
increases expression
EXP
Aripiprazole results in increased expression of PRKACA protein
CTD
PMID:26894264
NCBI chr19:41,059,843...41,083,189
Ensembl chr19:41,059,843...41,086,494
G
Prkcd
protein kinase C, delta
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of PRKCD mRNA
CTD
PMID:31476115
NCBI chr16:5,775,681...5,806,122
Ensembl chr16:5,775,681...5,805,839
G
Prl
prolactin
multiple interactions increases secretion decreases secretion decreases expression
ISO EXP
Aripiprazole inhibits the reaction [haloperidol decanoate results in increased expression of PRL protein]; Aripiprazole inhibits the reaction [Risperidone results in increased secretion of PRL protein] Aripiprazole results in increased secretion of PRL protein Aripiprazole results in decreased secretion of PRL protein Aripiprazole inhibits the reaction [talipexole results in decreased secretion of PRL protein]; Haloperidol inhibits the reaction [Aripiprazole results in decreased secretion of PRL protein] Aripiprazole results in decreased expression of PRL protein
CTD
PMID:8613910 PMID:17873694 PMID:19230981 PMID:19519261 PMID:19653986 PMID:19906340 PMID:20814333 More...
NCBI chr17:38,287,355...38,298,234
Ensembl chr17:38,288,162...38,298,217
G
Prodh1
proline dehydrogenase 1
decreases expression
EXP
Aripiprazole results in decreased expression of PRODH mRNA
CTD
PMID:17868501
NCBI chr11:96,414,275...96,431,604
Ensembl chr11:96,414,224...96,433,418
G
Psmc6
proteasome 26S subunit, ATPase 6
increases expression
EXP
Aripiprazole results in increased expression of PSMC6 mRNA
CTD
PMID:17868501
NCBI chr15:21,022,314...21,043,785
Ensembl chr15:21,022,314...21,043,785
G
Ptgs2
prostaglandin-endoperoxide synthase 2
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of PTGS2 mRNA
CTD
PMID:31476115
NCBI chr13:64,714,063...64,722,320
Ensembl chr13:64,713,619...64,722,320
G
Pycard
PYD and CARD domain containing
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in decreased expression of PYCARD mRNA
CTD
PMID:31476115
NCBI chr 1:192,032,124...192,033,419
Ensembl chr 1:192,032,124...192,033,419
G
Rab3a
RAB3A, member RAS oncogene family
increases expression
EXP
Aripiprazole results in increased expression of RAB3A mRNA
CTD
PMID:17868501
NCBI chr16:18,718,164...18,722,273
Ensembl chr16:18,718,167...18,721,842
G
Rasd1
ras related dexamethasone induced 1
increases expression
EXP
Aripiprazole results in increased expression of RASD1 mRNA
CTD
PMID:17868501
NCBI chr10:45,265,975...45,275,279
Ensembl chr10:45,265,979...45,267,710
G
Rbfox3
RNA binding fox-1 homolog 3
decreases expression
ISO
Aripiprazole results in decreased expression of RBFOX3 mRNA
CTD
PMID:39971107
NCBI chr10:104,218,940...104,655,863
Ensembl chr10:104,218,940...104,551,945
G
Relb
RELB proto-oncogene, NF-kB subunit
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of RELB mRNA
CTD
PMID:31476115
NCBI chr 1:88,385,717...88,413,380
Ensembl chr 1:88,385,717...88,413,420
G
Rig1
RNA sensor RIG-1
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of RIGI mRNA
CTD
PMID:31476115
NCBI chr 5:60,117,398...60,165,995
Ensembl chr 5:60,117,398...60,165,995
G
S100b
S100 calcium binding protein B
decreases expression
ISO
Aripiprazole results in decreased expression of S100B mRNA
CTD
PMID:39971107
NCBI chr20:12,372,345...12,381,159
Ensembl chr20:12,372,348...12,381,081
G
Sae1
SUMO1 activating enzyme subunit 1
increases expression
EXP
Aripiprazole results in increased expression of SAE1 mRNA
CTD
PMID:17868501
NCBI chr 1:86,159,114...86,215,089
Ensembl chr 1:86,159,114...86,215,089
G
Sbno2
strawberry notch homolog 2
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of SBNO2 mRNA
CTD
PMID:31476115
NCBI chr 7:10,256,221...10,300,175
Ensembl chr 7:10,253,248...10,300,176
G
Serpinb2
serpin family B member 2
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of SERPINB2 mRNA
CTD
PMID:31476115
NCBI chr13:24,051,933...24,065,032
Ensembl chr13:24,056,021...24,065,031
G
Sh2b2
SH2B adaptor protein 2
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in decreased expression of SH2B2 mRNA
CTD
PMID:31476115
NCBI chr12:26,063,812...26,093,468
Ensembl chr12:26,064,486...26,093,467
G
Slamf6
SLAM family member 6
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of SLAMF6 mRNA
CTD
PMID:31476115
NCBI chr13:86,916,956...86,937,697
Ensembl chr13:86,916,122...86,938,354
G
Slc6a4
solute carrier family 6 member 4
affects binding
ISO
Aripiprazole binds to SLC6A4 protein
CTD
PMID:21823597
NCBI chr10:62,322,688...62,357,060
Ensembl chr10:62,324,254...62,357,056
G
Slco2b1
solute carrier organic anion transporter family, member 2b1
decreases expression
EXP
Aripiprazole results in decreased expression of SLCO2B1 mRNA
CTD
PMID:17868501
NCBI chr 1:163,371,410...163,419,412
Ensembl chr 1:163,371,410...163,419,279
G
Slit3
slit guidance ligand 3
increases expression
EXP
Aripiprazole results in increased expression of SLIT3 mRNA
CTD
PMID:17868501
NCBI chr10:20,075,929...20,660,704
Ensembl chr10:20,076,021...20,660,704
G
Smad3
SMAD family member 3
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of SMAD3 mRNA
CTD
PMID:31476115
NCBI chr 8:73,022,204...73,132,324
Ensembl chr 8:73,024,760...73,132,324
G
Socs1
suppressor of cytokine signaling 1
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of SOCS1 mRNA
CTD
PMID:31476115
NCBI chr10:5,389,574...5,391,265
Ensembl chr10:5,389,334...5,391,847
G
Sox2
SRY-box transcription factor 2
decreases expression
ISO
Aripiprazole results in decreased expression of SOX2 mRNA
CTD
PMID:39971107
NCBI chr 2:119,465,131...119,467,542
Ensembl chr 2:119,454,541...119,496,350
G
Syn1
synapsin I
decreases expression
ISO
Aripiprazole results in decreased expression of SYN1 mRNA
CTD
PMID:39971107
NCBI chr X:3,725,745...3,780,940
Ensembl chr X:3,725,714...3,780,938
G
Syt17
synaptotagmin 17
decreases expression multiple interactions
ISO
Aripiprazole results in decreased expression of SYT17 mRNA [Aripiprazole co-treated with Ozone] results in decreased expression of SYT17 mRNA
CTD
PMID:31476115
NCBI chr 1:182,129,491...182,195,827
Ensembl chr 1:182,129,496...182,204,028
G
Tab1
TGF-beta activated kinase 1/MAP3K7 binding protein 1
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in decreased expression of TAB1 mRNA
CTD
PMID:31476115
NCBI chr 7:113,556,157...113,587,351
Ensembl chr 7:113,555,819...113,587,351
G
Tacr3
tachykinin receptor 3
decreases expression increases expression
EXP
Aripiprazole results in decreased expression of TACR3 mRNA Aripiprazole results in increased expression of TACR3 mRNA
CTD
PMID:17868501
NCBI chr 2:225,940,497...226,037,756
Ensembl chr 2:225,940,444...226,037,756
G
Thbd
thrombomodulin
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of THBD mRNA
CTD
PMID:31476115
NCBI chr 3:156,316,526...156,320,178
Ensembl chr 3:156,306,632...156,320,582
G
Thbs1
thrombospondin 1
multiple interactions
ISO
Aripiprazole inhibits the reaction [Ozone results in increased expression of THBS1 mRNA]
CTD
PMID:31476115
NCBI chr 3:125,510,250...125,525,402
Ensembl chr 3:125,510,250...125,525,402
G
Ticam1
TIR domain containing adaptor molecule 1
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of TICAM1 mRNA
CTD
PMID:31476115
NCBI chr 9:1,189,717...1,197,730
Ensembl chr 9:1,172,963...1,196,892
G
Tlr3
toll-like receptor 3
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in decreased expression of TLR3 mRNA
CTD
PMID:31476115
NCBI chr16:53,554,916...53,572,321
Ensembl chr16:53,555,131...53,568,385
G
Tlr5
toll-like receptor 5
increases expression multiple interactions
ISO
Aripiprazole results in increased expression of TLR5 mRNA [Aripiprazole co-treated with Ozone] results in decreased expression of TLR5 mRNA
CTD
PMID:31476115
NCBI chr13:97,166,430...97,190,642
Ensembl chr13:97,166,405...97,192,525
G
Tnf
tumor necrosis factor
multiple interactions
ISO
Aripiprazole promotes the reaction [Ozone results in increased expression of TNF mRNA]
CTD
PMID:31476115
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,626,532...3,629,303
G
Tnfaip3
TNF alpha induced protein 3
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of TNFAIP3 mRNA
CTD
PMID:31476115
NCBI chr 1:15,528,921...15,543,993
Ensembl chr 1:15,528,921...15,543,979
G
Tnfrsf11b
TNF receptor superfamily member 11B
multiple interactions
ISO
Aripiprazole inhibits the reaction [Ozone results in increased expression of TNFRSF11B mRNA]
CTD
PMID:31476115
NCBI chr 7:87,456,318...87,484,324
Ensembl chr 7:87,456,319...87,485,075
G
Tnfrsf12a
TNF receptor superfamily member 12A
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of TNFRSF12A mRNA
CTD
PMID:31476115
NCBI chr10:13,211,670...13,213,666
Ensembl chr10:13,211,673...13,213,704
G
Tnfrsf14
TNF receptor superfamily member 14
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in decreased expression of TNFRSF14 mRNA
CTD
PMID:31476115
NCBI chr 5:170,768,413...170,776,749
Ensembl chr 5:170,768,416...170,776,046
G
Tnfrsf1b
TNF receptor superfamily member 1B
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of TNFRSF1B mRNA
CTD
PMID:31476115
NCBI chr 5:162,356,250...162,387,411
Ensembl chr 5:162,353,848...162,387,411
G
Tnfrsf22
tumor necrosis factor receptor superfamily, member 22
multiple interactions
ISO
Aripiprazole inhibits the reaction [Ozone results in decreased expression of TNFRSF10C mRNA]
CTD
PMID:31476115
NCBI chr 1:208,269,844...208,285,823
Ensembl chr 1:208,258,836...208,289,832
G
Tnfrsf8
TNF receptor superfamily member 8
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of TNFRSF8 mRNA
CTD
PMID:31476115
NCBI chr 5:162,406,387...162,451,620
Ensembl chr 5:162,406,387...162,451,620
G
Tnfrsf9
TNF receptor superfamily member 9
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of TNFRSF9 mRNA
CTD
PMID:31476115
NCBI chr 5:166,664,494...166,690,834
Ensembl chr 5:166,664,494...166,690,831
G
Tnfsf10
TNF superfamily member 10
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in decreased expression of TNFSF10 mRNA
CTD
PMID:31476115
NCBI chr 2:112,136,550...112,155,903
G
Tnfsf12
TNF superfamily member 12
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in decreased expression of TNFSF12 mRNA
CTD
PMID:31476115
NCBI chr10:54,902,616...54,912,628
Ensembl chr10:54,902,616...54,911,913
G
Tnfsf15
TNF superfamily member 15
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of TNFSF15 mRNA
CTD
PMID:31476115
NCBI chr 5:82,150,376...82,171,743
Ensembl chr 5:82,150,376...82,171,882
G
Tnfsf18
TNF superfamily member 18
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of TNFSF18 mRNA
CTD
PMID:31476115
NCBI chr13:76,366,790...76,440,673
Ensembl chr13:76,366,771...76,376,608
G
Tubb2a
tubulin, beta 2A class IIa
decreases expression
EXP
Aripiprazole results in decreased expression of TUBB2A mRNA
CTD
PMID:17868501
NCBI chr17:31,002,186...31,006,057
Ensembl chr17:30,983,387...31,006,838
G
Tubb3
tubulin, beta 3 class III
decreases expression
ISO
Aripiprazole results in decreased expression of TUBB3 mRNA; Aripiprazole results in decreased expression of TUBB3 protein
CTD
PMID:39971107
NCBI chr19:68,365,687...68,374,741
Ensembl chr19:68,365,587...68,374,740
G
Vegfa
vascular endothelial growth factor A
multiple interactions
ISO
Aripiprazole promotes the reaction [Ozone results in increased expression of VEGFA mRNA]
CTD
PMID:31476115
NCBI chr 9:22,452,854...22,468,194
Ensembl chr 9:22,439,392...22,468,194
G
Wee1
WEE1 G2 checkpoint kinase
increases expression
EXP
Aripiprazole results in increased expression of WEE1 mRNA
CTD
PMID:17868501
NCBI chr 1:173,605,609...173,632,450
Ensembl chr 1:173,608,949...173,632,449
G
Zfp354c
zinc finger protein 354C
increases expression
EXP
Aripiprazole results in increased expression of ZNF354C mRNA
CTD
PMID:17868501
NCBI chr10:35,630,738...35,647,176
Ensembl chr10:35,630,738...35,646,754
G
Aass
aminoadipate-semialdehyde synthase
increases expression
EXP
Buspirone results in increased expression of AASS mRNA
CTD
PMID:24136188
NCBI chr 4:52,572,146...52,628,811
Ensembl chr 4:52,572,147...52,657,600
G
Abca1
ATP binding cassette subfamily A member 1
increases expression
EXP
Buspirone results in increased expression of ABCA1 mRNA
CTD
PMID:24136188
NCBI chr 5:72,473,676...72,596,563
Ensembl chr 5:72,473,676...72,596,473
G
Abca8a
ATP-binding cassette, subfamily A (ABC1), member 8a
decreases expression
EXP
Buspirone results in decreased expression of ABCA8A mRNA
CTD
PMID:24136188
NCBI chr10:95,501,798...95,571,770
Ensembl chr10:95,501,798...95,571,873
G
Abcc2
ATP binding cassette subfamily C member 2
decreases expression
EXP
Buspirone results in decreased expression of ABCC2 mRNA
CTD
PMID:24136188
NCBI chr 1:252,613,875...252,672,459
Ensembl chr 1:252,614,017...252,673,471
G
Abcf1
ATP binding cassette subfamily F member 1
decreases expression
EXP
Buspirone results in decreased expression of ABCF1 mRNA
CTD
PMID:24136188
NCBI chr20:2,807,315...2,820,240
Ensembl chr20:2,807,106...2,820,240
G
Abcg2
ATP binding cassette subfamily G member 2
decreases expression
EXP
Buspirone results in decreased expression of ABCG2 mRNA
CTD
PMID:24136188
NCBI chr 4:89,006,056...89,132,915
Ensembl chr 4:89,005,969...89,132,493
G
Abhd14b
abhydrolase domain containing 14b
increases expression
EXP
Buspirone results in increased expression of ABHD14B mRNA
CTD
PMID:24136188
NCBI chr 8:115,966,792...115,970,829
Ensembl chr 8:115,965,932...115,970,833
G
Abtb1
ankyrin repeat and BTB domain containing 1
increases expression
EXP
Buspirone results in increased expression of ABTB1 mRNA
CTD
PMID:24136188
NCBI chr 4:122,856,558...122,862,895
Ensembl chr 4:122,856,564...122,862,789
G
Acaa2
acetyl-CoA acyltransferase 2
increases expression
EXP
Buspirone results in increased expression of ACAA2 mRNA
CTD
PMID:24136188
NCBI chr18:70,620,310...70,648,417
Ensembl chr18:70,620,110...70,648,420
G
Acaca
acetyl-CoA carboxylase alpha
decreases expression
EXP
Buspirone results in decreased expression of ACACA mRNA
CTD
PMID:24136188
NCBI chr10:69,511,627...69,773,888
Ensembl chr10:69,511,857...69,773,888
G
Acbd4
acyl-CoA binding domain containing 4
increases expression
EXP
Buspirone results in increased expression of ACBD4 mRNA
CTD
PMID:24136188
NCBI chr10:88,548,146...88,558,588
Ensembl chr10:88,548,158...88,558,587
G
Acly
ATP citrate lyase
decreases expression
EXP
Buspirone results in decreased expression of ACLY mRNA
CTD
PMID:24136188
NCBI chr10:85,912,402...85,964,605
Ensembl chr10:85,912,402...85,963,631
G
Acsf2
acyl-CoA synthetase family member 2
decreases expression
EXP
Buspirone results in decreased expression of ACSF2 mRNA
CTD
PMID:24136188
NCBI chr10:80,001,389...80,043,796
Ensembl chr10:80,001,389...80,045,050
G
Acsl3
acyl-CoA synthetase long-chain family member 3
decreases expression
EXP
Buspirone results in decreased expression of ACSL3 mRNA
CTD
PMID:24136188
NCBI chr 9:87,563,601...87,613,078
Ensembl chr 9:87,563,601...87,613,097
G
Acsl4
acyl-CoA synthetase long-chain family member 4
increases expression
EXP
Buspirone results in increased expression of ACSL4 mRNA
CTD
PMID:24136188
NCBI chr X:110,739,633...110,803,416
Ensembl chr X:110,739,648...110,803,261
G
Acsl5
acyl-CoA synthetase long-chain family member 5
decreases expression
EXP
Buspirone results in decreased expression of ACSL5 mRNA
CTD
PMID:24136188
NCBI chr 1:264,294,851...264,341,943
Ensembl chr 1:264,294,864...264,341,943
G
Actb
actin, beta
decreases expression
EXP
Buspirone results in decreased expression of ACTB mRNA
CTD
PMID:24136188
NCBI chr12:16,776,664...16,779,634
Ensembl chr12:16,776,661...16,780,242
G
Actg1
actin, gamma 1
decreases expression
EXP
Buspirone results in decreased expression of ACTG1 mRNA
CTD
PMID:24136188
NCBI chr10:106,118,106...106,120,951
Ensembl chr10:106,118,108...106,120,951
G
Actn1
actinin, alpha 1
decreases expression
EXP
Buspirone results in decreased expression of ACTN1 mRNA
CTD
PMID:24136188
NCBI chr 6:104,731,485...104,826,312
Ensembl chr 6:104,731,485...104,826,172
G
Acy1
aminoacylase 1
decreases expression
EXP
Buspirone results in decreased expression of ACY1 mRNA
CTD
PMID:24136188
NCBI chr 8:115,951,068...115,956,471
Ensembl chr 8:115,951,068...115,956,405
G
Adamtsl4
ADAMTS-like 4
increases expression
EXP
Buspirone results in increased expression of ADAMTSL4 mRNA
CTD
PMID:24136188
NCBI chr 2:185,924,582...185,936,039
Ensembl chr 2:185,924,594...185,935,796
G
Adcy6
adenylate cyclase 6
increases expression
EXP
Buspirone results in increased expression of ADCY6 mRNA
CTD
PMID:24136188
NCBI chr 7:131,621,860...131,642,923
Ensembl chr 7:131,621,860...131,642,770
G
Adipor2
adiponectin receptor 2
decreases expression
EXP
Buspirone results in decreased expression of ADIPOR2 mRNA
CTD
PMID:24136188
NCBI chr 4:154,195,440...154,261,141
Ensembl chr 4:154,172,567...154,231,666
G
Adra1a
adrenoceptor alpha 1A
multiple interactions
EXP
Buspirone binds to and results in decreased activity of ADRA1A protein
CTD
PMID:16545797
NCBI chr15:45,005,648...45,111,416
Ensembl chr15:45,005,799...45,102,534
G
Adra1d
adrenoceptor alpha 1D
multiple interactions
EXP
Buspirone binds to and results in increased activity of ADRA1D protein
CTD
PMID:15872040
NCBI chr 3:139,246,333...139,262,331
Ensembl chr 3:139,246,323...139,262,331
G
Agmat
agmatinase
increases expression
EXP
Buspirone results in increased expression of AGMAT mRNA
CTD
PMID:24136188
NCBI chr 5:159,326,680...159,357,300
Ensembl chr 5:159,343,160...159,357,299
G
Ahcy
adenosylhomocysteinase
increases expression
EXP
Buspirone results in increased expression of AHCY mRNA
CTD
PMID:24136188
NCBI chr 3:164,029,338...164,044,562
Ensembl chr 3:164,029,338...164,044,587
G
Aif1
allograft inflammatory factor 1
decreases expression
EXP
Buspirone results in decreased expression of AIF1 mRNA
CTD
PMID:24136188
NCBI chr20:3,651,435...3,657,341
Ensembl chr20:3,652,243...3,657,339
G
Aig1
androgen-induced 1
increases expression
EXP
Buspirone results in increased expression of AIG1 mRNA
CTD
PMID:24136188
NCBI chr 1:9,866,546...10,089,454
Ensembl chr 1:9,866,548...10,089,155
G
Ak4
adenylate kinase 4
decreases expression
EXP
Buspirone results in decreased expression of AK4 mRNA
CTD
PMID:24136188
NCBI chr 5:121,154,565...121,214,403
Ensembl chr 5:121,154,572...121,214,401
G
Akap8l
A-kinase anchoring protein 8 like
increases expression
EXP
Buspirone results in increased expression of AKAP8L mRNA
CTD
PMID:24136188
NCBI chr 7:11,983,215...12,012,843
Ensembl chr 7:11,982,721...12,012,811
G
Akr1c14
aldo-keto reductase family 1, member C14
increases expression
EXP
Buspirone results in increased expression of AKR1C14 mRNA
CTD
PMID:24136188
NCBI chr17:71,066,197...71,083,184
Ensembl chr17:71,066,200...71,083,157
G
Akr7a3
aldo-keto reductase family 7 member A3
decreases expression
EXP
Buspirone results in decreased expression of AKR7A3 mRNA
CTD
PMID:24136188
NCBI chr 5:156,876,721...156,884,599
Ensembl chr 5:156,874,086...156,885,153
G
Aldh1b1
aldehyde dehydrogenase 1 family, member B1
decreases expression
EXP
Buspirone results in decreased expression of ALDH1B1 mRNA
CTD
PMID:24136188
NCBI chr 5:64,859,000...64,864,008
Ensembl chr 5:64,858,934...64,864,365
G
Alkbh7
alkB homolog 7
increases expression
EXP
Buspirone results in increased expression of ALKBH7 mRNA
CTD
PMID:24136188
NCBI chr 9:1,925,896...1,928,048
Ensembl chr 9:1,925,743...1,928,048
G
Ankh
ANKH inorganic pyrophosphate transport regulator
decreases expression
EXP
Buspirone results in decreased expression of ANKH mRNA
CTD
PMID:24136188
NCBI chr 2:79,883,350...80,011,222
Ensembl chr 2:79,883,544...80,011,699
G
Ankrd46
ankyrin repeat domain 46
increases expression
EXP
Buspirone results in increased expression of ANKRD46 mRNA
CTD
PMID:24136188
NCBI chr 7:69,532,303...69,553,311
Ensembl chr 7:69,532,304...69,545,421
G
Antxr2
ANTXR cell adhesion molecule 2
increases expression
EXP
Buspirone results in increased expression of ANTXR2 mRNA
CTD
PMID:24136188
NCBI chr14:11,845,774...11,986,166
Ensembl chr14:11,845,700...11,986,168
G
Anxa3
annexin A3
decreases expression
EXP
Buspirone results in decreased expression of ANXA3 mRNA
CTD
PMID:24136188
NCBI chr14:13,031,675...13,085,678
Ensembl chr14:13,023,762...13,085,849
G
Anxa5
annexin A5
decreases expression
EXP
Buspirone results in decreased expression of ANXA5 mRNA
CTD
PMID:24136188
NCBI chr 2:121,242,133...121,272,935
Ensembl chr 2:121,242,136...121,281,400
G
Apob
apolipoprotein B
decreases expression
EXP
Buspirone results in decreased expression of APOB mRNA
CTD
PMID:24136188
NCBI chr 6:36,563,704...36,603,300
Ensembl chr 6:36,563,704...36,611,814
G
Apol9a-Apol7a
Apol9a-Apol7a readthrough
decreases expression
EXP
Buspirone results in decreased expression of APOL7B mRNA
CTD
PMID:24136188
NCBI chr 7:111,011,645...111,019,326
Ensembl chr 7:111,011,645...111,017,084
G
Apon
apolipoprotein N
increases expression
EXP
Buspirone results in increased expression of APON mRNA
CTD
PMID:24136188
NCBI chr 7:1,271,514...1,272,917
Ensembl chr 7:1,271,515...1,272,917
G
Apoo
apolipoprotein O
decreases expression
EXP
Buspirone results in decreased expression of APOO mRNA
CTD
PMID:24136188
NCBI chr X:63,151,736...63,256,696
Ensembl chr X:63,151,814...63,256,690
G
Apool
apolipoprotein O-like
decreases expression
EXP
Buspirone results in decreased expression of APOOL mRNA
CTD
PMID:24136188
NCBI chr X:81,569,960...81,635,906
Ensembl chr X:81,570,053...81,640,036
G
App
amyloid beta precursor protein
decreases expression
EXP
Buspirone results in decreased expression of APP mRNA
CTD
PMID:24136188
NCBI chr11:37,506,207...37,724,351
Ensembl chr11:37,506,408...37,722,971
G
Arhgap24
Rho GTPase activating protein 24
decreases expression
EXP
Buspirone results in decreased expression of ARHGAP24 mRNA
CTD
PMID:24136188
NCBI chr14:7,105,200...7,488,437
Ensembl chr14:7,105,200...7,528,950
G
Arhgdib
Rho GDP dissociation inhibitor beta
decreases expression
EXP
Buspirone results in decreased expression of ARHGDIB mRNA
CTD
PMID:24136188
NCBI chr 4:171,554,139...171,573,057
Ensembl chr 4:171,554,140...171,573,068
G
Arl1
ARF like GTPase 1
decreases expression
EXP
Buspirone results in decreased expression of ARL1 mRNA
CTD
PMID:24136188
NCBI chr 7:25,007,401...25,018,572
Ensembl chr 7:25,006,981...25,019,319
G
Arl4a
ARF like GTPase 4A
increases expression
EXP
Buspirone results in increased expression of ARL4A mRNA
CTD
PMID:24136188
NCBI chr 6:62,809,287...62,811,297
Ensembl chr 6:62,804,548...62,820,760
G
Arl6ip1
ARL6 interacting reticulophagy regulator 1
decreases expression
EXP
Buspirone results in decreased expression of ARL6IP1 mRNA
CTD
PMID:24136188
NCBI chr 1:181,864,717...181,874,232
Ensembl chr 1:181,864,746...181,874,232
G
Armt1
acidic residue methyltransferase 1
decreases expression
EXP
Buspirone results in decreased expression of ARMT1 mRNA
CTD
PMID:24136188
NCBI chr 1:43,299,916...43,323,675
Ensembl chr 1:43,299,826...43,323,670
G
Arsb
arylsulfatase B
decreases expression
EXP
Buspirone results in decreased expression of ARSB mRNA
CTD
PMID:24136188
NCBI chr 2:26,736,395...26,895,682
Ensembl chr 2:26,736,957...26,897,611
G
As3mt
arsenite methyltransferase
increases expression
EXP
Buspirone results in increased expression of AS3MT mRNA
CTD
PMID:24136188
NCBI chr 1:255,536,879...255,569,245
Ensembl chr 1:255,537,109...255,569,249
G
Asap2
ArfGAP with SH3 domain, ankyrin repeat and PH domain 2
decreases expression
EXP
Buspirone results in decreased expression of ASAP2 mRNA
CTD
PMID:24136188
NCBI chr 6:46,386,605...46,549,669
Ensembl chr 6:46,386,605...46,549,669
G
Asgr1
asialoglycoprotein receptor 1
increases expression
EXP
Buspirone results in increased expression of ASGR1 mRNA
CTD
PMID:24136188
NCBI chr10:55,274,299...55,278,323
Ensembl chr10:55,274,706...55,278,322
G
Aspg
asparaginase
increases expression
EXP
Buspirone results in increased expression of ASPG mRNA
CTD
PMID:24136188
NCBI chr 6:136,997,832...137,017,417
Ensembl chr 6:136,998,023...137,017,417
G
Atf5
activating transcription factor 5
increases expression
EXP
Buspirone results in increased expression of ATF5 mRNA
CTD
PMID:24136188
NCBI chr 1:104,432,094...104,437,611
Ensembl chr 1:104,432,094...104,436,183
G
Atg2b
autophagy related 2B
increases expression
EXP
Buspirone results in increased expression of ATG2B mRNA
CTD
PMID:24136188
NCBI chr 6:130,286,979...130,357,109
Ensembl chr 6:130,286,986...130,357,109
G
Atl2
atlastin GTPase 2
increases expression
EXP
Buspirone results in increased expression of ATL2 mRNA
CTD
PMID:24136188
NCBI chr 6:20,891,220...20,932,644
Ensembl chr 6:20,891,227...20,933,320
G
Atp11c
ATPase phospholipid transporting 11C
increases expression
EXP
Buspirone results in increased expression of ATP11C mRNA
CTD
PMID:24136188
NCBI chr X:143,600,763...143,788,407
Ensembl chr X:143,600,767...143,788,432
G
Atp6v0b
ATPase H+ transporting V0 subunit B
increases expression
EXP
Buspirone results in increased expression of ATP6V0B mRNA
CTD
PMID:24136188
NCBI chr 5:136,708,823...136,710,339
Ensembl chr 5:136,708,823...136,716,828
G
Atp6v0e1
ATPase H+ transporting V0 subunit e1
increases expression
EXP
Buspirone results in increased expression of ATP6V0E1 mRNA
CTD
PMID:24136188
NCBI chr10:16,984,084...17,007,156
Ensembl chr10:16,984,084...17,028,858
G
Atp6v1g1
ATPase H+ transporting V1 subunit G1
increases expression
EXP
Buspirone results in increased expression of ATP6V1G1 mRNA
CTD
PMID:24136188
NCBI chr 5:81,976,959...81,983,139
Ensembl chr 5:81,977,015...81,985,930
G
Axl
Axl receptor tyrosine kinase
decreases expression
EXP
Buspirone results in decreased expression of AXL mRNA
CTD
PMID:24136188
NCBI chr 1:90,392,864...90,424,123
Ensembl chr 1:90,392,864...90,424,009
G
Azin1
antizyme inhibitor 1
decreases expression
EXP
Buspirone results in decreased expression of AZIN1 mRNA
CTD
PMID:24136188
NCBI chr 7:71,539,711...71,566,515
Ensembl chr 7:71,539,711...71,566,515
G
B4galnt1
beta-1,4-N-acetyl-galactosaminyl transferase 1
increases expression
EXP
Buspirone results in increased expression of B4GALNT1 mRNA
CTD
PMID:24136188
NCBI chr 7:64,873,909...64,881,512
Ensembl chr 7:64,874,022...64,881,516
G
Baiap2l1
BAR/IMD domain containing adaptor protein 2 like 1
increases expression
EXP
Buspirone results in increased expression of BAIAP2L1 mRNA
CTD
PMID:24136188
NCBI chr12:15,364,090...15,453,602
Ensembl chr12:15,364,109...15,453,605
G
Bgn
biglycan
decreases expression
EXP
Buspirone results in decreased expression of BGN mRNA
CTD
PMID:24136188
NCBI chr X:156,348,633...156,360,797
Ensembl chr X:156,348,615...156,360,799
G
Bhlhe40
basic helix-loop-helix family, member e40
decreases expression
EXP
Buspirone results in decreased expression of BHLHE40 mRNA
CTD
PMID:24136188
NCBI chr 4:143,174,450...143,180,150
Ensembl chr 4:143,174,048...143,180,783
G
Blvrb
biliverdin reductase B
increases expression
EXP
Buspirone results in increased expression of BLVRB mRNA
CTD
PMID:24136188
NCBI chr 1:91,866,258...91,883,921
Ensembl chr 1:91,866,258...91,884,225
G
Bnip3
BCL2 interacting protein 3
increases expression
EXP
Buspirone results in increased expression of BNIP3 mRNA
CTD
PMID:24136188
NCBI chr 1:203,137,778...203,154,962
Ensembl chr 1:203,137,778...203,154,962
G
Bola1
bolA family member 1
increases expression
EXP
Buspirone results in increased expression of BOLA1 mRNA
CTD
PMID:24136188
NCBI chr 2:186,447,386...186,448,402
Ensembl chr 2:186,443,583...186,501,358
G
Bpgm
bisphosphoglycerate mutase
decreases expression
EXP
Buspirone results in decreased expression of BPGM mRNA
CTD
PMID:24136188
NCBI chr 4:64,106,809...64,135,749
Ensembl chr 4:64,106,804...64,135,627
G
Btg2
BTG anti-proliferation factor 2
decreases expression
EXP
Buspirone results in decreased expression of BTG2 mRNA
CTD
PMID:24136188
NCBI chr13:48,083,931...48,087,690
Ensembl chr13:48,083,931...48,087,690
G
C10h17orf58
similar to human chromosome 17 open reading frame 58
increases expression
EXP
Buspirone results in increased expression of C10H17ORF58 mRNA
CTD
PMID:24136188
NCBI chr10:92,472,779...92,477,330
Ensembl chr10:92,471,934...92,477,330
G
C1qb
complement C1q B chain
decreases expression
EXP
Buspirone results in decreased expression of C1QB mRNA
CTD
PMID:24136188
NCBI chr 5:154,402,276...154,407,827
Ensembl chr 5:154,402,279...154,407,840
G
C5h1orf50
similar to human chromosome 1 open reading frame 50
increases expression
EXP
Buspirone results in increased expression of C5H1ORF50 mRNA
CTD
PMID:24136188
NCBI chr 5:138,122,595...138,126,973
Ensembl chr 5:138,122,236...138,127,240
G
C5l1
complement C5 like 1
increases expression
EXP
Buspirone results in increased expression of C5L1 mRNA
CTD
PMID:24136188
NCBI chr 3:38,799,165...38,818,443
Ensembl chr 3:38,799,731...38,817,527
G
C6
complement C6
decreases expression
EXP
Buspirone results in decreased expression of C6 mRNA
CTD
PMID:24136188
NCBI chr 2:55,573,596...55,648,857
Ensembl chr 2:55,573,653...55,649,120
G
C8g
complement C8 gamma chain
increases expression
EXP
Buspirone results in increased expression of C8G mRNA
CTD
PMID:24136188
NCBI chr 3:28,718,648...28,720,232
G
C8h11orf54
similar to human chromosome 11 open reading frame 54
decreases expression
EXP
Buspirone results in decreased expression of C8H11ORF54 mRNA
CTD
PMID:24136188
NCBI chr 8:20,405,240...20,427,811
Ensembl chr 8:20,405,241...20,427,811
G
C8h11orf65
similar to human chromosome 11 open reading frame 65
increases expression
EXP
Buspirone results in increased expression of C8H11ORF65 mRNA
CTD
PMID:24136188
NCBI chr 8:62,692,123...62,720,951
Ensembl chr 8:62,692,568...62,720,946
G
C8h11orf71
similar to human chromosome 11 open reading frame 71
increases expression
EXP
Buspirone results in increased expression of C8H11ORF71 mRNA
CTD
PMID:24136188
NCBI chr 8:57,735,075...57,735,489
Ensembl chr 8:57,734,900...57,738,597
G
C8h15orf61
similar to human chromosome 15 open reading frame 61
increases expression
EXP
Buspirone results in increased expression of C8H15ORF61 mRNA
CTD
PMID:24136188
NCBI chr 8:72,763,513...72,768,248
Ensembl chr 8:72,757,256...72,768,748
G
Ca3
carbonic anhydrase 3
decreases expression
EXP
Buspirone results in decreased expression of CAR3 mRNA
CTD
PMID:24136188
NCBI chr 2:88,491,666...88,501,299
Ensembl chr 2:88,491,670...88,500,524
G
Ca5a
carbonic anhydrase 5A
increases expression
EXP
Buspirone results in increased expression of CAR5A mRNA
CTD
PMID:24136188
NCBI chr19:66,881,678...66,911,486
Ensembl chr19:66,881,693...66,911,486
G
Cald1
caldesmon 1
decreases expression
EXP
Buspirone results in decreased expression of CALD1 mRNA
CTD
PMID:24136188
NCBI chr 4:64,232,906...64,414,085
Ensembl chr 4:64,233,171...64,414,085
G
Calm1
calmodulin 1
decreases expression
EXP
Buspirone results in decreased expression of CALM1 mRNA
CTD
PMID:24136188
NCBI chr 6:125,217,191...125,227,855
Ensembl chr 6:125,217,246...125,225,381
G
Calm2
calmodulin 2
decreases expression
EXP
Buspirone results in decreased expression of CALM2 mRNA
CTD
PMID:24136188
NCBI chr 6:12,845,170...12,857,830
Ensembl chr15:64,519,554...64,520,657 Ensembl chr 6:64,519,554...64,520,657
G
Calr
calreticulin
decreases expression
EXP
Buspirone results in decreased expression of CALR mRNA
CTD
PMID:24136188
NCBI chr19:40,213,367...40,218,262
Ensembl chr19:40,213,239...40,219,236
G
Cap1
cyclase associated actin cytoskeleton regulatory protein 1
decreases expression
EXP
Buspirone results in decreased expression of CAP1 mRNA
CTD
PMID:24136188
NCBI chr 5:140,427,265...140,507,678
Ensembl chr 5:140,427,269...140,453,470
G
Casp1
caspase 1
multiple interactions
EXP
Buspirone inhibits the reaction [Methotrexate results in increased cleavage of CASP1 protein]
CTD
PMID:37341015
NCBI chr 8:10,746,338...10,882,295
Ensembl chr 8:10,746,333...10,882,275
G
Casp3
caspase 3
decreases expression
EXP
Buspirone results in decreased expression of CASP3 mRNA
CTD
PMID:24136188
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:52,395,540...52,413,732
G
Casp6
caspase 6
increases expression
EXP
Buspirone results in increased expression of CASP6 mRNA
CTD
PMID:24136188
NCBI chr 2:221,140,287...221,152,727
Ensembl chr 2:221,140,256...221,152,726
G
Casp7
caspase 7
decreases expression
EXP
Buspirone results in decreased expression of CASP7 mRNA
CTD
PMID:24136188
NCBI chr 1:265,442,647...265,481,938
Ensembl chr 1:265,442,676...265,482,512
G
Cat
catalase
increases expression
EXP
Buspirone results in increased expression of CAT protein
CTD
PMID:19800952
NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:110,297,342...110,329,526
G
Cbr4
carbonyl reductase 4
increases expression
EXP
Buspirone results in increased expression of CBR4 mRNA
CTD
PMID:24136188
NCBI chr16:33,625,734...33,695,067
Ensembl chr16:33,617,399...33,656,832
G
Ccdc6
coiled-coil domain containing 6
increases expression
EXP
Buspirone results in increased expression of CCDC6 mRNA
CTD
PMID:24136188
NCBI chr20:18,431,243...18,527,227
Ensembl chr20:18,431,243...18,527,227
G
Ccdc80
coiled-coil domain containing 80
decreases expression
EXP
Buspirone results in decreased expression of CCDC80 mRNA
CTD
PMID:24136188
NCBI chr11:69,191,188...69,224,844
Ensembl chr11:69,191,189...69,224,844
G
Ccl9
C-C motif chemokine ligand 9
decreases expression
EXP
Buspirone results in decreased expression of CCL6 mRNA
CTD
PMID:24136188
NCBI chr10:68,863,994...68,868,928
Ensembl chr10:68,863,995...68,868,877
G
Ccnb2
cyclin B2
decreases expression
EXP
Buspirone results in decreased expression of CCNB2 mRNA
CTD
PMID:24136188
NCBI chr 8:79,968,459...79,981,717
Ensembl chr 8:79,968,465...79,981,682
G
Ccnd1
cyclin D1
decreases expression
EXP
Buspirone results in decreased expression of CCND1 mRNA
CTD
PMID:24136188
NCBI chr 1:209,518,288...209,527,986
Ensembl chr 1:209,518,288...209,527,810
G
Cd164
CD164 molecule
decreases expression
EXP
Buspirone results in decreased expression of CD164 mRNA
CTD
PMID:24136188
NCBI chr20:46,606,439...46,618,015
Ensembl chr20:46,606,107...46,638,649
G
Cd5l
Cd5 molecule-like
decreases expression
EXP
Buspirone results in decreased expression of CD5L mRNA
CTD
PMID:24136188
NCBI chr 2:175,088,915...175,099,928
Ensembl chr 2:175,088,884...175,099,926
G
Cd68
Cd68 molecule
decreases expression
EXP
Buspirone results in decreased expression of CD68 mRNA
CTD
PMID:24136188
NCBI chr10:54,880,562...54,882,441
Ensembl chr10:54,880,563...54,882,540
G
Cd74
CD74 molecule
decreases expression
EXP
Buspirone results in decreased expression of CD74 mRNA
CTD
PMID:24136188
NCBI chr18:56,527,071...56,536,406
Ensembl chr18:56,527,132...56,536,410
G
Cdc20
cell division cycle 20
decreases expression
EXP
Buspirone results in decreased expression of CDC20 mRNA
CTD
PMID:24136188
NCBI chr 5:137,251,596...137,255,799
Ensembl chr 5:137,251,596...137,255,799
G
Cdk1
cyclin-dependent kinase 1
decreases expression
EXP
Buspirone results in decreased expression of CDK1 mRNA
CTD
PMID:24136188
NCBI chr20:19,265,252...19,280,456
Ensembl chr20:19,265,289...19,280,455
G
Cdkn2c
cyclin-dependent kinase inhibitor 2C
decreases expression
EXP
Buspirone results in decreased expression of CDKN2C mRNA
CTD
PMID:24136188
NCBI chr 5:129,639,736...129,645,564
Ensembl chr 5:129,639,736...129,644,891
G
Cdkn3
cyclin-dependent kinase inhibitor 3
decreases expression
EXP
Buspirone results in decreased expression of CDKN3 mRNA
CTD
PMID:24136188
NCBI chr15:22,502,299...22,513,725
Ensembl chr15:22,502,382...22,513,722
G
Ceacam1
CEA cell adhesion molecule 1
decreases expression
EXP
Buspirone results in decreased expression of CEACAM1 mRNA
CTD
PMID:24136188
NCBI chr 1:90,171,401...90,187,810
Ensembl chr 1:90,171,401...90,187,798
G
Ceacam4
CEA cell adhesion molecule 4
decreases expression
EXP
Buspirone results in decreased expression of CEACAM10 mRNA
CTD
PMID:24136188
NCBI chr 1:89,504,555...89,510,831
Ensembl chr 1:89,504,555...89,510,831
G
Cep20
centrosomal protein 20
decreases expression
EXP
Buspirone results in decreased expression of CEP20 mRNA
CTD
PMID:24136188
NCBI chr10:1,221,294...1,243,144
Ensembl chr10:1,221,371...1,245,241
G
Cfl1
cofilin 1
decreases expression
EXP
Buspirone results in decreased expression of CFL1 mRNA
CTD
PMID:24136188
NCBI chr 1:212,227,124...212,230,656
Ensembl chr 1:212,226,121...212,231,353
G
Cgn
cingulin
decreases expression
EXP
Buspirone results in decreased expression of CGN mRNA
CTD
PMID:24136188
NCBI chr 2:184,997,425...185,024,785
Ensembl chr 2:184,997,425...185,023,635
G
Chpt1
choline phosphotransferase 1
increases expression
EXP
Buspirone results in increased expression of CHPT1 mRNA
CTD
PMID:24136188
NCBI chr 7:24,753,880...24,802,529
Ensembl chr 7:24,750,343...24,802,521
G
Churc1
churchill domain containing 1
increases expression
EXP
Buspirone results in increased expression of CHURC1 mRNA
CTD
PMID:24136188
NCBI chr 6:101,203,778...101,218,364
Ensembl chr 6:101,203,841...101,237,748
G
Cks2
CDC28 protein kinase regulatory subunit 2
decreases expression
EXP
Buspirone results in decreased expression of CKS2 mRNA
CTD
PMID:24136188
NCBI chr17:13,722,360...13,727,519
Ensembl chr17:13,722,361...13,727,519
G
Clec4f
C-type lectin domain family 4, member F
decreases expression
EXP
Buspirone results in decreased expression of CLEC4F mRNA
CTD
PMID:24136188
NCBI chr 4:117,686,686...117,696,407
Ensembl chr 4:117,686,686...117,696,438
G
Clic1
chloride intracellular channel 1
decreases expression
EXP
Buspirone results in decreased expression of CLIC1 mRNA
CTD
PMID:24136188
NCBI chr20:3,769,522...3,778,367
Ensembl chr20:3,769,527...3,778,367
G
Clpb
ClpB family mitochondrial disaggregase
decreases expression
EXP
Buspirone results in decreased expression of CLPB mRNA
CTD
PMID:24136188
NCBI chr 1:165,440,705...165,563,514
Ensembl chr 1:165,440,861...165,583,815
G
Cltb
clathrin, light chain B
increases expression
EXP
Buspirone results in increased expression of CLTB mRNA
CTD
PMID:24136188
NCBI chr17:10,006,416...10,024,278
Ensembl chr17:10,006,656...10,024,915
G
Cmtm6
CKLF-like MARVEL transmembrane domain containing 6
decreases expression
EXP
Buspirone results in decreased expression of CMTM6 mRNA
CTD
PMID:24136188
NCBI chr 8:123,301,131...123,319,230
Ensembl chr 8:123,300,918...123,319,230
G
Cnppd1
cyclin Pas1/PHO80 domain containing 1
increases expression
EXP
Buspirone results in increased expression of CNPPD1 mRNA
CTD
PMID:24136188
NCBI chr 9:84,082,148...84,088,888
Ensembl chr 9:84,082,149...84,089,788
G
Cnr1
cannabinoid receptor 1
affects response to substance
ISO
CNR1 affects the susceptibility to Buspirone
CTD
PMID:15081793
NCBI chr 5:53,204,867...53,230,396
Ensembl chr 5:53,204,260...53,239,252
G
Cobll1
cordon-bleu WH2 repeat protein-like 1
increases expression
EXP
Buspirone results in increased expression of COBLL1 mRNA
CTD
PMID:24136188
NCBI chr 3:70,161,369...70,324,844
Ensembl chr 3:70,161,372...70,323,460
G
Col14a1
collagen type XIV alpha 1 chain
decreases expression
EXP
Buspirone results in decreased expression of COL14A1 mRNA
CTD
PMID:24136188
NCBI chr 7:88,611,827...88,826,939
Ensembl chr 7:88,611,828...88,826,938
G
Col1a2
collagen type I alpha 2 chain
decreases expression
EXP
Buspirone results in decreased expression of COL1A2 mRNA
CTD
PMID:24136188
NCBI chr 4:33,518,557...33,553,484
Ensembl chr 4:33,518,420...33,553,995
G
Col3a1
collagen type III alpha 1 chain
decreases expression
EXP
Buspirone results in decreased expression of COL3A1 mRNA
CTD
PMID:24136188
NCBI chr 9:54,866,646...54,902,578
Ensembl chr 9:54,866,632...54,903,232
G
Commd5
COMM domain containing 5
increases expression
EXP
Buspirone results in increased expression of COMMD5 mRNA
CTD
PMID:24136188
NCBI chr 7:110,502,492...110,503,916
Ensembl chr 7:110,479,403...110,505,897
G
Copg1
COPI coat complex subunit gamma 1
decreases expression
EXP
Buspirone results in decreased expression of COPG1 mRNA
CTD
PMID:24136188
NCBI chr 4:121,923,644...121,949,819
Ensembl chr 4:121,923,873...121,949,812
G
Coro1c
coronin 1C
decreases expression
EXP
Buspirone results in decreased expression of CORO1C mRNA
CTD
PMID:24136188
NCBI chr12:48,373,573...48,445,718
Ensembl chr12:48,373,597...48,445,716
G
Cox14
cytochrome c oxidase assembly factor COX14
increases expression
EXP
Buspirone results in increased expression of COX14 mRNA
CTD
PMID:24136188
NCBI chr 7:132,731,069...132,733,159
Ensembl chr 7:132,731,069...132,733,159
G
Cox7a2l
cytochrome c oxidase subunit 7A2 like
increases expression
EXP
Buspirone results in increased expression of COX7A2L mRNA
CTD
PMID:24136188
NCBI chr 6:16,936,574...16,950,797
Ensembl chr 6:16,936,795...16,950,798
G
Cpt1a
carnitine palmitoyltransferase 1A
increases expression
EXP
Buspirone results in increased expression of CPT1A mRNA
CTD
PMID:24136188
NCBI chr 1:209,993,881...210,056,329
Ensembl chr 1:209,993,875...210,056,326
G
Cpt2
carnitine palmitoyltransferase 2
increases expression
EXP
Buspirone results in increased expression of CPT2 mRNA
CTD
PMID:24136188
NCBI chr 5:127,893,450...127,911,347
Ensembl chr 5:127,893,207...127,910,818
G
Crem
cAMP responsive element modulator
decreases expression
EXP
Buspirone results in decreased expression of CREM mRNA
CTD
PMID:24136188
NCBI chr17:58,932,011...59,001,160
Ensembl chr17:58,934,147...59,001,160
G
Cry1
cryptochrome circadian regulator 1
decreases expression
EXP
Buspirone results in decreased expression of CRY1 mRNA
CTD
PMID:24136188
NCBI chr 7:20,417,526...20,481,791
Ensembl chr 7:20,417,107...20,481,822
G
Cse1l
chromosome segregation 1 like
decreases expression
EXP
Buspirone results in decreased expression of CSE1L mRNA
CTD
PMID:24136188
NCBI chr 3:176,060,183...176,097,909
Ensembl chr 3:176,060,215...176,108,734
G
Csf1r
colony stimulating factor 1 receptor
decreases expression
EXP
Buspirone results in decreased expression of CSF1R mRNA
CTD
PMID:24136188
NCBI chr18:56,834,152...56,860,804
Ensembl chr18:56,817,049...56,860,806
G
Csnk2a2
casein kinase 2 alpha 2
increases expression
EXP
Buspirone results in increased expression of CSNK2A2 mRNA
CTD
PMID:24136188
NCBI chr19:9,562,340...9,602,136
Ensembl chr19:9,562,321...9,602,136
G
Csrp1
cysteine and glycine-rich protein 1
decreases expression
EXP
Buspirone results in decreased expression of CSRP1 mRNA
CTD
PMID:24136188
NCBI chr13:49,709,928...49,731,141
Ensembl chr13:49,709,914...49,731,139
G
Ctsd
cathepsin D
increases expression
EXP
Buspirone results in increased expression of CTSD mRNA
CTD
PMID:24136188
NCBI chr 1:206,956,945...206,968,821
Ensembl chr 1:206,956,944...206,968,821
G
Ctsl
cathepsin L
increases expression
EXP
Buspirone results in increased expression of CTSL mRNA
CTD
PMID:24136188
NCBI chr17:770,104...776,266
Ensembl chr17:770,093...777,113
G
Ctss
cathepsin S
decreases expression
EXP
Buspirone results in decreased expression of CTSS mRNA
CTD
PMID:24136188
NCBI chr 2:185,775,316...185,803,440
Ensembl chr 2:185,775,296...185,803,440
G
Ctsz
cathepsin Z
decreases expression
EXP
Buspirone results in decreased expression of CTSZ mRNA
CTD
PMID:24136188
NCBI chr 3:183,643,077...183,653,847
Ensembl chr 3:183,643,077...183,657,012
G
Cxcl11
C-X-C motif chemokine ligand 11
increases expression
EXP
Buspirone results in increased expression of CXCL11 mRNA
CTD
PMID:24136188
NCBI chr14:15,973,728...15,976,503
Ensembl chr14:15,973,720...15,976,567
G
Cybb
cytochrome b-245 beta chain
decreases expression
EXP
Buspirone results in decreased expression of CYBB mRNA
CTD
PMID:24136188
NCBI chr X:16,030,596...16,065,065
Ensembl chr X:16,030,596...16,065,065
G
Cyp27a1
cytochrome P450, family 27, subfamily a, polypeptide 1
increases expression
EXP
Buspirone results in increased expression of CYP27A1 mRNA
CTD
PMID:24136188
NCBI chr 9:83,712,402...83,743,222
Ensembl chr 9:83,713,293...83,743,215
G
Cyp2c22
cytochrome P450, family 2, subfamily c, polypeptide 22
decreases expression
EXP
Buspirone results in decreased expression of CYP2C22 mRNA
CTD
PMID:24136188
NCBI chr 1:248,941,143...248,980,767
Ensembl chr 1:248,904,062...248,971,182
G
Cyp2d4
cytochrome P450, family 2, subfamily d, polypeptide 4
increases oxidation increases expression
ISO EXP
CYP2D6 protein results in increased oxidation of Buspirone Buspirone results in increased expression of CYP2D4 mRNA
CTD
PMID:15640381 PMID:24136188
NCBI chr 7:115,762,662...115,771,832
Ensembl chr 7:115,761,696...115,771,837
G
Cyp2j3
cytochrome P450, family 2, subfamily j, polypeptide 3
increases expression
EXP
Buspirone results in increased expression of CYP2J3 mRNA
CTD
PMID:24136188
NCBI chr 5:116,335,755...116,360,677
Ensembl chr 5:116,335,755...116,360,499
G
Cyp3a2
cytochrome P450, family 3, subfamily a, polypeptide 2
increases oxidation increases metabolic processing multiple interactions
ISO
CYP3A4 protein results in increased oxidation of Buspirone CYP3A4 protein results in increased metabolism of Buspirone Resveratrol inhibits the reaction [CYP3A4 protein results in increased metabolism of Buspirone]
CTD
PMID:15640381 PMID:20716633
NCBI chr12:14,321,771...14,343,886
Ensembl chr12:14,321,771...14,343,857
G
Cyp3a9
cytochrome P450, family 3, subfamily a, polypeptide 9
increases oxidation increases expression
ISO EXP
CYP3A5 protein results in increased oxidation of Buspirone Buspirone results in increased expression of CYP3A9 mRNA
CTD
PMID:15640381 PMID:24136188
NCBI chr12:21,919,955...21,960,160
Ensembl chr12:21,919,940...21,960,154
G
Cyp4a1
cytochrome P450, family 4, subfamily a, polypeptide 1
increases expression
EXP
Buspirone results in increased expression of CYP4A1 mRNA
CTD
PMID:24136188
NCBI chr 5:134,360,096...134,374,233
Ensembl chr 5:134,360,111...134,374,231
G
Cyp4b1
cytochrome P450, family 4, subfamily b, polypeptide 1
increases expression
EXP
Buspirone results in increased expression of CYP4B1 mRNA
CTD
PMID:24136188
NCBI chr 5:134,375,807...134,413,635
Ensembl chr 5:134,375,807...134,393,116
G
Cyp4f1
cytochrome P450, family 4, subfamily f, polypeptide 1
decreases expression
EXP
Buspirone results in decreased expression of CYP4F1 mRNA
CTD
PMID:24136188
NCBI chr 7:12,661,357...12,672,952
Ensembl chr 7:12,661,359...12,672,612
G
Cyp4f4
cytochrome P450, family 4, subfamily f, polypeptide 4
increases expression
EXP
Buspirone results in increased expression of CYP4F4 mRNA
CTD
PMID:24136188
NCBI chr 7:12,367,711...12,384,010
Ensembl chr 7:12,367,660...12,384,010
G
Cyp8b1
cytochrome P450 family 8 subfamily B member 1
increases expression
EXP
Buspirone results in increased expression of CYP8B1 mRNA
CTD
PMID:24136188
NCBI chr 8:130,455,622...130,457,592
Ensembl chr 8:130,442,503...130,457,689
G
Daam1
dishevelled associated activator of morphogenesis 1
decreases expression
EXP
Buspirone results in decreased expression of DAAM1 mRNA
CTD
PMID:24136188
NCBI chr 6:96,125,521...96,286,049
Ensembl chr 6:96,125,621...96,286,049
G
Dab2
DAB adaptor protein 2
decreases expression
EXP
Buspirone results in decreased expression of DAB2 mRNA
CTD
PMID:24136188
NCBI chr 2:57,241,947...57,294,893
Ensembl chr 2:57,242,064...57,294,888
G
Dapk1
death associated protein kinase 1
decreases expression
EXP
Buspirone results in decreased expression of DAPK1 mRNA
CTD
PMID:24136188
NCBI chr17:3,935,826...4,096,858
Ensembl chr17:3,935,625...4,096,581
G
Dbi
diazepam binding inhibitor
decreases expression
EXP
Buspirone results in decreased expression of DBI mRNA
CTD
PMID:24136188
NCBI chr13:33,794,231...33,802,632
Ensembl chr13:33,759,845...33,821,450
G
Ddc
dopa decarboxylase
decreases expression
EXP
Buspirone results in decreased expression of DDC mRNA
CTD
PMID:24136188
NCBI chr14:90,592,304...90,682,830
Ensembl chr14:90,592,304...90,682,806
G
Ddhd1
DDHD domain containing 1
decreases expression
EXP
Buspirone results in decreased expression of DDHD1 mRNA
CTD
PMID:24136188
NCBI chr15:21,304,053...21,370,608
Ensembl chr15:21,303,826...21,370,608
G
Ddx1
DEAD-box helicase 1
decreases expression
EXP
Buspirone results in decreased expression of DDX1 mRNA
CTD
PMID:24136188
NCBI chr 6:41,725,365...41,756,236
Ensembl chr 6:41,725,367...41,758,302
G
Decr1
2,4-dienoyl-CoA reductase 1
increases expression
EXP
Buspirone results in increased expression of DECR1 mRNA
CTD
PMID:24136188
NCBI chr 5:34,208,195...34,236,074
Ensembl chr 5:34,208,195...34,236,033
G
Dek
DEK proto-oncogene
decreases expression
EXP
Buspirone results in decreased expression of DEK mRNA
CTD
PMID:24136188
NCBI chr17:17,786,989...17,809,096
Ensembl chr17:17,787,139...17,810,122
G
Deptor
DEP domain containing MTOR-interacting protein
increases expression
EXP
Buspirone results in increased expression of DEPTOR mRNA
CTD
PMID:24136188
NCBI chr 7:88,404,745...88,574,065
Ensembl chr 7:88,404,620...88,574,041
G
Dhrs7
dehydrogenase/reductase 7
increases expression
EXP
Buspirone results in increased expression of DHRS7 mRNA
CTD
PMID:24136188
NCBI chr 6:97,068,149...97,083,744
Ensembl chr 6:97,068,149...97,083,744
G
Dld
dihydrolipoamide dehydrogenase
decreases expression
EXP
Buspirone results in decreased expression of DLD mRNA
CTD
PMID:24136188
NCBI chr 6:53,631,686...53,655,059
Ensembl chr 6:53,619,631...53,652,354
G
Dnajb1
DnaJ heat shock protein family (Hsp40) member B1
increases expression
EXP
Buspirone results in increased expression of DNAJB1 mRNA
CTD
PMID:24136188
NCBI chr19:41,427,453...41,431,141
Ensembl chr19:41,427,453...41,431,416
G
Dnajc9
DnaJ heat shock protein family (Hsp40) member C9
decreases expression
EXP
Buspirone results in decreased expression of DNAJC9 mRNA
CTD
PMID:24136188
NCBI chr15:3,970,843...4,003,009
Ensembl chr15:3,970,114...3,977,304
G
Dpm1
dolichyl-phosphate mannosyltransferase subunit 1, catalytic
increases expression
EXP
Buspirone results in increased expression of DPM1 mRNA
CTD
PMID:24136188
NCBI chr 3:177,338,855...177,358,398
Ensembl chr 3:177,338,855...177,358,412
G
Dpm3
dolichyl-phosphate mannosyltransferase subunit 3, regulatory
increases expression
EXP
Buspirone results in increased expression of DPM3 mRNA
CTD
PMID:24136188
NCBI chr 2:176,974,290...176,974,805
Ensembl chr15:52,612,418...52,612,696
G
Dpysl2
dihydropyrimidinase-like 2
decreases expression
EXP
Buspirone results in decreased expression of DPYSL2 mRNA
CTD
PMID:24136188
NCBI chr15:45,181,041...45,287,065
Ensembl chr15:45,181,041...45,287,065
G
Dtymk
deoxythymidylate kinase
decreases expression
EXP
Buspirone results in decreased expression of DTYMK mRNA
CTD
PMID:24136188
NCBI chr 9:101,762,899...101,771,733
Ensembl chr 9:101,762,899...101,774,504
G
Dut
deoxyuridine triphosphatase
decreases expression
EXP
Buspirone results in decreased expression of DUT mRNA
CTD
PMID:24136188
NCBI chr 3:132,952,258...132,963,433
Ensembl chr 3:132,952,394...132,964,956
G
Dynll1
dynein light chain LC8-type 1
decreases expression
EXP
Buspirone results in decreased expression of DYNLL1 mRNA
CTD
PMID:24136188
NCBI chr12:46,945,291...46,976,867
Ensembl chr12:46,973,050...46,976,861
G
Dynlt3
dynein light chain Tctex-type 3
decreases expression
EXP
Buspirone results in decreased expression of DYNLT3 mRNA
CTD
PMID:24136188
NCBI chr X:16,000,425...16,009,632
Ensembl chr X:16,000,395...16,009,627
G
Ech1
enoyl-CoA hydratase 1
increases expression
EXP
Buspirone results in increased expression of ECH1 mRNA
CTD
PMID:24136188
NCBI chr 1:93,241,076...93,248,314
Ensembl chr 1:93,241,734...93,248,440
G
Echdc1
ethylmalonyl-CoA decarboxylase 1
decreases expression
EXP
Buspirone results in decreased expression of ECHDC1 mRNA
CTD
PMID:24136188
NCBI chr 1:30,304,968...30,355,957
Ensembl chr 1:30,304,971...30,337,208
G
Echdc3
enoyl CoA hydratase domain containing 3
increases expression
EXP
Buspirone results in increased expression of ECHDC3 mRNA
CTD
PMID:24136188
NCBI chr17:76,980,112...77,002,934
Ensembl chr17:76,980,083...77,002,934
G
Eci1
enoyl-CoA delta isomerase 1
increases expression
EXP
Buspirone results in increased expression of ECI1 mRNA
CTD
PMID:24136188
NCBI chr10:13,961,250...13,974,595
Ensembl chr10:13,961,218...13,974,773
G
Edem1
ER degradation enhancing alpha-mannosidase like protein 1
increases expression
EXP
Buspirone results in increased expression of EDEM1 mRNA
CTD
PMID:24136188
NCBI chr 4:143,350,989...143,385,693
Ensembl chr 4:143,353,624...143,388,060
G
Eftud2
elongation factor Tu GTP binding domain containing 2
decreases expression
EXP
Buspirone results in decreased expression of EFTUD2 mRNA
CTD
PMID:24136188
NCBI chr10:88,304,992...88,352,229
Ensembl chr10:88,304,992...88,346,299
G
Ehbp1
EH domain binding protein 1
decreases expression
EXP
Buspirone results in decreased expression of EHBP1 mRNA
CTD
PMID:24136188
NCBI chr14:100,294,585...100,581,764
Ensembl chr14:100,294,585...100,546,579
G
Ei24
EI24, autophagy associated transmembrane protein
increases expression
EXP
Buspirone results in increased expression of EI24 mRNA
CTD
PMID:24136188
NCBI chr 8:44,683,138...44,699,502
Ensembl chr 8:44,683,144...44,695,214
G
Eif3c
eukaryotic translation initiation factor 3, subunit C
decreases expression
EXP
Buspirone results in decreased expression of EIF3C mRNA
CTD
PMID:24136188
NCBI chr 1:190,565,183...190,583,067
Ensembl chr 1:190,565,184...190,583,067
G
Eif3l
eukaryotic translation initiation factor 3, subunit L
decreases expression
EXP
Buspirone results in decreased expression of EIF3L mRNA
CTD
PMID:24136188
NCBI chr 7:112,522,222...112,544,063
Ensembl chr 7:112,507,831...112,544,062
G
Eif4a2
eukaryotic translation initiation factor 4A2
increases expression
EXP
Buspirone results in increased expression of EIF4A2 mRNA
CTD
PMID:24136188
NCBI chr11:91,268,730...91,276,738
Ensembl chr11:91,268,731...91,275,323
G
Eif4b
eukaryotic translation initiation factor 4B
increases expression
EXP
Buspirone results in increased expression of EIF4B mRNA
CTD
PMID:24136188
NCBI chr 7:135,085,259...135,107,054
Ensembl chr 7:135,085,066...135,107,064
G
Elovl5
ELOVL fatty acid elongase 5
decreases expression
EXP
Buspirone results in decreased expression of ELOVL5 mRNA
CTD
PMID:24136188
NCBI chr 8:87,671,164...87,737,618
Ensembl chr 8:87,671,159...87,737,616
G
Elovl6
ELOVL fatty acid elongase 6
decreases expression
EXP
Buspirone results in decreased expression of ELOVL6 mRNA
CTD
PMID:24136188
NCBI chr 2:220,738,095...220,845,528
Ensembl chr 2:220,738,064...220,845,549
G
Enpep
glutamyl aminopeptidase
decreases expression
EXP
Buspirone results in decreased expression of ENPEP mRNA
CTD
PMID:24136188
NCBI chr 2:220,456,258...220,526,218
Ensembl chr 2:220,456,278...220,526,218
G
Ephx1
epoxide hydrolase 1
decreases expression
EXP
Buspirone results in decreased expression of EPHX1 mRNA
CTD
PMID:24136188
NCBI chr13:95,246,079...95,275,852
Ensembl chr13:95,246,080...95,321,981
G
Erg28
ergosterol biosynthesis 28 homolog
increases expression
EXP
Buspirone results in increased expression of ERG28 mRNA
CTD
PMID:24136188
NCBI chr 6:111,205,102...111,214,068
Ensembl chr 6:111,205,103...111,214,068
G
Ergic1
endoplasmic reticulum-golgi intermediate compartment 1
decreases expression
EXP
Buspirone results in decreased expression of ERGIC1 mRNA
CTD
PMID:24136188
NCBI chr10:17,035,615...17,131,411
Ensembl chr10:17,035,615...17,131,376
G
Erp29
endoplasmic reticulum protein 29
decreases expression
EXP
Buspirone results in decreased expression of ERP29 mRNA
CTD
PMID:24136188
NCBI chr12:40,750,177...40,756,607
Ensembl chr12:40,750,314...40,757,010
G
Etnk2
ethanolamine kinase 2
increases expression
EXP
Buspirone results in increased expression of ETNK2 mRNA
CTD
PMID:24136188
NCBI chr13:47,362,964...47,381,100
Ensembl chr13:47,363,060...47,381,100
G
Ewsr1
EWS RNA-binding protein 1
decreases expression
EXP
Buspirone results in decreased expression of EWSR1 mRNA
CTD
PMID:24136188
NCBI chr14:84,179,413...84,208,149
Ensembl chr14:84,179,618...84,208,095
G
Exosc5
exosome component 5
increases expression
EXP
Buspirone results in increased expression of EXOSC5 mRNA
CTD
PMID:24136188
NCBI chr 1:90,295,495...90,305,047
Ensembl chr 1:90,293,797...90,305,046
G
Fabp5
fatty acid binding protein 5
decreases expression
EXP
Buspirone results in decreased expression of FABP5 mRNA
CTD
PMID:24136188
NCBI chr 2:93,672,451...93,676,186
Ensembl chr 2:93,672,458...93,676,127
G
Fads1
fatty acid desaturase 1
decreases expression
EXP
Buspirone results in decreased expression of FADS1 mRNA
CTD
PMID:24136188
NCBI chr 1:216,252,605...216,267,618
Ensembl chr 1:216,252,602...216,267,615
G
Fads2
fatty acid desaturase 2
decreases expression
EXP
Buspirone results in decreased expression of FADS2 mRNA
CTD
PMID:24136188
NCBI chr 1:216,132,277...216,172,190
Ensembl chr 1:216,133,676...216,172,066
G
Fam111a
FAM111 trypsin like peptidase A
decreases expression
EXP
Buspirone results in decreased expression of FAM111A mRNA
CTD
PMID:24136188
NCBI chr 1:219,065,542...219,081,213
Ensembl chr 1:219,065,601...219,081,211
G
Fam98a
family with sequence similarity 98, member A
decreases expression
EXP
Buspirone results in decreased expression of FAM98A mRNA
CTD
PMID:24136188
NCBI chr 6:25,626,108...25,640,767
Ensembl chr 6:25,625,984...25,640,767
G
Fasn
fatty acid synthase
decreases expression
EXP
Buspirone results in decreased expression of FASN mRNA
CTD
PMID:24136188
NCBI chr10:106,570,415...106,588,581
Ensembl chr10:106,570,413...106,588,583
G
Fat1
FAT atypical cadherin 1
decreases expression
EXP
Buspirone results in decreased expression of FAT1 mRNA
CTD
PMID:24136188
NCBI chr16:53,909,759...54,029,175
Ensembl chr16:53,909,556...54,028,609
G
Fbxo31
F-box protein 31
increases expression
EXP
Buspirone results in increased expression of FBXO31 mRNA
CTD
PMID:24136188
NCBI chr19:66,533,437...66,564,674
Ensembl chr19:66,533,437...66,564,674
G
Fbxw2
F-box and WD repeat domain containing 2
increases expression
EXP
Buspirone results in increased expression of FBXW2 mRNA
CTD
PMID:24136188
NCBI chr 3:38,486,358...38,511,683
Ensembl chr 3:38,486,362...38,511,667
G
Fcgr2a
Fc gamma receptor 2A
decreases expression
EXP
Buspirone results in decreased expression of FCGR2A mRNA
CTD
PMID:24136188
NCBI chr13:85,813,516...85,830,269
Ensembl chr13:85,855,437...85,864,394 Ensembl chr13:85,855,437...85,864,394
G
Fcna
ficolin A
decreases expression
EXP
Buspirone results in decreased expression of FCNA mRNA
CTD
PMID:24136188
NCBI chr 3:28,844,036...28,847,441
Ensembl chr 3:28,844,039...28,847,237
G
Fez2
fasciculation and elongation protein zeta 2
decreases expression
EXP
Buspirone results in decreased expression of FEZ2 mRNA
CTD
PMID:24136188
NCBI chr 6:22,406,685...22,446,745
Ensembl chr 6:22,406,632...22,447,041
G
Fga
fibrinogen alpha chain
decreases expression
EXP
Buspirone results in decreased expression of FGA mRNA
CTD
PMID:24136188
NCBI chr 2:170,672,169...170,679,572
Ensembl chr 2:170,672,012...170,679,577
G
Fgfr2
fibroblast growth factor receptor 2
decreases expression
EXP
Buspirone results in decreased expression of FGFR2 mRNA
CTD
PMID:24136188
NCBI chr 1:194,175,703...194,280,914
Ensembl chr 1:194,175,705...194,280,914
G
Fjx1
four-jointed box kinase 1
increases expression
EXP
Buspirone results in increased expression of ANKHD1-EIF4EBP3 mRNA
CTD
PMID:24136188
NCBI chr 3:109,229,223...109,231,324
Ensembl chr 3:109,227,170...109,232,479
G
Flcn
folliculin
increases expression
EXP
Buspirone results in increased expression of FLCN mRNA
CTD
PMID:24136188
NCBI chr10:45,088,164...45,107,581
Ensembl chr10:45,088,167...45,107,309
G
Fmo3
flavin containing dimethylaniline monoxygenase 3
increases expression
EXP
Buspirone results in increased expression of FMO3 mRNA
CTD
PMID:24136188
NCBI chr13:77,838,899...77,868,869
Ensembl chr13:77,842,602...77,861,256
G
Fmo5
flavin containing dimethylaniline monoxygenase 5
increases expression
EXP
Buspirone results in increased expression of FMO5 mRNA
CTD
PMID:24136188
NCBI chr 2:187,885,741...187,938,468
Ensembl chr 2:187,910,964...187,938,464
G
Foxa3
forkhead box A3
increases expression
EXP
Buspirone results in increased expression of FOXA3 mRNA
CTD
PMID:24136188
NCBI chr 1:87,790,111...87,800,259
Ensembl chr 1:87,790,012...87,800,953
G
Foxo1
forkhead box O1
increases expression
EXP
Buspirone results in increased expression of FOXO1 mRNA
CTD
PMID:24136188
NCBI chr 2:138,462,974...138,541,420
Ensembl chr 2:138,462,697...138,541,419
G
Fstl1
follistatin-like 1
decreases expression
EXP
Buspirone results in decreased expression of FSTL1 mRNA
CTD
PMID:24136188
NCBI chr11:76,400,870...76,454,053
Ensembl chr11:76,391,315...76,455,126
G
Ftcd
formimidoyltransferase cyclodeaminase
increases expression
EXP
Buspirone results in increased expression of FTCD mRNA
CTD
PMID:24136188
NCBI chr20:12,054,710...12,068,219
Ensembl chr20:12,054,711...12,068,237
G
Fus
Fus RNA binding protein
decreases expression
EXP
Buspirone results in decreased expression of FUS mRNA
CTD
PMID:24136188
NCBI chr 1:192,007,011...192,020,887
Ensembl chr 1:192,007,006...192,020,884
G
Fxyd1
FXYD domain-containing ion transport regulator 1
increases expression
EXP
Buspirone results in increased expression of FXYD1 mRNA
CTD
PMID:24136188
NCBI chr 1:95,414,556...95,418,645
Ensembl chr 1:95,414,557...95,418,591
G
G0s2
G0/G1switch 2
increases expression
EXP
Buspirone results in increased expression of G0S2 mRNA
CTD
PMID:24136188
NCBI chr13:107,335,036...107,335,948
Ensembl chr13:107,335,036...107,336,293
G
G6pd
glucose-6-phosphate dehydrogenase
decreases expression
EXP
Buspirone results in decreased expression of G6PD mRNA
CTD
PMID:24136188
NCBI chr X:157,352,364...157,372,144
Ensembl chr X:157,352,373...157,372,144
G
Gadd45g
growth arrest and DNA-damage-inducible, gamma
decreases expression
EXP
Buspirone results in decreased expression of GADD45G mRNA
CTD
PMID:24136188
NCBI chr17:13,528,606...13,530,351
Ensembl chr17:13,528,610...13,530,369
G
Galnt1
polypeptide N-acetylgalactosaminyltransferase 1
decreases expression
EXP
Buspirone results in decreased expression of GALNT1 mRNA
CTD
PMID:24136188
NCBI chr18:15,763,697...15,843,598
Ensembl chr18:15,764,277...15,843,588
G
Gars1
glycyl-tRNA synthetase 1
decreases expression
EXP
Buspirone results in decreased expression of GARS1 mRNA
CTD
PMID:24136188
NCBI chr 4:85,484,939...85,542,876
Ensembl chr 4:85,493,753...85,542,876
G
Gas5
growth arrest specific 5
increases expression
EXP
Buspirone results in increased expression of GAS5 mRNA
CTD
PMID:24136188
NCBI chr13:75,836,963...75,840,284
G
Gbe1
1,4-alpha-glucan branching enzyme 1
decreases expression
EXP
Buspirone results in decreased expression of GBE1 mRNA
CTD
PMID:24136188
NCBI chr11:22,181,194...22,446,640
Ensembl chr11:22,181,103...22,446,638
G
Gcdh
glutaryl-CoA dehydrogenase
increases expression
EXP
Buspirone results in increased expression of GCDH mRNA
CTD
PMID:24136188
NCBI chr19:40,168,038...40,174,536
Ensembl chr19:40,168,141...40,175,686
G
Gchfr
GTP cyclohydrolase I feedback regulator
increases expression
EXP
Buspirone results in increased expression of GCHFR mRNA
CTD
PMID:24136188
NCBI chr 3:126,611,892...126,615,926
Ensembl chr 3:126,613,240...126,615,926
G
Gclc
glutamate-cysteine ligase, catalytic subunit
decreases expression
EXP
Buspirone results in decreased expression of GCLC mRNA
CTD
PMID:24136188
NCBI chr 8:87,510,251...87,548,896
Ensembl chr 8:87,510,463...87,548,893
G
Gde1
glycerophosphodiester phosphodiesterase 1
increases expression
EXP
Buspirone results in increased expression of GDE1 mRNA
CTD
PMID:24136188
NCBI chr 1:182,451,182...182,466,569
Ensembl chr 1:182,451,184...182,466,772
G
Gdi2
GDP dissociation inhibitor 2
decreases expression
EXP
Buspirone results in decreased expression of GDI2 mRNA
CTD
PMID:24136188
NCBI chr17:71,559,460...71,586,147
Ensembl chr17:71,559,461...71,586,147
G
Gfm1
G elongation factor, mitochondrial 1
decreases expression
EXP
Buspirone results in decreased expression of GFM1 mRNA
CTD
PMID:24136188
NCBI chr 2:154,010,601...154,055,523
Ensembl chr 2:154,010,614...154,065,805
G
Ggcx
gamma-glutamyl carboxylase
decreases expression
EXP
Buspirone results in decreased expression of GGCX mRNA
CTD
PMID:24136188
NCBI chr 4:106,027,918...106,043,653
Ensembl chr 4:106,027,912...106,043,923
G
Ghr
growth hormone receptor
decreases expression
EXP
Buspirone results in decreased expression of GHR mRNA
CTD
PMID:24136188
NCBI chr 2:54,269,066...54,532,595
Ensembl chr 2:54,270,206...54,532,331
G
Gldc
glycine decarboxylase
decreases expression
EXP
Buspirone results in decreased expression of GLDC mRNA
CTD
PMID:24136188
NCBI chr 1:237,296,753...237,375,620
Ensembl chr 1:237,296,753...237,375,604
G
Glrx
glutaredoxin
increases expression
EXP
Buspirone results in increased expression of GLRX mRNA
CTD
PMID:24136188
NCBI chr 2:7,073,737...7,083,548
Ensembl chr 2:7,073,759...7,083,543
G
Glyat
glycine-N-acyltransferase
increases expression
EXP
Buspirone results in increased expression of GLYAT mRNA
CTD
PMID:24136188
NCBI chr 1:219,128,798...219,149,615
Ensembl chr 1:219,128,811...219,150,774
G
Glyatl2
glycine-N-acyltransferase-like 2
increases expression
EXP
Buspirone results in increased expression of GLYATL2 mRNA
CTD
PMID:24136188
NCBI chr 1:219,232,154...219,265,142
Ensembl chr 1:219,232,103...219,266,322
G
Gnpnat1
glucosamine-phosphate N-acetyltransferase 1
decreases expression
EXP
Buspirone results in decreased expression of GNPNAT1 mRNA
CTD
PMID:24136188
NCBI chr15:21,076,129...21,088,526
Ensembl chr15:21,076,130...21,088,423
G
Gpam
glycerol-3-phosphate acyltransferase, mitochondrial
decreases expression
EXP
Buspirone results in decreased expression of GPAM mRNA
CTD
PMID:24136188
NCBI chr 1:264,111,599...264,176,112
Ensembl chr 1:264,113,813...264,175,911
G
Gpd1
glycerol-3-phosphate dehydrogenase 1
decreases expression
EXP
Buspirone results in decreased expression of GPD1 mRNA
CTD
PMID:24136188
NCBI chr 7:132,722,982...132,730,373
Ensembl chr 7:132,721,915...132,730,368
G
Gpt
glutamic--pyruvic transaminase
increases expression
EXP
Buspirone results in increased expression of GPT mRNA
CTD
PMID:24136188
NCBI chr 7:110,295,599...110,300,134
Ensembl chr 7:110,296,206...110,300,160
G
Gspt1
G1 to S phase transition 1
decreases expression
EXP
Buspirone results in decreased expression of GSPT1 mRNA
CTD
PMID:24136188
NCBI chr10:4,867,687...4,904,186
Ensembl chr10:4,869,465...4,908,040
G
Gstp1
glutathione S-transferase pi 1
increases expression
EXP
Buspirone results in increased expression of GSTP1 mRNA
CTD
PMID:24136188
NCBI chr 1:210,767,237...210,770,242
Ensembl chr 1:210,767,237...210,769,705
G
Gstt2
glutathione S-transferase theta 2
increases expression
EXP
Buspirone results in increased expression of GSTT2 mRNA
CTD
PMID:24136188
NCBI chr20:12,819,053...12,822,724
Ensembl chr20:12,818,540...12,822,718
G
Gulo
gulonolactone (L-) oxidase
decreases expression
EXP
Buspirone results in decreased expression of GULO mRNA
CTD
PMID:24136188
NCBI chr15:44,381,226...44,403,314
Ensembl chr15:44,381,214...44,403,422
G
H1f0
H1.0 linker histone
decreases expression
EXP
Buspirone results in decreased expression of H1F0 mRNA
CTD
PMID:24136188
NCBI chr 7:112,473,280...112,475,140
Ensembl chr 7:112,473,222...112,475,006
G
H2az1
H2A.Z variant histone 1
decreases expression
EXP
Buspirone results in decreased expression of H2AZ1 mRNA
CTD
PMID:24136188
NCBI chr 2:229,026,464...229,031,411
Ensembl chr 2:229,028,843...229,031,411
G
Hacd2
3-hydroxyacyl-CoA dehydratase 2
decreases expression
EXP
Buspirone results in decreased expression of HACD2 mRNA
CTD
PMID:24136188
NCBI chr11:79,175,470...79,268,975
Ensembl chr11:79,175,482...79,268,126
G
Hacd3
3-hydroxyacyl-CoA dehydratase 3
decreases expression
EXP
Buspirone results in decreased expression of HACD3 mRNA
CTD
PMID:24136188
NCBI chr 8:74,396,441...74,433,700
Ensembl chr 8:74,396,442...74,433,700
G
Hacl1
2-hydroxyacyl-CoA lyase 1
increases expression
EXP
Buspirone results in increased expression of HACL1 mRNA
CTD
PMID:24136188
NCBI chr16:6,831,293...6,869,410
Ensembl chr16:6,833,268...6,869,410
G
Hadhb
hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit beta
increases expression
EXP
Buspirone results in increased expression of HADHB mRNA
CTD
PMID:24136188
NCBI chr 6:31,873,404...31,907,557
Ensembl chr 6:31,873,404...31,907,835
G
Hao1
hydroxyacid oxidase 1
decreases expression
EXP
Buspirone results in decreased expression of HAO1 mRNA
CTD
PMID:24136188
NCBI chr 3:142,102,873...142,281,527
Ensembl chr 3:142,224,612...142,281,494
G
Hat1
histone acetyltransferase 1
decreases expression
EXP
Buspirone results in decreased expression of HAT1 mRNA
CTD
PMID:24136188
NCBI chr 3:76,624,442...76,672,701
Ensembl chr 3:76,624,869...76,672,696
G
Haus4
HAUS augmin-like complex, subunit 4
decreases expression
EXP
Buspirone results in decreased expression of HAUS4 mRNA
CTD
PMID:24136188
NCBI chr15:31,964,555...31,976,853
Ensembl chr15:31,964,556...31,975,941
G
Hba-a1
hemoglobin alpha, adult chain 1
decreases expression
EXP
Buspirone results in decreased expression of HBA-A1 mRNA
CTD
PMID:24136188
NCBI chr10:15,841,724...15,842,580
Ensembl chr10:15,841,763...15,842,603
G
Hba-a2
hemoglobin alpha, adult chain 2
decreases expression
EXP
Buspirone results in decreased expression of HBA1 mRNA
CTD
PMID:24136188
NCBI chr10:15,828,291...15,829,138
Ensembl chr10:15,828,377...15,829,141
G
Hectd1
HECT domain E3 ubiquitin protein ligase 1
increases expression
EXP
Buspirone results in increased expression of HECTD1 mRNA
CTD
PMID:24136188
NCBI chr 6:74,916,803...75,003,408
Ensembl chr 6:74,916,803...75,003,408
G
Herpud1
homocysteine inducible ER protein with ubiquitin like domain 1
increases expression
EXP
Buspirone results in increased expression of HERPUD1 mRNA
CTD
PMID:24136188
NCBI chr19:10,604,360...10,624,168
Ensembl chr19:10,604,362...10,624,081
G
Hes1
hes family bHLH transcription factor 1
increases expression
EXP
Buspirone results in increased expression of HES1 mRNA
CTD
PMID:24136188
NCBI chr11:84,210,632...84,213,045
Ensembl chr11:84,210,633...84,213,061
G
Hes6
hes family bHLH transcription factor 6
decreases expression
EXP
Buspirone results in decreased expression of HES6 mRNA
CTD
PMID:24136188
NCBI chr 9:99,449,375...99,451,343
Ensembl chr 9:99,449,371...99,451,096
G
Hexb
hexosaminidase subunit beta
increases expression
EXP
Buspirone results in increased expression of HEXB mRNA
CTD
PMID:24136188
NCBI chr 2:30,218,608...30,238,771
Ensembl chr 2:30,218,608...30,238,771
G
Hhex
hematopoietically expressed homeobox
decreases expression
EXP
Buspirone results in decreased expression of HHEX mRNA
CTD
PMID:24136188
NCBI chr 1:244,602,945...244,608,532
Ensembl chr 1:244,602,825...244,608,604
G
Hibch
3-hydroxyisobutyryl-CoA hydrolase
increases expression
EXP
Buspirone results in increased expression of HIBCH mRNA
CTD
PMID:24136188
NCBI chr 9:56,082,082...56,161,796
Ensembl chr 9:56,082,091...56,161,886
G
Higd2a
HIG1 hypoxia inducible domain family, member 2A
increases expression
EXP
Buspirone results in increased expression of HIGD2A mRNA
CTD
PMID:24136188
NCBI chr17:10,026,961...10,027,885
Ensembl chr17:10,026,961...10,027,874
G
Hmgb2
high mobility group box 2
decreases expression
EXP
Buspirone results in decreased expression of HMGB2 mRNA
CTD
PMID:24136188
NCBI chr16:37,721,374...37,723,950
Ensembl chr16:37,721,379...37,723,860
G
Hmgn2
high mobility group nucleosomal binding domain 2
decreases expression
EXP
Buspirone results in decreased expression of HMGN2 mRNA
CTD
PMID:24136188
NCBI chr 5:151,475,907...151,479,361
Ensembl chr 5:151,475,909...151,479,397
G
Hmgn3
high mobility group nucleosomal binding domain 3
decreases expression
EXP
Buspirone results in decreased expression of HMGN3 mRNA
CTD
PMID:24136188
NCBI chr 8:92,902,555...92,939,980
G
Hmox1
heme oxygenase 1
multiple interactions increases expression
EXP
Buspirone inhibits the reaction [Methotrexate results in decreased expression of HMOX1 mRNA] Buspirone results in increased expression of HMOX1 mRNA
CTD
PMID:37341015
NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,472,884...13,479,818
G
Hnrnpa1
heterogeneous nuclear ribonucleoprotein A1
decreases expression
EXP
Buspirone results in decreased expression of HNRNPA1 mRNA
CTD
PMID:24136188
NCBI chr 7:136,253,633...136,260,085
Ensembl chr 7:136,253,278...136,260,085
G
Hnrnpa2b1
heterogeneous nuclear ribonucleoprotein A2/B1
decreases expression
EXP
Buspirone results in decreased expression of HNRNPA2B1 mRNA
CTD
PMID:24136188
NCBI chr 4:81,867,354...81,875,886
Ensembl chr 4:81,869,661...81,877,572
G
Hnrnpm
heterogeneous nuclear ribonucleoprotein M
decreases expression
EXP
Buspirone results in decreased expression of HNRNPM mRNA
CTD
PMID:24136188
NCBI chr 7:15,140,877...15,178,871
Ensembl chr 7:15,129,287...15,178,871
G
Hnrnpr
heterogeneous nuclear ribonucleoprotein R
decreases expression
EXP
Buspirone results in decreased expression of HNRNPR mRNA
CTD
PMID:24136188
NCBI chr 5:153,826,482...153,872,272
Ensembl chr 5:153,826,692...153,858,344
G
Hprt1
hypoxanthine phosphoribosyltransferase 1
increases expression
EXP
Buspirone results in increased expression of HPRT1 mRNA
CTD
PMID:24136188
NCBI chr X:137,655,744...137,687,718
Ensembl chr X:137,655,680...137,687,712
G
Hsdl2
hydroxysteroid dehydrogenase like 2
increases expression
EXP
Buspirone results in increased expression of HSDL2 mRNA
CTD
PMID:24136188
NCBI chr 5:79,238,881...79,274,051
Ensembl chr 5:79,212,525...79,274,798
G
Hspa13
heat shock protein family A (Hsp70) member 13
decreases expression
EXP
Buspirone results in decreased expression of HSPA13 mRNA
CTD
PMID:24136188
NCBI chr11:27,862,717...27,876,898
Ensembl chr11:27,862,593...27,876,898
G
Hspa5
heat shock protein family A (Hsp70) member 5
decreases expression
EXP
Buspirone results in decreased expression of HSPA5 mRNA
CTD
PMID:24136188
NCBI chr 3:38,453,016...38,457,475
Ensembl chr 3:38,453,041...38,458,790
G
Htatsf1
HIV-1 Tat specific factor 1
decreases expression
EXP
Buspirone results in decreased expression of HTATSF1 mRNA
CTD
PMID:24136188
NCBI chr X:139,972,742...139,986,923
Ensembl chr X:139,972,742...139,986,923
G
Htr1a
5-hydroxytryptamine receptor 1A
multiple interactions
ISO EXP
Buspirone binds to and affects the activity of HTR1A protein Buspirone binds to and results in decreased activity of HTR1A protein
CTD
PMID:2207497 PMID:15482641
NCBI chr 2:38,427,169...38,431,733
Ensembl chr 2:38,427,083...38,540,760
G
Htr2a
5-hydroxytryptamine receptor 2A
decreases expression
EXP
Buspirone results in decreased expression of HTR2A protein
CTD
PMID:1664741
NCBI chr15:56,360,647...56,428,703
Ensembl chr15:56,359,596...56,431,619
G
Hyal3
hyaluronidase 3
decreases expression
EXP
Buspirone results in decreased expression of HYAL3 mRNA
CTD
PMID:24136188
NCBI chr 8:117,133,028...117,138,663
Ensembl chr 8:117,132,649...117,139,289
G
Hycc2
hyccin PI4KA lipid kinase complex subunit 2
increases expression
EXP
Buspirone results in increased expression of HYCC2 mRNA
CTD
PMID:24136188
NCBI chr 9:67,551,064...67,623,353
Ensembl chr 9:67,551,064...67,587,186
G
Iars1
isoleucyl-tRNA synthetase 1
decreases expression
EXP
Buspirone results in decreased expression of IARS1 mRNA
CTD
PMID:24136188
NCBI chr17:15,147,357...15,193,716
Ensembl chr17:15,147,357...15,193,652
G
Icam1
intercellular adhesion molecule 1
decreases expression
EXP
Buspirone results in decreased expression of ICAM1 mRNA
CTD
PMID:24136188
NCBI chr 8:27,829,688...27,841,618
Ensembl chr 8:27,829,161...27,841,617
G
Ifit2
interferon-induced protein with tetratricopeptide repeats 2
decreases expression
EXP
Buspirone results in decreased expression of IFIT2 mRNA
CTD
PMID:24136188
NCBI chr 1:241,515,735...241,521,799
Ensembl chr 1:241,515,709...241,521,798
G
Ifitm1
interferon induced transmembrane protein 1
decreases expression
EXP
Buspirone results in decreased expression of IFITM1 mRNA
CTD
PMID:24136188
NCBI chr 1:205,496,757...205,498,796
Ensembl chr 1:205,496,807...205,498,776
G
Igf1
insulin-like growth factor 1
decreases expression
EXP
Buspirone results in decreased expression of IGF1 mRNA
CTD
PMID:24136188
NCBI chr 7:24,169,608...24,249,446
Ensembl chr 7:24,130,137...24,246,764
G
Igfbp7
insulin-like growth factor binding protein 7
decreases expression
EXP
Buspirone results in decreased expression of IGFBP7 mRNA
CTD
PMID:24136188
NCBI chr14:31,091,681...31,151,623
Ensembl chr14:31,091,347...31,151,620
G
Ik
IK cytokine
decreases expression
EXP
Buspirone results in decreased expression of IK mRNA
CTD
PMID:24136188
NCBI chr18:28,632,025...28,646,829
Ensembl chr18:28,631,616...28,653,463
G
Il1b
interleukin 1 beta
multiple interactions
EXP
Buspirone inhibits the reaction [Methotrexate results in increased expression of IL1B protein]
CTD
PMID:37341015
NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:137,030,205...137,036,601
G
Il6
interleukin 6
multiple interactions
EXP
Buspirone inhibits the reaction [Methotrexate results in increased expression of IL6 protein]
CTD
PMID:37341015
NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,889,999...5,894,610
G
Il6r
interleukin 6 receptor
increases expression
EXP
Buspirone results in increased expression of IL6R mRNA
CTD
PMID:24136188
NCBI chr 2:177,582,020...177,646,705
Ensembl chr 2:177,582,164...177,645,221
G
Imp3
IMP U3 small nucleolar ribonucleoprotein 3
increases expression
EXP
Buspirone results in increased expression of IMP3 mRNA
CTD
PMID:24136188
NCBI chr 8:66,235,498...66,236,386
G
Inhba
inhibin subunit beta A
decreases expression
EXP
Buspirone results in decreased expression of INHBA mRNA
CTD
PMID:24136188
NCBI chr17:53,787,159...53,810,942
Ensembl chr17:53,791,444...53,804,508
G
Ip6k1
inositol hexakisphosphate kinase 1
increases expression
EXP
Buspirone results in increased expression of IP6K1 mRNA
CTD
PMID:24136188
NCBI chr 8:117,594,177...117,613,266
Ensembl chr 8:117,594,317...117,613,274
G
Ipo9
importin 9
decreases expression
EXP
Buspirone results in decreased expression of IPO9 mRNA
CTD
PMID:24136188
NCBI chr13:49,362,244...49,414,477
Ensembl chr13:49,365,716...49,414,477
G
Irf1
interferon regulatory factor 1
decreases expression
EXP
Buspirone results in decreased expression of IRF1 mRNA
CTD
PMID:24136188
NCBI chr10:38,417,935...38,424,946
Ensembl chr10:38,417,148...38,424,947
G
Irf7
interferon regulatory factor 7
decreases expression
EXP
Buspirone results in decreased expression of IRF7 mRNA
CTD
PMID:24136188
NCBI chr 1:205,796,956...205,800,543
Ensembl chr 1:205,796,959...205,800,023
G
Irgm
immunity-related GTPase M
decreases expression
EXP
Buspirone results in decreased expression of IRGM mRNA
CTD
PMID:24136188
NCBI chr10:33,734,640...33,742,720
Ensembl chr10:33,732,961...33,743,228
G
Itga6
integrin subunit alpha 6
decreases expression
EXP
Buspirone results in decreased expression of ITGA6 mRNA
CTD
PMID:24136188
NCBI chr 3:77,012,168...77,097,076
Ensembl chr 3:77,017,766...77,097,076
G
Itgb2
integrin subunit beta 2
decreases expression
EXP
Buspirone results in decreased expression of ITGB2 mRNA
CTD
PMID:24136188
NCBI chr20:11,061,009...11,097,242
Ensembl chr20:11,058,492...11,097,182
G
Jak1
Janus kinase 1
decreases expression
EXP
Buspirone results in decreased expression of JAK1 mRNA
CTD
PMID:24136188
NCBI chr 5:120,895,606...121,004,207
Ensembl chr 5:120,896,046...120,996,758
G
Jam2
junctional adhesion molecule 2
decreases expression
EXP
Buspirone results in decreased expression of JAM2 mRNA
CTD
PMID:24136188
NCBI chr11:37,316,287...37,366,517
Ensembl chr11:37,317,511...37,367,510
G
Jpt2
Jupiter microtubule associated homolog 2
decreases expression
EXP
Buspirone results in decreased expression of JPT2 mRNA
CTD
PMID:24136188
NCBI chr10:14,467,652...14,487,769
Ensembl chr10:14,467,661...14,535,664
G
Jun
Jun proto-oncogene, AP-1 transcription factor subunit
decreases expression
EXP
Buspirone results in decreased expression of JUN mRNA
CTD
PMID:24136188
NCBI chr 5:115,009,900...115,012,993
Ensembl chr 5:114,973,151...115,013,285
G
Jup
junction plakoglobin
decreases expression
EXP
Buspirone results in decreased expression of JUP mRNA
CTD
PMID:24136188
NCBI chr10:85,800,812...85,827,881
Ensembl chr10:85,800,814...85,827,429
G
Kctd5
potassium channel tetramerization domain containing 5
increases expression
EXP
Buspirone results in increased expression of KCTD5 mRNA
CTD
PMID:24136188
NCBI chr10:13,583,781...13,609,762
Ensembl chr10:13,583,781...13,610,062
G
Keap1
Kelch-like ECH-associated protein 1
multiple interactions
EXP
Buspirone inhibits the reaction [Methotrexate results in increased expression of KEAP1 mRNA]
CTD
PMID:37341015
NCBI chr 8:28,044,555...28,054,042
Ensembl chr 8:28,044,555...28,054,042
G
Khdrbs1
KH RNA binding domain containing, signal transduction associated 1
decreases expression
EXP
Buspirone results in decreased expression of KHDRBS1 mRNA
CTD
PMID:24136188
NCBI chr 5:147,337,048...147,374,604
Ensembl chr 5:147,347,904...147,373,448
G
Klf15
KLF transcription factor 15
increases expression
EXP
Buspirone results in increased expression of KLF15 mRNA
CTD
PMID:24136188
NCBI chr 4:124,522,652...124,535,613
Ensembl chr 4:124,522,909...124,542,373
G
Klf9
KLF transcription factor 9
increases expression
EXP
Buspirone results in increased expression of KLF9 mRNA
CTD
PMID:24136188
NCBI chr 1:230,126,646...230,151,641
Ensembl chr 1:230,126,646...230,151,641
G
Klhl24
kelch-like family member 24
increases expression
EXP
Buspirone results in increased expression of KLHL24 mRNA
CTD
PMID:24136188
NCBI chr11:94,348,024...94,382,085
Ensembl chr11:94,351,157...94,382,050
G
Kpna2
karyopherin subunit alpha 2
decreases expression
EXP
Buspirone results in decreased expression of KPNA2 mRNA
CTD
PMID:24136188
NCBI chr10:92,433,678...92,445,841
Ensembl chr10:92,433,679...92,445,937
G
Kpnb1
karyopherin subunit beta 1
decreases expression
EXP
Buspirone results in decreased expression of KPNB1 mRNA
CTD
PMID:24136188
NCBI chr10:82,642,082...82,670,856
Ensembl chr10:82,642,082...82,670,856
G
Krt18
keratin 18
decreases expression
EXP
Buspirone results in decreased expression of KRT18 mRNA
CTD
PMID:24136188
NCBI chr 7:135,036,168...135,039,844
Ensembl chr 7:135,035,982...135,039,848 Ensembl chr10:135,035,982...135,039,848
G
Kyat1
kynurenine aminotransferase 1
increases expression
EXP
Buspirone results in increased expression of KYAT1 mRNA
CTD
PMID:24136188
NCBI chr 3:33,857,407...33,891,153
Ensembl chr 3:33,857,743...33,890,642
G
Kyat3
kynurenine aminotransferase 3
increases expression
EXP
Buspirone results in increased expression of KYAT3 mRNA
CTD
PMID:24136188
NCBI chr 2:234,362,306...234,407,646
Ensembl chr 2:234,362,322...234,407,878
G
Lactb
lactamase, beta
decreases expression
EXP
Buspirone results in decreased expression of LACTB mRNA
CTD
PMID:24136188
NCBI chr 8:76,452,679...76,469,986
Ensembl chr 8:76,452,349...76,468,716
G
Lamtor2
late endosomal/lysosomal adaptor, MAPK and MTOR activator 2
increases expression
EXP
Buspirone results in increased expression of LAMTOR2 mRNA
CTD
PMID:24136188
NCBI chr 2:176,306,353...176,310,617
Ensembl chr 2:176,306,280...176,310,730
G
Lbp
lipopolysaccharide binding protein
increases expression
EXP
Buspirone results in increased expression of LBP mRNA
CTD
PMID:24136188
NCBI chr 3:167,373,786...167,400,941
Ensembl chr 3:167,373,924...167,401,518
G
Lcmt1
leucine carboxyl methyltransferase 1
decreases expression
EXP
Buspirone results in decreased expression of LCMT1 mRNA
CTD
PMID:24136188
NCBI chr 1:187,335,173...187,391,195
Ensembl chr 1:187,327,706...187,391,516
G
Lcp1
lymphocyte cytosolic protein 1
decreases expression
EXP
Buspirone results in decreased expression of LCP1 mRNA
CTD
PMID:24136188
NCBI chr15:56,846,375...56,954,090
Ensembl chr15:56,847,433...56,954,092
G
Leprotl1
leptin receptor overlapping transcript-like 1
increases expression
EXP
Buspirone results in increased expression of LEPROTL1 mRNA
CTD
PMID:24136188
NCBI chr16:64,744,148...64,756,776
Ensembl chr16:64,743,717...64,756,776
G
Letm1
leucine zipper and EF-hand containing transmembrane protein 1
decreases expression
EXP
Buspirone results in decreased expression of LETM1 mRNA
CTD
PMID:24136188
NCBI chr14:81,167,268...81,206,776
Ensembl chr14:81,162,309...81,209,459
G
Lgals3
galectin 3
decreases expression
EXP
Buspirone results in decreased expression of LGALS3 mRNA
CTD
PMID:24136188
NCBI chr15:23,099,795...23,111,731
Ensembl chr15:23,086,841...23,111,737
G
Lgals5
galectin 5
decreases expression
EXP
Buspirone results in decreased expression of LGALS5 mRNA
CTD
PMID:24136188
NCBI chr10:64,351,976...64,355,137
Ensembl chr10:64,351,964...64,355,180
G
Lgals9
galectin 9
decreases expression
EXP
Buspirone results in decreased expression of LGALS9 mRNA
CTD
PMID:24136188
NCBI chr10:64,405,044...64,428,249
Ensembl chr10:64,405,044...64,428,070
G
Lgalsl
galectin-like
decreases expression
EXP
Buspirone results in decreased expression of LGALSL mRNA
CTD
PMID:24136188
NCBI chr14:99,198,340...99,205,846
Ensembl chr14:99,198,339...99,206,487
G
Lgmn
legumain
decreases expression
EXP
Buspirone results in decreased expression of LGMN mRNA
CTD
PMID:24136188
NCBI chr 6:127,308,913...127,347,355
Ensembl chr 6:127,308,913...127,347,328
G
Lipc
lipase C, hepatic type
decreases expression
EXP
Buspirone results in decreased expression of LIPC mRNA
CTD
PMID:24136188
NCBI chr 8:80,390,470...80,516,463
Ensembl chr 8:80,390,471...80,516,285
G
Lman1
lectin, mannose-binding, 1
decreases expression
EXP
Buspirone results in decreased expression of LMAN1 mRNA
CTD
PMID:24136188
NCBI chr18:61,778,971...61,800,960
Ensembl chr18:61,772,917...61,800,820
G
Lrat
lecithin retinol acyltransferase
decreases expression
EXP
Buspirone results in decreased expression of LRAT mRNA
CTD
PMID:24136188
NCBI chr 2:170,562,148...170,571,212
Ensembl chr 2:170,565,543...170,571,148
G
Lrp11
LDL receptor related protein 11
increases expression
EXP
Buspirone results in increased expression of LRP11 mRNA
CTD
PMID:24136188
NCBI chr 1:3,868,665...3,928,513
Ensembl chr 1:3,899,985...3,928,507
G
Lrrc59
leucine rich repeat containing 59
decreases expression
EXP
Buspirone results in decreased expression of LRRC59 mRNA
CTD
PMID:24136188
NCBI chr10:80,069,162...80,083,820
Ensembl chr10:80,069,120...80,084,079
G
Lsm6
LSM6 homolog, U6 small nuclear RNA and mRNA degradation associated
decreases expression
EXP
Buspirone results in decreased expression of LSM6 mRNA
CTD
PMID:24136188
NCBI chr19:46,002,592...46,017,152
G
Lta4h
leukotriene A4 hydrolase
decreases expression
EXP
Buspirone results in decreased expression of LTA4H mRNA
CTD
PMID:24136188
NCBI chr 7:29,856,846...29,888,642
Ensembl chr 7:29,856,802...29,888,641
G
Ly6e
lymphocyte antigen 6 family member E
decreases expression
EXP
Buspirone results in decreased expression of LY6E mRNA
CTD
PMID:24136188
NCBI chr 7:108,815,970...108,820,444
Ensembl chr 7:108,816,887...108,820,443
G
Lyve1
lymphatic vessel endothelial hyaluronan receptor 1
decreases expression
EXP
Buspirone results in decreased expression of LYVE1 mRNA
CTD
PMID:24136188
NCBI chr 1:174,393,387...174,410,977
G
Lyz2
lysozyme 2
decreases expression
EXP
Buspirone results in decreased expression of LYZ2 mRNA
CTD
PMID:24136188
NCBI chr 7:54,792,715...54,798,060
Ensembl chr 7:54,792,716...54,798,011
G
Map1lc3b
microtubule-associated protein 1 light chain 3 beta
increases expression
EXP
Buspirone results in increased expression of MAP1LC3B mRNA
CTD
PMID:24136188
NCBI chr19:66,571,631...66,582,270
Ensembl chr19:66,574,407...66,584,358 Ensembl chr16:66,574,407...66,584,358
G
Mapk9
mitogen-activated protein kinase 9
decreases expression
EXP
Buspirone results in decreased expression of MAPK9 mRNA
CTD
PMID:24136188
NCBI chr10:34,670,750...34,711,972
Ensembl chr10:34,670,756...34,712,228
G
Mapre1
microtubule-associated protein, RP/EB family, member 1
decreases expression
EXP
Buspirone results in decreased expression of MAPRE1 mRNA
CTD
PMID:24136188
NCBI chr 3:162,679,020...162,707,167
Ensembl chr 3:162,673,195...162,711,210
G
Marchf2
membrane associated ring-CH-type finger 2
increases expression
EXP
Buspirone results in increased expression of MARCHF2 mRNA
CTD
PMID:24136188
NCBI chr 7:15,183,931...15,209,988
Ensembl chr 7:15,183,925...15,202,002
G
Marchf6
membrane associated ring-CH-type finger 6
increases expression
EXP
Buspirone results in increased expression of MARCHF6 mRNA
CTD
PMID:24136188
NCBI chr 2:84,166,570...84,243,817
Ensembl chr 2:84,166,570...84,243,792
G
Marcksl1
MARCKS-like 1
decreases expression
EXP
Buspirone results in decreased expression of MARCKSL1 mRNA
CTD
PMID:24136188
NCBI chr 5:147,135,827...147,138,150
Ensembl chr 5:147,134,514...147,138,417
G
Marf1
meiosis regulator and mRNA stability factor 1
increases expression
EXP
Buspirone results in increased expression of MARF1 mRNA
CTD
PMID:24136188
NCBI chr10:1,395,271...1,439,974
Ensembl chr10:1,395,282...1,439,974
G
Mat1a
methionine adenosyltransferase 1A
increases expression
EXP
Buspirone results in increased expression of MAT1A mRNA
CTD
PMID:24136188
NCBI chr16:17,017,168...17,035,368
Ensembl chr16:17,016,030...17,035,367
G
Mbl2
mannose binding lectin 2
decreases expression
EXP
Buspirone results in decreased expression of MBL2 mRNA
CTD
PMID:24136188
NCBI chr 1:237,429,873...237,465,567
Ensembl chr 1:237,429,973...237,437,546
G
Mcm7
minichromosome maintenance complex component 7
decreases expression
EXP
Buspirone results in decreased expression of MCM7 mRNA
CTD
PMID:24136188
NCBI chr12:22,155,921...22,163,320
Ensembl chr12:22,155,921...22,163,771
G
Me1
malic enzyme 1
decreases expression
EXP
Buspirone results in decreased expression of ME1 mRNA
CTD
PMID:24136188
NCBI chr 8:96,429,057...96,540,244
Ensembl chr 8:96,429,057...96,540,275
G
Mettl23
methyltransferase 23, arginine
increases expression
EXP
Buspirone results in increased expression of METTL23 mRNA
CTD
PMID:24136188
NCBI chr10:102,546,102...102,550,782
Ensembl chr10:102,545,430...102,553,909
G
Mfsd2a
MFSD2 lysolipid transporter A, lysophospholipid
increases expression
EXP
Buspirone results in increased expression of MFSD2A mRNA
CTD
PMID:24136188
NCBI chr 5:140,510,933...140,525,828
Ensembl chr 5:140,510,953...140,525,916
G
Mgll
monoglyceride lipase
decreases expression
EXP
Buspirone results in decreased expression of MGLL mRNA
CTD
PMID:24136188
NCBI chr 4:122,749,436...122,851,440
Ensembl chr 4:122,749,436...122,851,440
G
Mid1ip1
MID1 interacting protein 1
decreases expression
EXP
Buspirone results in decreased expression of MID1IP1 mRNA
CTD
PMID:24136188
NCBI chr X:14,733,539...14,735,859
Ensembl chr X:14,732,830...14,739,079
G
Mif
macrophage migration inhibitory factor
decreases expression
EXP
Buspirone results in decreased expression of MIF mRNA
CTD
PMID:24136188
NCBI chr20:12,767,138...12,791,222
Ensembl chr 4:134,041,774...134,042,121 Ensembl chr20:134,041,774...134,042,121
G
Morf4l2
mortality factor 4 like 2
decreases expression
EXP
Buspirone results in decreased expression of MORF4L2 mRNA
CTD
PMID:24136188
NCBI chr X:104,874,850...104,885,946
Ensembl chr X:104,852,693...104,892,855
G
Mrpl1
mitochondrial ribosomal protein L1
decreases expression
EXP
Buspirone results in decreased expression of MRPL1 mRNA
CTD
PMID:24136188
NCBI chr14:13,604,498...13,663,633
Ensembl chr14:13,604,499...13,663,602
G
Mrpl15
mitochondrial ribosomal protein L15
decreases expression
EXP
Buspirone results in decreased expression of MRPL15 mRNA
CTD
PMID:24136188
NCBI chr 5:19,527,745...19,539,061
Ensembl chr 5:19,524,588...19,538,004
G
Mrpl34
mitochondrial ribosomal protein L34
increases expression
EXP
Buspirone results in increased expression of MRPL34 mRNA
CTD
PMID:24136188
NCBI chr16:18,186,447...18,187,182
Ensembl chr16:18,185,306...18,187,181
G
Mrps22
mitochondrial ribosomal protein S22
decreases expression
EXP
Buspirone results in decreased expression of MRPS22 mRNA
CTD
PMID:24136188
NCBI chr 8:108,063,468...108,076,638
Ensembl chr 8:108,063,471...108,076,638
G
Mt1a
metallothionein 1A
increases expression
EXP
Buspirone results in increased expression of MT1A mRNA
CTD
PMID:24136188
NCBI chr19:10,831,959...10,832,975
Ensembl chr17:79,695,809...79,696,200 Ensembl chr X:79,695,809...79,696,200 Ensembl chr19:79,695,809...79,696,200
G
Mtarc2
mitochondrial amidoxime reducing component 2
increases expression
EXP
Buspirone results in increased expression of MTARC2 mRNA
CTD
PMID:24136188
NCBI chr13:98,894,347...98,928,754
Ensembl chr13:98,897,108...98,928,781
G
Mthfd1
methylenetetrahydrofolate dehydrogenase, cyclohydrolase and formyltetrahydrofolate synthetase 1
decreases expression
EXP
Buspirone results in decreased expression of MTHFD1 mRNA
CTD
PMID:24136188
NCBI chr 6:100,713,510...100,781,013
Ensembl chr 6:100,713,681...100,781,957
G
Mtss1
MTSS I-BAR domain containing 1
increases expression
EXP
Buspirone results in increased expression of MTSS1 mRNA
CTD
PMID:24136188
NCBI chr 7:92,378,228...92,517,444
Ensembl chr 7:92,378,238...92,517,303
G
Mttp
microsomal triglyceride transfer protein
decreases expression
EXP
Buspirone results in decreased expression of MTTP mRNA
CTD
PMID:24136188
NCBI chr 2:229,286,501...229,327,650
Ensembl chr 2:229,286,501...229,327,650
G
Mug1
murinoglobulin 1
decreases expression
EXP
Buspirone results in decreased expression of MUG1 mRNA
CTD
PMID:24136188
NCBI chr 4:156,748,351...156,802,132
G
Myd88
MYD88, innate immune signal transduction adaptor
increases expression
EXP
Buspirone results in increased expression of MYD88 mRNA
CTD
PMID:24136188
NCBI chr 8:127,952,161...127,956,230
Ensembl chr 8:127,952,161...127,956,230
G
Myh9
myosin, heavy chain 9
decreases expression
EXP
Buspirone results in decreased expression of MYH9 mRNA
CTD
PMID:24136188
NCBI chr 7:111,224,291...111,304,963
Ensembl chr 7:111,224,291...111,304,963
G
Naa15
N(alpha)-acetyltransferase 15, NatA auxiliary subunit
decreases expression
EXP
Buspirone results in decreased expression of NAA15 mRNA
CTD
PMID:24136188
NCBI chr 2:137,608,883...137,671,618
Ensembl chr 2:137,608,797...137,671,619
G
Nans
N-acetylneuraminate synthase
decreases expression
EXP
Buspirone results in decreased expression of NANS mRNA
CTD
PMID:24136188
NCBI chr 5:65,575,970...65,593,164
Ensembl chr 5:65,576,015...65,610,547
G
Ndfip1
Nedd4 family interacting protein 1
increases expression
EXP
Buspirone results in increased expression of NDFIP1 mRNA
CTD
PMID:24136188
NCBI chr18:30,516,931...30,567,199
Ensembl chr18:30,516,981...30,568,471
G
Ndufa6
NADH:ubiquinone oxidoreductase subunit A6
increases expression
EXP
Buspirone results in increased expression of NDUFA6 mRNA
CTD
PMID:24136188
NCBI chr 7:115,746,460...115,750,317
Ensembl chr 7:115,746,460...115,750,317
G
Ndufa7
NADH:ubiquinone oxidoreductase subunit A7
increases expression
EXP
Buspirone results in increased expression of NDUFA7 mRNA
CTD
PMID:24136188
NCBI chr 7:15,311,446...15,324,226
Ensembl chr 7:15,311,286...15,334,138
G
Ndufb2
NADH:ubiquinone oxidoreductase subunit B2
increases expression
EXP
Buspirone results in increased expression of NDUFB2 mRNA
CTD
PMID:24136188
NCBI chr 4:69,334,307...69,341,394
Ensembl chr 4:69,334,307...69,340,136 Ensembl chr15:69,334,307...69,340,136
G
Nectin3
nectin cell adhesion molecule 3
decreases expression
EXP
Buspirone results in decreased expression of NECTIN3 mRNA
CTD
PMID:24136188
NCBI chr11:67,825,296...67,931,999
Ensembl chr11:67,827,137...67,871,383
G
Nfe2l2
NFE2 like bZIP transcription factor 2
decreases expression multiple interactions increases expression
EXP
Buspirone results in decreased expression of NFE2L2 mRNA Buspirone inhibits the reaction [Methotrexate results in decreased expression of NFE2L2 mRNA] Buspirone results in increased expression of NFE2L2 mRNA
CTD
PMID:24136188 PMID:37341015
NCBI chr 3:81,001,529...81,031,165
Ensembl chr 3:81,001,529...81,029,090
G
Nhp2
NHP2 ribonucleoprotein
decreases expression
EXP
Buspirone results in decreased expression of NHP2 mRNA
CTD
PMID:24136188
NCBI chr10:36,378,020...36,381,362
Ensembl chr10:36,377,997...36,381,354
G
Nid1
nidogen 1
decreases expression
EXP
Buspirone results in decreased expression of NID1 mRNA
CTD
PMID:24136188
NCBI chr17:93,069,013...93,142,416
Ensembl chr17:93,069,278...93,142,386
G
Nit1
nitrilase 1
increases expression
EXP
Buspirone results in increased expression of NIT1 mRNA
CTD
PMID:24136188
NCBI chr13:86,302,334...86,305,770
Ensembl chr13:86,298,387...86,305,770
G
Nln
neurolysin
decreases expression
EXP
Buspirone results in decreased expression of NLN mRNA
CTD
PMID:24136188
NCBI chr 2:36,867,436...36,966,749
Ensembl chr 2:36,853,551...36,966,680
G
Nlrp3
NLR family, pyrin domain containing 3
multiple interactions
EXP
Buspirone inhibits the reaction [Methotrexate results in increased expression of NLRP3 protein]
CTD
PMID:37341015
NCBI chr10:44,826,299...44,853,373
Ensembl chr10:44,828,014...44,853,394
G
Nme1
NME/NM23 nucleoside diphosphate kinase 1
decreases expression
EXP
Buspirone results in decreased expression of NME1 mRNA
CTD
PMID:24136188
NCBI chr10:79,403,939...79,426,620
Ensembl chr10:79,403,940...79,413,310
G
Nme3
NME/NM23 nucleoside diphosphate kinase 3
increases expression
EXP
Buspirone results in increased expression of NME3 mRNA
CTD
PMID:24136188
NCBI chr10:14,421,922...14,422,878
Ensembl chr10:14,421,702...14,422,907
G
Nop53
NOP53 ribosome biogenesis factor
increases expression
EXP
Buspirone results in increased expression of NOP53 mRNA
CTD
PMID:24136188
NCBI chr 1:85,757,271...85,765,089
Ensembl chr 1:85,756,586...85,765,089
G
Nop58
NOP58 ribonucleoprotein
decreases expression
EXP
Buspirone results in decreased expression of NOL5 mRNA
CTD
PMID:24136188
NCBI chr 9:68,614,992...68,638,911
Ensembl chr 9:68,615,010...68,638,909
G
Nos1
nitric oxide synthase 1
multiple interactions
EXP
Buspirone inhibits the reaction [Methotrexate results in increased expression of NOS1 mRNA]
CTD
PMID:37341015
NCBI chr12:44,276,011...44,456,371
Ensembl chr12:44,287,614...44,371,837
G
Notch2
notch receptor 2
decreases expression
EXP
Buspirone results in decreased expression of NOTCH2 mRNA
CTD
PMID:24136188
NCBI chr 2:188,299,336...188,432,823
Ensembl chr 2:188,299,336...188,432,823
G
Nr1d2
nuclear receptor subfamily 1, group D, member 2
increases expression
EXP
Buspirone results in increased expression of NR1D2 mRNA
CTD
PMID:24136188
NCBI chr15:9,955,034...9,981,329
Ensembl chr15:9,954,906...9,981,330
G
Nr1i2
nuclear receptor subfamily 1, group I, member 2
increases expression
EXP
Buspirone results in increased expression of NR1I2 mRNA
CTD
PMID:24136188
NCBI chr11:75,965,717...76,006,733
Ensembl chr11:75,965,632...76,002,380
G
Nrbp2
nuclear receptor binding protein 2
increases expression
EXP
Buspirone results in increased expression of NRBP2 mRNA
CTD
PMID:24136188
NCBI chr 7:109,679,330...109,685,656
Ensembl chr 7:109,679,330...109,685,588
G
Nrep
neuronal regeneration related protein
decreases expression
EXP
Buspirone results in decreased expression of NREP mRNA
CTD
PMID:24136188
NCBI chr18:25,291,219...25,320,742
Ensembl chr18:25,291,219...25,320,742
G
Nsdhl
NAD(P) dependent 3-beta-hydroxysteroid dehydrogenase NSDHL
decreases expression
EXP
Buspirone results in decreased expression of NSDHL mRNA
CTD
PMID:24136188
NCBI chr X:155,817,301...155,848,224
Ensembl chr X:155,817,340...155,848,220
G
Nt5e
5' nucleotidase, ecto
decreases expression
EXP
Buspirone results in decreased expression of NT5E mRNA
CTD
PMID:24136188
NCBI chr 8:98,150,925...98,195,646
Ensembl chr 8:98,150,900...98,195,645
G
Ntpcr
nucleoside-triphosphatase, cancer-related
increases expression
EXP
Buspirone results in increased expression of NTPCR mRNA
CTD
PMID:24136188
NCBI chr19:70,598,816...70,612,580
Ensembl chr19:70,593,274...70,613,197
G
Nucb2
nucleobindin 2
decreases expression
EXP
Buspirone results in decreased expression of NUCB2 mRNA
CTD
PMID:24136188
NCBI chr 1:180,185,121...180,221,644
Ensembl chr 1:180,199,551...180,230,116
G
Nudt4
nudix hydrolase 4
increases expression
EXP
Buspirone results in increased expression of NUDT4 mRNA
CTD
PMID:24136188
NCBI chr 7:32,074,978...32,091,491
Ensembl chr 7:32,075,002...32,091,491
G
Obp3
alpha-2u globulin PGCL4
increases expression
EXP
Buspirone results in increased expression of OBP3 mRNA
CTD
PMID:24136188
NCBI chr 5:79,637,234...79,640,810
Ensembl chr 5:79,637,234...79,640,675
G
Ola1
Obg-like ATPase 1
decreases expression
EXP
Buspirone results in decreased expression of OLA1 mRNA
CTD
PMID:24136188
NCBI chr 3:78,374,440...78,493,401
Ensembl chr 3:78,374,441...78,492,012
G
Oplah
5-oxoprolinase (ATP-hydrolysing)
increases expression
EXP
Buspirone results in increased expression of OPLAH mRNA
CTD
PMID:24136188
NCBI chr 7:109,892,136...109,932,403
Ensembl chr 7:109,891,405...109,915,979
G
Osbpl1a
oxysterol binding protein-like 1A
decreases expression
EXP
Buspirone results in decreased expression of OSBPL1A mRNA
CTD
PMID:24136188
NCBI chr18:4,178,734...4,383,511
Ensembl chr18:4,179,631...4,369,421
G
Pald1
phosphatase domain containing, paladin 1
increases expression
EXP
Buspirone results in increased expression of PALD1 mRNA
CTD
PMID:24136188
NCBI chr20:29,812,650...29,877,733
Ensembl chr20:29,812,650...29,850,063
G
Palmd
palmdelphin
decreases expression
EXP
Buspirone results in decreased expression of PALMD mRNA
CTD
PMID:24136188
NCBI chr 2:207,574,413...207,626,239
Ensembl chr 2:207,574,249...207,626,239
G
Paqr9
progestin and adipoQ receptor family member 9
decreases expression
EXP
Buspirone results in decreased expression of PAQR9 mRNA
CTD
PMID:24136188
NCBI chr 8:104,993,884...104,996,180
Ensembl chr 8:104,993,827...104,998,285
G
Parp14
poly (ADP-ribose) polymerase family, member 14
decreases expression
EXP
Buspirone results in decreased expression of PARP14 mRNA
CTD
PMID:24136188
NCBI chr11:78,408,134...78,440,201
Ensembl chr11:78,408,058...78,440,195
G
Pbld1
phenazine biosynthesis-like protein domain containing 1
increases expression
EXP
Buspirone results in increased expression of PBLD1 mRNA
CTD
PMID:24136188
NCBI chr20:25,549,974...25,565,390
Ensembl chr20:25,549,974...25,565,226
G
Pcna
proliferating cell nuclear antigen
decreases expression
EXP
Buspirone results in decreased expression of PCNA mRNA
CTD
PMID:24136188
NCBI chr 3:139,951,948...139,955,820
Ensembl chr 3:139,951,941...139,955,901
G
Pctp
phosphatidylcholine transfer protein
decreases expression
EXP
Buspirone results in decreased expression of PCTP mRNA
CTD
PMID:24136188
NCBI chr10:75,305,999...75,351,919
Ensembl chr10:75,305,999...75,326,432
G
Pcyt1a
phosphate cytidylyltransferase 1A, choline
increases expression
EXP
Buspirone results in increased expression of PCYT1A mRNA
CTD
PMID:24136188
NCBI chr11:81,818,914...81,862,623
Ensembl chr11:81,819,285...81,862,395
G
Pdcd4
programmed cell death 4
decreases expression
EXP
Buspirone results in decreased expression of PDCD4 mRNA
CTD
PMID:24136188
NCBI chr 1:262,912,659...262,949,581
Ensembl chr 1:262,926,656...262,950,189
G
Pde4b
phosphodiesterase 4B
decreases expression
EXP
Buspirone results in decreased expression of PDE4B mRNA
CTD
PMID:24136188
NCBI chr 5:122,028,956...122,598,267
Ensembl chr 5:122,135,174...122,598,267
G
Pdia5
protein disulfide isomerase family A, member 5
decreases expression
EXP
Buspirone results in decreased expression of PDIA5 mRNA
CTD
PMID:24136188
NCBI chr11:78,777,436...78,892,370
Ensembl chr11:78,777,419...78,864,329
G
Pdia6
protein disulfide isomerase family A, member 6
decreases expression
EXP
Buspirone results in decreased expression of PDIA6 mRNA
CTD
PMID:24136188
NCBI chr 6:45,791,704...45,808,947
Ensembl chr 6:45,791,678...45,810,091
G
Pdlim1
PDZ and LIM domain 1
decreases expression
EXP
Buspirone results in decreased expression of PDLIM1 mRNA
CTD
PMID:24136188
NCBI chr 1:248,991,818...249,040,409
Ensembl chr 1:248,991,818...249,047,379
G
Pex11a
peroxisomal biogenesis factor 11 alpha
increases expression
EXP
Buspirone results in increased expression of PEX11A mRNA
CTD
PMID:24136188
NCBI chr 1:143,089,410...143,096,491
Ensembl chr 1:143,089,410...143,096,645
G
Pgd
phosphogluconate dehydrogenase
decreases expression
EXP
Buspirone results in decreased expression of PGD mRNA
CTD
PMID:24136188
NCBI chr 5:164,865,830...164,882,029
Ensembl chr 5:164,865,830...164,882,029
G
Pgk1
phosphoglycerate kinase 1
decreases expression
EXP
Buspirone results in decreased expression of PGK1 mRNA
CTD
PMID:24136188
NCBI chr X:75,336,988...75,352,962
Ensembl chr X:75,336,687...75,352,959
G
Phf11
PHD finger protein 11
decreases expression
EXP
Buspirone results in decreased expression of PHF11 mRNA
CTD
PMID:24136188
NCBI chr15:37,568,090...37,592,490
Ensembl chr15:37,568,090...37,591,016
G
Phyhd1
phytanoyl-CoA dioxygenase domain containing 1
increases expression
EXP
Buspirone results in increased expression of PHYHD1 mRNA
CTD
PMID:24136188
NCBI chr 3:33,933,487...33,951,614
Ensembl chr 3:33,937,898...33,951,614
G
Pim3
Pim-3 proto-oncogene, serine/threonine kinase
increases expression
EXP
Buspirone results in increased expression of PIM3 mRNA
CTD
PMID:24136188
NCBI chr 7:121,822,076...121,836,257
Ensembl chr 7:121,832,742...121,836,259
G
Pink1
PTEN induced kinase 1
increases expression
EXP
Buspirone results in increased expression of PINK1 mRNA
CTD
PMID:24136188
NCBI chr 5:155,813,838...155,825,950
Ensembl chr 5:155,813,838...155,825,950
G
Pklr
pyruvate kinase L/R
decreases expression
EXP
Buspirone results in decreased expression of PKLR mRNA
CTD
PMID:24136188
NCBI chr 2:176,840,779...176,849,637
Ensembl chr 2:176,840,764...176,849,644
G
Pla2g12a
phospholipase A2, group XIIA
increases expression
EXP
Buspirone results in increased expression of PLA2G12A mRNA
CTD
PMID:24136188
NCBI chr 2:221,110,722...221,126,966
Ensembl chr 2:221,110,685...221,126,964
G
Plcb1
phospholipase C beta 1
decreases expression
EXP
Buspirone results in decreased expression of PLCB1 mRNA; Buspirone results in decreased expression of PLCB1 protein
CTD
PMID:12527476
NCBI chr 3:142,512,765...143,224,042
Ensembl chr 3:142,513,033...143,225,646
G
Plin2
perilipin 2
decreases expression
EXP
Buspirone results in decreased expression of PLIN2 mRNA
CTD
PMID:24136188
NCBI chr 5:106,202,634...106,258,748
Ensembl chr 5:106,202,634...106,258,878
G
Plin3
perilipin 3
decreases expression
EXP
Buspirone results in decreased expression of PLIN3 mRNA
CTD
PMID:24136188
NCBI chr 9:1,198,336...1,210,212
Ensembl chr 9:1,198,336...1,210,231
G
Plpp3
phospholipid phosphatase 3
increases expression
EXP
Buspirone results in increased expression of PLPP3 mRNA
CTD
PMID:24136188
NCBI chr 5:125,156,000...125,231,119
Ensembl chr 5:125,155,945...125,235,667
G
Plxna2
plexin A2
decreases expression
EXP
Buspirone results in decreased expression of PLXNA2 mRNA
CTD
PMID:24136188
NCBI chr13:108,683,155...108,888,336
Ensembl chr13:108,691,530...108,887,453
G
Pnpla2
patatin-like phospholipase domain containing 2
increases expression
EXP
Buspirone results in increased expression of PNPLA2 mRNA
CTD
PMID:24136188
NCBI chr 1:205,982,279...205,987,361
Ensembl chr 1:205,982,258...205,987,359
G
Pnpla7
patatin-like phospholipase domain containing 7
increases expression
EXP
Buspirone results in increased expression of PNPLA7 mRNA
CTD
PMID:24136188
NCBI chr 3:28,180,670...28,259,673
Ensembl chr 3:28,180,751...28,259,672
G
Pnpla8
patatin-like phospholipase domain containing 8
increases expression
EXP
Buspirone results in increased expression of PNPLA8 mRNA
CTD
PMID:24136188
NCBI chr 6:67,056,783...67,118,714
Ensembl chr 6:67,056,697...67,120,512
G
Pold4
DNA polymerase delta 4, accessory subunit
increases expression
EXP
Buspirone results in increased expression of POLD4 mRNA
CTD
PMID:24136188
NCBI chr 1:210,956,110...210,957,863
Ensembl chr 1:210,956,099...210,957,860
G
Polg2
DNA polymerase gamma 2, accessory subunit
increases expression
EXP
Buspirone results in increased expression of POLG2 mRNA
CTD
PMID:24136188
NCBI chr10:92,212,303...92,222,849
Ensembl chr10:92,212,304...92,222,726
G
Polr2b
RNA polymerase II subunit B
decreases expression
EXP
Buspirone results in decreased expression of POLR2B mRNA
CTD
PMID:24136188
NCBI chr14:31,151,534...31,189,222
Ensembl chr14:31,151,390...31,189,222
G
Polr2h-ps1
polymerase (RNA) II (DNA directed) polypeptide H, pseudogene 1
increases expression
EXP
Buspirone results in increased expression of POLR2H-PS1 mRNA
CTD
PMID:24136188
NCBI chr10:105,353,439...105,357,591
G
Pomc
proopiomelanocortin
increases expression multiple interactions
ISO
Buspirone results in increased expression of POMC protein Imipramine inhibits the reaction [Buspirone results in increased expression of POMC protein]
CTD
PMID:19762159
NCBI chr 6:32,659,137...32,665,175
Ensembl chr 6:32,659,346...32,665,173
G
Por
cytochrome p450 oxidoreductase
increases expression
EXP
Buspirone results in increased expression of POR mRNA
CTD
PMID:24136188
NCBI chr12:26,587,674...26,655,612
Ensembl chr12:26,587,674...26,635,809
G
Ppa1
inorganic pyrophosphatase 1
decreases expression
EXP
Buspirone results in decreased expression of PPA1 mRNA
CTD
PMID:24136188
NCBI chr20:30,132,088...30,160,492
Ensembl chr20:30,133,504...30,160,489
G
Pparg
peroxisome proliferator-activated receptor gamma
multiple interactions
EXP
Buspirone inhibits the reaction [Methotrexate results in decreased expression of PPARG mRNA]
CTD
PMID:37341015
NCBI chr 4:150,095,743...150,221,104
Ensembl chr 4:150,095,787...150,221,104
G
Ppcs
phosphopantothenoylcysteine synthetase
increases expression
EXP
Buspirone results in increased expression of PPCS mRNA
CTD
PMID:24136188
NCBI chr 5:138,308,394...138,312,047
Ensembl chr 5:138,308,397...138,312,012
G
Ppox
protoporphyrinogen oxidase
decreases expression
EXP
Buspirone results in decreased expression of PPOX mRNA
CTD
PMID:24136188
NCBI chr13:86,230,111...86,235,028
Ensembl chr13:86,230,111...86,234,246
G
Ppp1r14a
protein phosphatase 1, regulatory (inhibitor) subunit 14A
decreases expression
EXP
Buspirone results in decreased expression of PPP1R14A mRNA
CTD
PMID:24136188
NCBI chr 1:93,708,269...93,718,218
Ensembl chr 1:93,708,218...93,719,147
G
Ppp1r21
protein phosphatase 1, regulatory subunit 21
decreases expression
EXP
Buspirone results in decreased expression of PPP1R21 mRNA
CTD
PMID:24136188
NCBI chr 6:11,655,059...11,724,219
Ensembl chr 6:11,655,059...11,724,219
G
Prc1
protein regulator of cytokinesis 1
decreases expression
EXP
Buspirone results in decreased expression of PRC1 mRNA
CTD
PMID:24136188
NCBI chr 1:143,659,312...143,681,019
Ensembl chr 1:143,659,481...143,681,012
G
Prdx5
peroxiredoxin 5
increases expression
EXP
Buspirone results in increased expression of PRDX5 mRNA
CTD
PMID:24136188
NCBI chr 1:213,529,042...213,532,787
Ensembl chr 1:213,529,035...213,533,020
G
Prkaca
protein kinase cAMP-activated catalytic subunit alpha
decreases expression
EXP
Buspirone results in decreased expression of PRKACA mRNA
CTD
PMID:24136188
NCBI chr19:41,059,843...41,083,189
Ensembl chr19:41,059,843...41,086,494
G
Prl
prolactin
increases secretion multiple interactions increases expression
ISO EXP
Buspirone results in increased secretion of PRL protein Pindolol inhibits the reaction [Buspirone results in increased secretion of PRL protein] Buspirone results in increased expression of PRL protein
CTD
PMID:18194152 PMID:19762159
NCBI chr17:38,287,355...38,298,234
Ensembl chr17:38,288,162...38,298,217
G
Proser2
proline and serine rich 2
increases expression
EXP
Buspirone results in increased expression of PROSER2 mRNA
CTD
PMID:24136188
NCBI chr17:77,061,371...77,096,788
Ensembl chr17:77,077,727...77,095,194
G
Prr13
proline rich 13
decreases expression
EXP
Buspirone results in decreased expression of PRR13 mRNA
CTD
PMID:24136188
NCBI chr 7:135,471,040...135,474,344
Ensembl chr 7:135,470,933...135,474,579
G
Prss23
serine protease 23
decreases expression
EXP
Buspirone results in decreased expression of PRSS23 mRNA
CTD
PMID:24136188
NCBI chr 1:152,815,301...152,835,005
Ensembl chr 1:152,813,670...152,947,871
G
Psenen
presenilin enhancer gamma secretase subunit
increases expression
EXP
Buspirone results in increased expression of PSENEN mRNA
CTD
PMID:24136188
NCBI chr 1:94,942,348...94,943,545
Ensembl chr 1:94,942,225...94,943,752
G
Psmb10
proteasome 20S subunit beta 10
decreases expression
EXP
Buspirone results in decreased expression of PSMB10 mRNA
CTD
PMID:24136188
NCBI chr19:50,740,808...50,743,292
Ensembl chr19:50,740,811...50,743,210
G
Psmb3
proteasome 20S subunit beta 3
increases expression
EXP
Buspirone results in increased expression of PSMB3 mRNA
CTD
PMID:24136188
NCBI chr10:83,193,787...83,200,883
Ensembl chr10:83,193,787...83,200,883
G
Psmb4
proteasome 20S subunit beta 4
increases expression
EXP
Buspirone results in increased expression of PSMB4 mRNA
CTD
PMID:24136188
NCBI chr 2:185,131,787...185,134,561
Ensembl chr 2:185,131,786...185,135,287
G
Psmb8
proteasome 20S subunit beta 8
decreases expression
EXP
Buspirone results in decreased expression of PSMB8 mRNA
CTD
PMID:24136188
NCBI chr20:4,654,068...4,657,049
Ensembl chr20:4,654,068...4,657,031
G
Psmb9
proteasome 20S subunit beta 9
decreases expression
EXP
Buspirone results in decreased expression of PSMB9 mRNA
CTD
PMID:24136188
NCBI chr20:4,668,952...4,674,421
Ensembl chr20:4,668,739...4,674,421
G
Ptgr3
prostaglandin reductase 3
increases expression
EXP
Buspirone results in increased expression of PTGR3 mRNA
CTD
PMID:24136188
NCBI chr18:79,729,282...79,738,632
Ensembl chr18:79,729,282...79,738,632
G
Ptma
prothymosin alpha
decreases expression
EXP
Buspirone results in decreased expression of PTMA mRNA
CTD
PMID:24136188
NCBI chr 9:94,624,194...94,628,276
Ensembl chr 9:94,624,196...94,628,276
G
Ptprf
protein tyrosine phosphatase, receptor type, F
decreases expression
EXP
Buspirone results in decreased expression of PTPRF mRNA
CTD
PMID:24136188
NCBI chr 5:137,027,376...137,109,405
Ensembl chr 5:137,028,164...137,095,426
G
Pttg1
PTTG1 regulator of sister chromatid separation, securin
decreases expression
EXP
Buspirone results in decreased expression of PTTG1 mRNA
CTD
PMID:24136188
NCBI chr10:28,394,940...28,406,410
Ensembl chr10:28,394,814...28,406,309
G
Pycard
PYD and CARD domain containing
multiple interactions
EXP
Buspirone inhibits the reaction [Methotrexate results in increased expression of PYCARD protein]
CTD
PMID:37341015
NCBI chr 1:192,032,124...192,033,419
Ensembl chr 1:192,032,124...192,033,419
G
Pygl
glycogen phosphorylase L
decreases expression
EXP
Buspirone results in decreased expression of PYGL mRNA
CTD
PMID:24136188
NCBI chr 6:94,433,558...94,476,219
Ensembl chr 6:94,426,346...94,476,269
G
R3hdm2
R3H domain containing 2
decreases expression
EXP
Buspirone results in decreased expression of R3HDM2 mRNA
CTD
PMID:24136188
NCBI chr 7:65,097,685...65,225,863
Ensembl chr 7:65,097,923...65,225,862
G
Rab17
RAB17, member RAS oncogene family
increases expression
EXP
Buspirone results in increased expression of RAB17 mRNA
CTD
PMID:24136188
NCBI chr 9:99,001,044...99,014,340
Ensembl chr 9:99,001,045...99,014,032
G
Rab29
RAB29, member RAS oncogene family
increases expression
EXP
Buspirone results in increased expression of RAB29 mRNA
CTD
PMID:24136188
NCBI chr13:45,859,930...45,865,468
Ensembl chr13:45,859,961...45,865,610
G
Rab30
RAB30, member RAS oncogene family
increases expression
EXP
Buspirone results in increased expression of RAB30 mRNA
CTD
PMID:24136188
NCBI chr 1:156,216,137...156,310,778
Ensembl chr 1:156,216,137...156,310,778
G
Rab34
RAB34, member RAS oncogene family
increases expression
EXP
Buspirone results in increased expression of RAB34 mRNA
CTD
PMID:24136188
NCBI chr10:63,581,542...63,585,608
Ensembl chr10:63,580,997...63,586,083
G
Rab38
RAB38, member RAS oncogene family
decreases expression
EXP
Buspirone results in decreased expression of RAB38 mRNA
CTD
PMID:24136188
NCBI chr 1:151,595,153...151,675,492
Ensembl chr 1:151,595,078...151,675,493
G
Rab5if
RAB5 interacting factor
increases expression
EXP
Buspirone results in increased expression of RAB5IF mRNA
CTD
PMID:24136188
NCBI chr 3:165,818,060...165,828,071
Ensembl chr 3:165,816,588...165,828,067
G
Rab7a
RAB7A, member RAS oncogene family
decreases expression
EXP
Buspirone results in decreased expression of RAB7A mRNA
CTD
PMID:24136188
NCBI chr 4:122,019,281...122,068,067
Ensembl chr 4:121,983,938...122,064,185
G
Rabac1
Rab acceptor 1
increases expression
EXP
Buspirone results in increased expression of RABAC1 mRNA
CTD
PMID:24136188
NCBI chr 1:89,691,884...89,695,017
Ensembl chr 1:89,691,884...89,695,017
G
Ran
RAN, member RAS oncogene family
decreases expression
EXP
Buspirone results in decreased expression of RAN mRNA
CTD
PMID:24136188
NCBI chr12:33,311,155...33,314,339
Ensembl chr12:33,311,158...33,314,317
G
Rangap1
RAN GTPase activating protein 1
decreases expression
EXP
Buspirone results in decreased expression of RANGAP1 mRNA
CTD
PMID:24136188
NCBI chr 7:115,104,820...115,130,564
Ensembl chr 7:115,104,823...115,130,564
G
Rapgef4
Rap guanine nucleotide exchange factor 4
increases expression
EXP
Buspirone results in increased expression of RAPGEF4 mRNA
CTD
PMID:24136188
NCBI chr 3:77,217,024...77,509,933
Ensembl chr 3:77,217,039...77,509,978
G
Rarb
retinoic acid receptor, beta
decreases expression
EXP
Buspirone results in decreased expression of RARB mRNA
CTD
PMID:24136188
NCBI chr15:10,837,252...11,482,037
Ensembl chr15:11,131,358...11,482,040
G
Rb1
RB transcriptional corepressor 1
decreases expression
EXP
Buspirone results in decreased expression of RB1 mRNA
CTD
PMID:24136188
NCBI chr15:54,780,858...54,911,989
Ensembl chr15:54,780,858...54,911,857
G
Rbfa
ribosome binding factor A
decreases expression
EXP
Buspirone results in decreased expression of RBFA mRNA
CTD
PMID:24136188
NCBI chr18:75,914,247...75,923,893
Ensembl chr18:75,914,145...75,939,219
G
Rcan1
regulator of calcineurin 1
decreases expression
EXP
Buspirone results in decreased expression of RCAN1 mRNA
CTD
PMID:24136188
NCBI chr11:45,108,123...45,188,065
Ensembl chr11:45,108,124...45,118,236
G
Rcl1
RNA terminal phosphate cyclase-like 1
increases expression
EXP
Buspirone results in increased expression of RCL1 mRNA
CTD
PMID:24136188
NCBI chr 1:236,238,078...236,282,597
Ensembl chr 1:236,238,031...236,315,894
G
Rdh11
retinol dehydrogenase 11
decreases expression
EXP
Buspirone results in decreased expression of RDH11 mRNA
CTD
PMID:24136188
NCBI chr 6:103,712,373...103,728,247
Ensembl chr 6:103,712,374...103,729,741
G
Rela
RELA proto-oncogene, NF-kB subunit
multiple interactions
EXP
Buspirone inhibits the reaction [Methotrexate results in increased expression of RELA mRNA]
CTD
PMID:37341015
NCBI chr 1:212,354,336...212,364,815
Ensembl chr 1:212,333,035...212,364,817
G
Retreg1
reticulophagy regulator 1
increases expression
EXP
Buspirone results in increased expression of RETREG1 mRNA
CTD
PMID:24136188
NCBI chr 2:78,045,435...78,205,316
Ensembl chr 2:78,066,031...78,225,356
G
Rex1bd
required for excision 1-B domain containing
increases expression
EXP
Buspirone results in increased expression of REX1BD mRNA
CTD
PMID:24136188
NCBI chr16:18,956,023...18,958,494
Ensembl chr16:18,955,969...18,958,494
G
Rhob
ras homolog family member B
decreases expression
EXP
Buspirone results in decreased expression of RHOB mRNA
CTD
PMID:24136188
NCBI chr 6:37,083,030...37,085,204
Ensembl chr 6:37,075,015...37,112,772
G
Rig1
RNA sensor RIG-1
decreases expression
EXP
Buspirone results in decreased expression of RIGI mRNA
CTD
PMID:24136188
NCBI chr 5:60,117,398...60,165,995
Ensembl chr 5:60,117,398...60,165,995
G
Rnd2
Rho family GTPase 2
increases expression
EXP
Buspirone results in increased expression of RND2 mRNA
CTD
PMID:24136188
NCBI chr10:86,899,395...86,902,992
Ensembl chr10:86,899,395...86,902,992
G
Rnf125
ring finger protein 125
decreases expression
EXP
Buspirone results in decreased expression of RNF125 mRNA
CTD
PMID:24136188
NCBI chr18:12,528,995...12,550,646
Ensembl chr18:12,528,838...12,554,430
G
Rnf139
ring finger protein 139
increases expression
EXP
Buspirone results in increased expression of RNF139 mRNA
CTD
PMID:24136188
NCBI chr 7:92,329,201...92,340,386
Ensembl chr 7:92,329,157...92,341,721
G
Rnf149
ring finger protein 149
increases expression
EXP
Buspirone results in increased expression of RNF149 mRNA
CTD
PMID:24136188
NCBI chr 9:49,322,524...49,350,361
Ensembl chr 9:49,323,857...49,350,042
G
Rnf26
ring finger protein 26
decreases expression
EXP
Buspirone results in decreased expression of RNF26 mRNA
CTD
PMID:24136188
NCBI chr 8:53,351,388...53,353,586
Ensembl chr 8:53,341,487...53,355,777
G
Rorc
RAR-related orphan receptor C
decreases expression
EXP
Buspirone results in decreased expression of RORC mRNA
CTD
PMID:24136188
NCBI chr 2:184,698,779...184,723,942
Ensembl chr 2:184,698,818...184,724,566
G
Rpa1
replication protein A1
decreases expression
EXP
Buspirone results in decreased expression of RPA1 mRNA
CTD
PMID:24136188
NCBI chr10:60,647,185...60,698,279
Ensembl chr10:60,647,185...60,698,279
G
Rpa3
replication protein A3
decreases expression
EXP
Buspirone results in decreased expression of RPA3 mRNA
CTD
PMID:24136188
NCBI chr 4:37,270,966...37,273,997
Ensembl chr 4:37,270,966...37,274,183
G
Rpe
ribulose-5-phosphate-3-epimerase
decreases expression
EXP
Buspirone results in decreased expression of RPE mRNA
CTD
PMID:24136188
NCBI chr 9:75,640,867...75,661,009
Ensembl chr 9:75,640,982...75,661,643
G
Rpl7l1
ribosomal protein L7-like 1
decreases expression
EXP
Buspirone results in decreased expression of RPL7L1 mRNA
CTD
PMID:24136188
NCBI chr 9:21,695,718...21,703,736
Ensembl chr 9:21,695,707...21,703,735
G
Rpn1
ribophorin I
decreases expression
EXP
Buspirone results in decreased expression of RPN1 mRNA
CTD
PMID:24136188
NCBI chr 4:122,100,976...122,122,382
Ensembl chr 4:122,100,813...122,122,382
G
Rrm2
ribonucleotide reductase regulatory subunit M2
decreases expression
EXP
Buspirone results in decreased expression of RRM2 mRNA
CTD
PMID:24136188
NCBI chr 6:47,044,755...47,075,370
Ensembl chr 6:47,067,690...47,075,370
G
RT1-Ba
RT1 class II, locus Ba
decreases expression
EXP
Buspirone results in decreased expression of RT1-BA mRNA
CTD
PMID:24136188
NCBI chr20:4,577,057...4,581,650
Ensembl chr20:4,576,843...4,581,653
G
RT1-Da
RT1 class II, locus Da
decreases expression
EXP
Buspirone results in decreased expression of RT1-DA mRNA
CTD
PMID:24136188
NCBI chr20:4,515,393...4,520,387
Ensembl chr20:4,513,908...4,520,383
G
RT1-DMb
RT1 class II, locus DMb
decreases expression
EXP
Buspirone results in decreased expression of HLA-DMB mRNA
CTD
PMID:24136188
NCBI chr20:4,695,009...4,702,560
Ensembl chr20:4,695,010...4,702,246
G
RT1-S3
RT1 class Ib, locus S3
decreases expression
EXP
Buspirone results in decreased expression of RT1-S3 mRNA
CTD
PMID:24136188
NCBI chr20:2,675,463...2,680,229
G
S100b
S100 calcium binding protein B
decreases response to substance
ISO
S100B results in decreased susceptibility to Buspirone
CTD
PMID:12888777
NCBI chr20:12,372,345...12,381,159
Ensembl chr20:12,372,348...12,381,081
G
Sae1
SUMO1 activating enzyme subunit 1
decreases expression
EXP
Buspirone results in decreased expression of SAE1 mRNA
CTD
PMID:24136188
NCBI chr 1:86,159,114...86,215,089
Ensembl chr 1:86,159,114...86,215,089
G
Sall1
spalt-like transcription factor 1
increases expression
EXP
Buspirone results in increased expression of SALL1 mRNA
CTD
PMID:24136188
NCBI chr19:34,179,316...34,196,278
Ensembl chr19:34,181,078...34,196,278
G
Sar1b
secretion associated, Ras related GTPase 1B
increases expression
EXP
Buspirone results in increased expression of SAR1B mRNA
CTD
PMID:24136188
NCBI chr10:36,525,365...36,555,009
Ensembl chr10:36,519,384...36,555,005
G
Sarnp
SAP domain containing ribonucleoprotein
decreases expression
EXP
Buspirone results in decreased expression of SARNP mRNA
CTD
PMID:24136188
NCBI chr 7:1,835,597...1,889,833
Ensembl chr 7:1,835,597...1,897,295
G
Sat2
spermidine/spermine N1-acetyltransferase family member 2
increases expression
EXP
Buspirone results in increased expression of SAT2 mRNA
CTD
PMID:24136188
NCBI chr10:54,839,531...54,841,651
Ensembl chr10:54,839,189...54,841,958
G
Scarb1
scavenger receptor class B, member 1
decreases expression
EXP
Buspirone results in decreased expression of SCARB1 mRNA
CTD
PMID:24136188
NCBI chr12:36,957,302...37,023,982
Ensembl chr12:36,957,496...37,023,980
G
Scd
stearoyl-CoA desaturase
decreases expression
EXP
Buspirone results in decreased expression of SCD1 mRNA
CTD
PMID:24136188
NCBI chr 1:253,218,968...253,232,101
Ensembl chr 1:253,218,970...253,231,785
G
Scfd1
sec1 family domain containing 1
decreases expression
EXP
Buspirone results in decreased expression of SCFD1 mRNA
CTD
PMID:24136188
NCBI chr 6:74,531,225...74,609,463
Ensembl chr 6:74,531,276...74,633,750
G
Scly
selenocysteine lyase
decreases expression
EXP
Buspirone results in decreased expression of SCLY mRNA
CTD
PMID:24136188
NCBI chr 9:99,337,796...99,358,487
Ensembl chr 9:99,327,873...99,358,487
G
Sdc4
syndecan 4
increases expression
EXP
Buspirone results in increased expression of SDC4 mRNA
CTD
PMID:24136188
NCBI chr 3:173,574,239...173,592,923
Ensembl chr 3:173,574,239...173,593,670
G
Sdf2
stromal cell derived factor 2
increases expression
EXP
Buspirone results in increased expression of SDF2 mRNA
CTD
PMID:24136188
NCBI chr10:63,638,634...63,649,109
Ensembl chr10:63,638,634...63,649,108
G
Sds
serine dehydratase
increases expression
EXP
Buspirone results in increased expression of SDS mRNA
CTD
PMID:24136188
NCBI chr12:41,743,796...41,751,108
Ensembl chr12:41,743,799...41,748,773
G
Sec13
SEC13 homolog, nuclear pore and COPII coat complex component
decreases expression
EXP
Buspirone results in decreased expression of SEC13 mRNA
CTD
PMID:24136188
NCBI chr 4:148,433,344...148,446,735
Ensembl chr 4:148,433,349...148,446,755
G
Sec22b
SEC22 homolog B, vesicle trafficking protein
decreases expression
EXP
Buspirone results in decreased expression of SEC22B mRNA
CTD
PMID:24136188
NCBI chr 2:188,188,783...188,209,565
Ensembl chr 2:188,188,751...188,211,600
G
Sec23b
Sec23 homolog B, COPII coat complex component
decreases expression
EXP
Buspirone results in decreased expression of SEC23B mRNA
CTD
PMID:24136188
NCBI chr 3:152,392,340...152,434,813
Ensembl chr 3:152,392,308...152,434,800
G
Sec61a1
SEC61 translocon subunit alpha 1
decreases expression
EXP
Buspirone results in decreased expression of SEC61A1 mRNA
CTD
PMID:24136188
NCBI chr 4:122,530,785...122,545,141
Ensembl chr 4:122,530,789...122,545,141
G
Sec63
SEC63 homolog, protein translocation regulator
decreases expression
EXP
Buspirone results in decreased expression of SEC63 mRNA
CTD
PMID:24136188
NCBI chr20:47,827,291...47,896,248
Ensembl chr20:47,827,291...47,896,248
G
Secisbp2l
SECIS binding protein 2-like
decreases expression
EXP
Buspirone results in decreased expression of SECISBP2L mRNA
CTD
PMID:24136188
NCBI chr 3:133,443,023...133,489,467
Ensembl chr 3:133,445,317...133,489,291
G
Sectm1b
secreted and transmembrane 1B
decreases expression
EXP
Buspirone results in decreased expression of SECTM1B mRNA
CTD
PMID:24136188
NCBI chr10:106,822,397...106,832,105
Ensembl chr10:106,822,397...106,832,104
G
Septin10
septin 10
decreases expression
EXP
Buspirone results in decreased expression of SEPTIN10 mRNA
CTD
PMID:24136188
NCBI chr20:27,644,862...27,737,817
Ensembl chr20:27,643,876...27,737,902
G
Septin7
septin 7
decreases expression
EXP
Buspirone results in decreased expression of SEPTIN7 mRNA
CTD
PMID:24136188
NCBI chr 8:31,995,597...32,059,069
Ensembl chr 8:31,995,005...32,059,072
G
Septin9
septin 9
decreases expression
EXP
Buspirone results in decreased expression of SEPTIN9 mRNA
CTD
PMID:24136188
NCBI chr10:102,908,557...103,077,789
Ensembl chr10:102,908,560...103,077,788
G
Serpina11
serpin family A member 11
increases expression
EXP
Buspirone results in increased expression of SERPINA11 mRNA
CTD
PMID:24136188
NCBI chr 6:128,668,030...128,677,476
Ensembl chr 6:128,668,034...128,677,454
G
Serpina6
serpin family A member 6
decreases expression
EXP
Buspirone results in decreased expression of SERPINA6 mRNA
CTD
PMID:24136188
NCBI chr 6:128,544,828...128,555,064
Ensembl chr 6:128,544,831...128,555,139
G
Serpinb9
serpin family B member 9
decreases expression
EXP
Buspirone results in decreased expression of SERPINB9 mRNA
CTD
PMID:24136188
NCBI chr17:31,628,887...31,652,003
Ensembl chr17:31,629,392...31,651,974
G
Sf3a3
splicing factor 3a, subunit 3
decreases expression
EXP
Buspirone results in decreased expression of SF3A3 mRNA
CTD
PMID:24136188
NCBI chr 5:142,246,556...142,272,053
Ensembl chr 5:142,246,568...142,272,052
G
Sfpq
splicing factor proline and glutamine rich
decreases expression
EXP
Buspirone results in decreased expression of SFPQ mRNA
CTD
PMID:24136188
NCBI chr 5:144,621,678...144,637,930
Ensembl chr 5:144,622,476...144,637,926
G
Sft2d2
SFT2 domain containing 2
increases expression
EXP
Buspirone results in increased expression of SFT2D2 mRNA
CTD
PMID:24136188
NCBI chr13:80,017,854...80,037,144
Ensembl chr13:80,008,480...80,037,473
G
Sgk1
serum/glucocorticoid regulated kinase 1
decreases expression
EXP
Buspirone results in decreased expression of SGK1 mRNA
CTD
PMID:24136188
NCBI chr 1:24,799,391...24,916,886
Ensembl chr 1:24,799,396...24,807,231
G
Sgpp1
sphingosine-1-phosphate phosphatase 1
increases expression
EXP
Buspirone results in increased expression of SGPP1 mRNA
CTD
PMID:24136188
NCBI chr 6:100,161,024...100,182,214
Ensembl chr 6:100,161,024...100,182,259
G
Sh3bgrl3
SH3 domain binding glutamate-rich protein like 3
decreases expression
EXP
Buspirone results in decreased expression of SH3BGRL3 mRNA
CTD
PMID:24136188
NCBI chr 5:151,637,897...151,639,270
Ensembl chr 5:151,637,674...151,639,395
G
Sh3bp5
SH3-domain binding protein 5
increases expression
EXP
Buspirone results in increased expression of SH3BP5 mRNA
CTD
PMID:24136188
NCBI chr16:6,589,877...6,676,524
Ensembl chr16:6,589,877...6,655,211
G
Shmt2
serine hydroxymethyltransferase 2
decreases expression
EXP
Buspirone results in decreased expression of SHMT2 mRNA
CTD
PMID:24136188
NCBI chr 7:65,244,247...65,249,580
Ensembl chr 7:65,244,247...65,249,567
G
Sidt2
SID1 transmembrane family, member 2
increases expression
EXP
Buspirone results in increased expression of SIDT2 mRNA
CTD
PMID:24136188
NCBI chr 8:55,129,091...55,146,446
Ensembl chr 8:55,129,091...55,145,408
G
Sin3b
SIN3 transcription regulator family member B
increases expression
EXP
Buspirone results in increased expression of SIN3B mRNA
CTD
PMID:24136188
NCBI chr16:17,157,352...17,194,051
Ensembl chr16:17,157,352...17,270,664
G
Sirt5
sirtuin 5
decreases expression
EXP
Buspirone results in decreased expression of SIRT5 mRNA
CTD
PMID:24136188
NCBI chr17:21,515,982...21,543,529
Ensembl chr17:21,515,985...21,537,442
G
Slc17a3
solute carrier family 17 member 3
decreases expression
EXP
Buspirone results in decreased expression of SLC17A3 mRNA
CTD
PMID:24136188
NCBI chr17:41,698,679...41,729,057
Ensembl chr17:41,698,680...41,723,329
G
Slc22a2
solute carrier family 22 member 2
multiple interactions
ISO
Buspirone inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium]
CTD
PMID:21599003
NCBI chr 1:50,668,817...50,711,019
Ensembl chr 1:50,668,817...50,711,019
G
Slc25a17
solute carrier family 25 member 17
increases expression
EXP
Buspirone results in increased expression of SLC25A17 mRNA
CTD
PMID:24136188
NCBI chr 7:114,724,533...114,767,163
Ensembl chr 7:114,724,533...114,767,345
G
Slc25a20
solute carrier family 25 member 20
increases expression
EXP
Buspirone results in increased expression of SLC25A20 mRNA
CTD
PMID:24136188
NCBI chr 8:118,243,573...118,265,027
Ensembl chr 8:118,243,519...118,265,027
G
Slc25a22
solute carrier family 25 member 22
increases expression
EXP
Buspirone results in increased expression of SLC25A22 mRNA
CTD
PMID:24136188
NCBI chr 1:205,954,713...205,966,188
Ensembl chr 1:205,958,032...205,965,877
G
Slc26a8
solute carrier family 26 member 8
increases expression
EXP
Buspirone results in increased expression of SLC26A8 mRNA
CTD
PMID:24136188
NCBI chr20:6,687,207...6,751,184
Ensembl chr20:6,699,445...6,751,184
G
Slc27a5
solute carrier family 27 member 5
increases expression
EXP
Buspirone results in increased expression of SLC27A5 mRNA
CTD
PMID:24136188
NCBI chr 1:82,688,742...82,699,335
Ensembl chr 1:82,688,750...82,699,358
G
Slc28a2
solute carrier family 28 member 2
decreases expression
EXP
Buspirone results in decreased expression of SLC28A2 mRNA
CTD
PMID:24136188
NCBI chr 3:129,778,425...129,841,292
Ensembl chr 3:129,807,537...129,841,291
G
Slc34a1
solute carrier family 34 member 1
increases expression
EXP
Buspirone results in increased expression of SLC34A1 mRNA
CTD
PMID:24136188
NCBI chr17:9,224,010...9,238,983
Ensembl chr17:9,224,010...9,238,983
G
Slc34a2
solute carrier family 34 member 2
decreases expression
EXP
Buspirone results in decreased expression of SLC34A2 mRNA
CTD
PMID:24136188
NCBI chr14:62,123,313...62,153,020
Ensembl chr14:62,123,316...62,143,360
G
Slc35b4
solute carrier family 35 member B4
decreases expression
EXP
Buspirone results in decreased expression of SLC35B4 mRNA
CTD
PMID:24136188
NCBI chr 4:63,744,188...63,766,200
Ensembl chr 4:63,744,188...63,766,196
G
Slc37a4
solute carrier family 37 member 4
increases expression
EXP
Buspirone results in increased expression of SLC37A4 mRNA
CTD
PMID:24136188
NCBI chr 8:53,619,952...53,626,110
Ensembl chr 8:53,620,141...53,626,110
G
Slc41a2
solute carrier family 41 member 2
decreases expression
EXP
Buspirone results in decreased expression of SLC41A2 mRNA
CTD
PMID:24136188
NCBI chr 7:22,271,298...22,378,764
Ensembl chr 7:22,271,313...22,378,764
G
Slc49a4
solute carrier family 49 member 4
increases expression
EXP
Buspirone results in increased expression of SLC49A4 mRNA
CTD
PMID:24136188
NCBI chr11:78,500,918...78,574,205
Ensembl chr11:78,500,960...78,574,202
G
Slco1a4
solute carrier organic anion transporter family, member 1a4
increases expression
EXP
Buspirone results in increased expression of SLCO1A2 mRNA
CTD
PMID:24136188
NCBI chr 4:176,441,104...176,495,846
Ensembl chr 4:176,441,104...176,495,816
G
Slfn3
schlafen 3
decreases expression
EXP
Buspirone results in decreased expression of SLFN3 mRNA
CTD
PMID:24136188
NCBI chr10:68,515,815...68,557,674
G
Smim26
small integral membrane protein 26
increases expression
EXP
Buspirone results in increased expression of SMIM26 mRNA
CTD
PMID:24136188
NCBI chr 3:152,443,397...152,445,102
Ensembl chr 3:152,443,579...152,445,447
G
Smoc1
SPARC related modular calcium binding 1
increases expression
EXP
Buspirone results in increased expression of SMOC1 mRNA
CTD
PMID:24136188
NCBI chr 6:106,432,592...106,593,956
Ensembl chr 6:106,432,603...106,593,956
G
Snd1
staphylococcal nuclease and tudor domain containing 1
decreases expression
EXP
Buspirone results in decreased expression of SND1 mRNA
CTD
PMID:24136188
NCBI chr 4:58,060,689...58,459,926
Ensembl chr 4:58,060,640...58,459,925
G
Snrnp25
small nuclear ribonucleoprotein U11/U12 subunit 25
increases expression
EXP
Buspirone results in increased expression of SNRNP25 mRNA
CTD
PMID:24136188
NCBI chr10:15,924,932...15,928,279
Ensembl chr10:15,924,940...15,928,252
G
Sod3
superoxide dismutase 3
decreases expression
EXP
Buspirone results in decreased expression of SOD3 mRNA
CTD
PMID:24136188
NCBI chr14:62,822,865...62,828,602
Ensembl chr14:62,811,177...62,829,125
G
Sparc
secreted protein acidic and cysteine rich
decreases expression
EXP
Buspirone results in decreased expression of SPARC mRNA
CTD
PMID:24136188
NCBI chr10:40,017,065...40,038,816
Ensembl chr10:40,017,075...40,039,268
G
Spart
spartin
decreases expression
EXP
Buspirone results in decreased expression of SPART mRNA
CTD
PMID:24136188
NCBI chr 2:141,442,770...141,469,388
Ensembl chr 2:141,442,737...141,469,382
G
Spcs2
signal peptidase complex subunit 2
decreases expression
EXP
Buspirone results in decreased expression of SPCS2 mRNA
CTD
PMID:24136188
NCBI chr 1:163,575,842...163,595,269
Ensembl chr 1:163,575,842...163,595,271
G
Spg21
SPG21 abhydrolase domain containing, maspardin
increases expression
EXP
Buspirone results in increased expression of SPG21 mRNA
CTD
PMID:24136188
NCBI chr 8:74,876,136...74,903,676
Ensembl chr 8:74,876,136...74,903,676
G
Spink1
serine peptidase inhibitor, Kazal type 1
increases expression
EXP
Buspirone results in increased expression of SPINK1 mRNA
CTD
PMID:24136188
NCBI chr18:36,121,626...36,133,596
Ensembl chr18:36,076,399...36,133,545
G
Spns1
SPNS lysolipid transporter 1, lysophospholipid
increases expression
EXP
Buspirone results in increased expression of SPNS1 mRNA
CTD
PMID:24136188
NCBI chr 1:190,372,663...190,380,192
Ensembl chr 1:190,372,666...190,379,943
G
Sptssa
serine palmitoyltransferase, small subunit A
increases expression
EXP
Buspirone results in increased expression of SPTSSA mRNA
CTD
PMID:24136188
NCBI chr 6:77,879,931...77,891,344
Ensembl chr 6:77,879,941...77,891,403
G
Srebf1
sterol regulatory element binding transcription factor 1
decreases expression
EXP
Buspirone results in decreased expression of SREBF1 mRNA
CTD
PMID:24136188
NCBI chr10:45,507,152...45,529,164
Ensembl chr10:45,507,152...45,529,164
G
Srgn
serglycin
decreases expression
EXP
Buspirone results in decreased expression of SRGN mRNA
CTD
PMID:24136188
NCBI chr20:30,985,508...31,022,296
Ensembl chr20:30,985,508...31,000,327
G
Srp72
signal recognition particle 72
decreases expression
EXP
Buspirone results in decreased expression of SRP72 mRNA
CTD
PMID:24136188
NCBI chr14:31,522,424...31,549,978
Ensembl chr14:31,522,963...31,550,151
G
Srpra
SRP receptor subunit alpha
decreases expression
EXP
Buspirone results in decreased expression of SRPRA mRNA
CTD
PMID:24136188
NCBI chr 8:41,818,199...41,824,292
Ensembl chr 8:41,818,229...41,824,280
G
Srprb
SRP receptor subunit beta
decreases expression
EXP
Buspirone results in decreased expression of SRPRB mRNA
CTD
PMID:24136188
NCBI chr 8:112,647,577...112,661,524
G
Srrm2
serine/arginine repetitive matrix 2
increases expression
EXP
Buspirone results in increased expression of SRRM2 mRNA
CTD
PMID:24136188
NCBI chr10:13,320,059...13,353,337
Ensembl chr10:13,320,059...13,353,337
G
Srsf2
serine and arginine rich splicing factor 2
decreases expression
EXP
Buspirone results in decreased expression of SRSF2 mRNA
CTD
PMID:24136188
NCBI chr10:102,550,962...102,554,200
Ensembl chr10:102,553,072...102,554,141
G
Srsf3
serine and arginine rich splicing factor 3
decreases expression
EXP
Buspirone results in decreased expression of SRSF3 mRNA
CTD
PMID:24136188
NCBI chr20:7,093,529...7,103,517
Ensembl chr20:7,093,565...7,103,516
G
Srsf4
serine and arginine rich splicing factor 4
increases expression
EXP
Buspirone results in increased expression of SRSF4 mRNA
CTD
PMID:24136188
NCBI chr 5:149,345,538...149,373,309
Ensembl chr 5:149,345,422...149,374,609
G
Ssr1
signal sequence receptor subunit 1
decreases expression
EXP
Buspirone results in decreased expression of SSR1 mRNA
CTD
PMID:24136188
NCBI chr17:27,039,203...27,067,352
Ensembl chr17:27,039,269...27,067,348
G
Ssx2ip
SSX family member 2 interacting protein
decreases expression
EXP
Buspirone results in decreased expression of SSX2IP mRNA
CTD
PMID:24136188
NCBI chr 2:237,958,286...237,991,026
Ensembl chr 2:237,958,465...237,991,017
G
St6gal1
ST6 beta-galactoside alpha-2,6-sialyltransferase 1
decreases expression
EXP
Buspirone results in decreased expression of ST6GAL1 mRNA
CTD
PMID:24136188
NCBI chr11:91,031,481...91,158,111
Ensembl chr11:91,032,450...91,040,415
G
Stac3
SH3 and cysteine rich domain 3
decreases expression
EXP
Buspirone results in decreased expression of STAC3 mRNA
CTD
PMID:24136188
NCBI chr 7:65,227,151...65,235,884
Ensembl chr 7:65,228,352...65,235,878
G
Stap2
signal transducing adaptor family member 2
increases expression
EXP
Buspirone results in increased expression of STAP2 mRNA
CTD
PMID:24136188
NCBI chr 9:915,546...924,604
Ensembl chr 9:915,550...924,380
G
Stard5
StAR-related lipid transfer domain containing 5
decreases expression
EXP
Buspirone results in decreased expression of STARD5 mRNA
CTD
PMID:24136188
NCBI chr 1:147,015,304...147,025,170
Ensembl chr 1:147,015,299...147,026,351
G
Stat1
signal transducer and activator of transcription 1
decreases expression
EXP
Buspirone results in decreased expression of STAT1 mRNA
CTD
PMID:24136188
NCBI chr 9:56,911,522...56,951,926
Ensembl chr 9:56,911,523...57,077,346
G
Stbd1
starch binding domain 1
increases expression
EXP
Buspirone results in increased expression of STBD1 mRNA
CTD
PMID:24136188
NCBI chr14:15,754,769...15,758,174
Ensembl chr14:15,754,644...15,761,659
G
Steap3
STEAP3 metalloreductase
decreases expression
EXP
Buspirone results in decreased expression of STEAP3 mRNA
CTD
PMID:24136188
NCBI chr13:33,904,710...33,950,100
Ensembl chr13:33,904,710...33,950,080
G
Stmn1
stathmin 1
decreases expression
EXP
Buspirone results in decreased expression of STMN1 mRNA
CTD
PMID:24136188
NCBI chr 5:151,964,308...151,970,843
Ensembl chr 5:151,964,351...151,970,842
G
Sumo3
small ubiquitin-like modifier 3
decreases expression
EXP
Buspirone results in decreased expression of SUMO3 mRNA
CTD
PMID:24136188
NCBI chr20:11,009,730...11,020,502
Ensembl chr20:11,009,734...11,020,287
G
Sun2
Sad1 and UNC84 domain containing 2
increases expression
EXP
Buspirone results in increased expression of SUN2 mRNA
CTD
PMID:24136188
NCBI chr 7:113,155,766...113,172,950
Ensembl chr 7:113,155,766...113,172,940
G
Svip
small VCP interacting protein
increases expression
EXP
Buspirone results in increased expression of SVIP mRNA
CTD
PMID:24136188
NCBI chr 1:110,723,051...110,728,741
Ensembl chr 1:110,723,051...110,729,075
G
Tagln2
transgelin 2
decreases expression
EXP
Buspirone results in decreased expression of TAGLN2 mRNA
CTD
PMID:24136188
NCBI chr13:87,499,350...87,506,328
Ensembl chr13:87,499,394...87,506,330
G
Tars1
threonyl-tRNA synthetase 1
decreases expression
EXP
Buspirone results in decreased expression of TARS1 mRNA
CTD
PMID:24136188
NCBI chr 2:62,095,978...62,114,802
Ensembl chr 2:62,087,763...62,114,802
G
Tcerg1
transcription elongation regulator 1
decreases expression
EXP
Buspirone results in decreased expression of TCERG1 mRNA
CTD
PMID:24136188
NCBI chr18:34,756,558...34,817,441
Ensembl chr18:34,756,725...34,817,441
G
Tcirg1
T-cell immune regulator 1, ATPase H+ transporting V0 subunit A3
decreases expression
EXP
Buspirone results in decreased expression of TCIRG1 mRNA
CTD
PMID:24136188
NCBI chr 1:210,556,270...210,568,021
Ensembl chr 1:210,556,270...210,568,033
G
Tcta
T-cell leukemia translocation altered
increases expression
EXP
Buspirone results in increased expression of TCTA mRNA
CTD
PMID:24136188
NCBI chr 8:117,867,153...117,871,132
Ensembl chr 8:117,867,153...117,871,331
G
Tdo2
tryptophan 2,3-dioxygenase
increases expression
EXP
Buspirone results in increased expression of TDO2 mRNA
CTD
PMID:24136188
NCBI chr 2:169,567,656...169,585,586
Ensembl chr 2:169,567,654...169,585,586
G
Tef
TEF transcription factor, PAR bZIP family member
increases expression
EXP
Buspirone results in increased expression of TEF mRNA
CTD
PMID:24136188
NCBI chr 7:115,197,180...115,221,930
Ensembl chr 7:115,193,282...115,221,928
G
Tent2
terminal nucleotidyltransferase 2
decreases expression
EXP
Buspirone results in decreased expression of TENT2 mRNA
CTD
PMID:24136188
NCBI chr 2:26,115,150...26,167,465
Ensembl chr 2:26,115,240...26,167,113
G
Tex264
testis expressed 264, ER-phagy receptor
increases expression
EXP
Buspirone results in increased expression of TEX264 mRNA
CTD
PMID:24136188
NCBI chr 8:116,174,517...116,201,578
Ensembl chr 8:116,174,518...116,201,667
G
Tfg
trafficking from ER to golgi regulator
decreases expression
EXP
Buspirone results in decreased expression of TFG mRNA
CTD
PMID:24136188
NCBI chr11:57,354,607...57,381,071
Ensembl chr11:57,354,687...57,382,267
G
Tgm2
transglutaminase 2
decreases expression
EXP
Buspirone results in decreased expression of TGM2 mRNA
CTD
PMID:24136188
NCBI chr 3:167,192,612...167,221,845
Ensembl chr 3:167,192,612...167,304,240
G
Thrsp
thyroid hormone responsive
decreases expression
EXP
Buspirone results in decreased expression of THRSP mRNA
CTD
PMID:24136188
NCBI chr 1:161,134,640...161,138,964
Ensembl chr 1:161,133,453...161,139,827
G
Timm10b
translocase of inner mitochondrial membrane 10B
increases expression
EXP
Buspirone results in increased expression of TIMM10B mRNA
CTD
PMID:24136188
NCBI chr 1:169,392,355...169,395,201
Ensembl chr 1:169,392,177...169,395,205
G
Tkfc
triokinase and FMN cyclase
decreases expression
EXP
Buspirone results in decreased expression of TKFC mRNA
CTD
PMID:24136188
NCBI chr 1:216,664,446...216,677,815
Ensembl chr 1:216,661,477...216,677,928
G
Tkt
transketolase
decreases expression
EXP
Buspirone results in decreased expression of TKT mRNA
CTD
PMID:24136188
NCBI chr16:5,729,381...5,755,170
Ensembl chr16:5,729,991...5,756,431
G
Tle1
TLE family member 1, transcriptional corepressor
increases expression
EXP
Buspirone results in increased expression of TLE1 mRNA
CTD
PMID:24136188
NCBI chr 5:90,898,182...90,982,118
Ensembl chr 5:90,898,182...90,980,928
G
Tm2d2
TM2 domain containing 2
increases expression
EXP
Buspirone results in increased expression of TM2D2 mRNA
CTD
PMID:24136188
NCBI chr16:73,719,331...73,724,853
Ensembl chr16:73,719,332...73,724,981
G
Tm2d3
TM2 domain containing 3
increases expression
EXP
Buspirone results in increased expression of TM2D3 mRNA
CTD
PMID:24136188
NCBI chr 1:128,677,680...128,687,580
Ensembl chr 1:128,677,629...128,687,580
G
Tmed9
transmembrane p24 trafficking protein 9
decreases expression
EXP
Buspirone results in decreased expression of TMED9 mRNA
CTD
PMID:24136188
NCBI chr17:9,034,797...9,039,311
Ensembl chr17:9,034,823...9,039,319
G
Tmem106b
transmembrane protein 106B
increases expression
EXP
Buspirone results in increased expression of TMEM106B mRNA
CTD
PMID:24136188
NCBI chr 4:42,294,074...42,313,426
Ensembl chr 4:42,294,101...42,313,407
G
Tmem14c
transmembrane protein 14C
increases expression
EXP
Buspirone results in increased expression of TMEM14C mRNA
CTD
PMID:24136188
NCBI chr17:23,939,501...23,945,622
Ensembl chr17:23,939,509...23,959,055
G
Tmem203
transmembrane protein 203
increases expression
EXP
Buspirone results in increased expression of TMEM203 mRNA
CTD
PMID:24136188
NCBI chr 3:28,469,062...28,469,890
Ensembl chr 3:28,465,345...28,472,140
G
Tmem205
transmembrane protein 205
increases expression
EXP
Buspirone results in increased expression of TMEM205 mRNA
CTD
PMID:24136188
NCBI chr 8:28,728,172...28,733,908
Ensembl chr 8:28,728,172...28,733,908
G
Tmem214
transmembrane protein 214
decreases expression
EXP
Buspirone results in decreased expression of TMEM214 mRNA
CTD
PMID:24136188
NCBI chr 6:31,222,635...31,231,659
Ensembl chr 6:31,222,635...31,230,381
G
Tmem250
transmembrane protein 250
increases expression
EXP
Buspirone results in increased expression of TMEM250 mRNA
CTD
PMID:24136188
NCBI chr 3:29,360,770...29,364,756
Ensembl chr 3:29,360,770...29,364,462
G
Tmem256
transmembrane protein 256
increases expression
EXP
Buspirone results in increased expression of TMEM256 mRNA
CTD
PMID:24136188
NCBI chr10:55,056,959...55,058,869
Ensembl chr10:55,056,760...55,058,862
G
Tmem263
transmembrane protein 263
decreases expression
EXP
Buspirone results in decreased expression of TMEM263 mRNA
CTD
PMID:24136188
NCBI chr 7:20,497,852...20,516,011
Ensembl chr 7:20,497,852...20,516,428
G
Tmem33
transmembrane protein 33
increases expression
EXP
Buspirone results in increased expression of TMEM33 mRNA
CTD
PMID:24136188
NCBI chr14:41,242,358...41,264,586
Ensembl chr14:41,242,358...41,264,586
G
Tmem38b
transmembrane protein 38B
increases expression
EXP
Buspirone results in increased expression of TMEM38B mRNA
CTD
PMID:24136188
NCBI chr 5:73,255,662...73,291,383
Ensembl chr 5:73,255,632...73,292,384
G
Tmem59
transmembrane protein 59
increases expression
EXP
Buspirone results in increased expression of TMEM59 mRNA
CTD
PMID:24136188
NCBI chr 5:127,191,320...127,212,436
Ensembl chr 5:127,191,030...127,217,531
G
Tmem97
transmembrane protein 97
decreases expression
EXP
Buspirone results in decreased expression of TMEM97 mRNA
CTD
PMID:24136188
NCBI chr10:63,936,276...63,945,359
Ensembl chr10:63,936,271...63,945,818
G
Tmsb4x
thymosin beta 4, X-linked
decreases expression
EXP
Buspirone results in decreased expression of TMSB4X mRNA
CTD
PMID:24136188
NCBI chr X:30,761,611...30,763,612
Ensembl chr X:30,761,612...30,763,613
G
Tmt1a
thiol methyltransferase 1A
increases expression
EXP
Buspirone results in increased expression of TMT1A mRNA
CTD
PMID:24136188
NCBI chr 7:133,330,141...133,377,172
Ensembl chr 7:133,330,447...133,338,959
G
Tmx2
thioredoxin-related transmembrane protein 2
decreases expression
EXP
Buspirone results in decreased expression of TMX2 mRNA
CTD
PMID:24136188
NCBI chr 3:90,161,628...90,169,278
Ensembl chr 3:90,160,930...90,169,278
G
Tnf
tumor necrosis factor
multiple interactions
EXP
Buspirone inhibits the reaction [Methotrexate results in increased expression of TNF protein]
CTD
PMID:37341015
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,626,532...3,629,303
G
Tp53
tumor protein p53
decreases expression
EXP
Buspirone results in decreased expression of TP53 mRNA
CTD
PMID:24136188
NCBI chr10:54,798,871...54,810,300
Ensembl chr10:54,798,851...54,810,299
G
Tpm1
tropomyosin 1
decreases expression
EXP
Buspirone results in decreased expression of TPM1 mRNA
CTD
PMID:24136188
NCBI chr 8:76,516,654...76,543,661
Ensembl chr 8:76,511,871...76,543,468
G
Tpm3
tropomyosin 3
decreases expression
EXP
Buspirone results in decreased expression of TPM3 mRNA
CTD
PMID:24136188
NCBI chr 2:177,812,534...177,842,661
Ensembl chr 2:177,814,883...177,842,660
G
Tpm4
tropomyosin 4
decreases expression
EXP
Buspirone results in decreased expression of TPM4 mRNA
CTD
PMID:24136188
NCBI chr16:17,718,442...17,732,483
Ensembl chr16:17,717,230...17,732,494
G
Trim5
tripartite motif-containing 5
decreases expression
EXP
Buspirone results in decreased expression of TRIM5 mRNA
CTD
PMID:24136188
NCBI chr 1:168,132,277...168,149,263
Ensembl chr 1:168,132,308...168,141,657
G
Tsc22d3
TSC22 domain family, member 3
increases expression
EXP
Buspirone results in increased expression of TSC22D3 mRNA
CTD
PMID:24136188
NCBI chr X:109,006,410...109,066,389
Ensembl chr X:109,006,420...109,015,519
G
Ttc13
tetratricopeptide repeat domain 13
decreases expression
EXP
Buspirone results in decreased expression of TTC13 mRNA
CTD
PMID:24136188
NCBI chr19:69,534,989...69,589,590
Ensembl chr19:69,534,989...69,589,563
G
Tuba1c
tubulin, alpha 1C
decreases expression
EXP
Buspirone results in decreased expression of TUBA1C mRNA
CTD
PMID:24136188
NCBI chr 7:131,636,974...132,078,589
Ensembl chr 7:132,070,536...132,079,311
G
Tuba4a
tubulin, alpha 4A
decreases expression
EXP
Buspirone results in decreased expression of TUBA4A mRNA
CTD
PMID:24136188
NCBI chr 9:84,158,871...84,174,041
Ensembl chr 9:84,158,280...84,162,584
G
Tubb2a
tubulin, beta 2A class IIa
decreases expression
EXP
Buspirone results in decreased expression of TUBB2A mRNA
CTD
PMID:24136188
NCBI chr17:31,002,186...31,006,057
Ensembl chr17:30,983,387...31,006,838
G
Tubb4b
tubulin, beta 4B class IVb
decreases expression
EXP
Buspirone results in decreased expression of TUBB4B mRNA
CTD
PMID:24136188
NCBI chr 3:28,435,999...28,438,455
Ensembl chr 3:28,435,148...28,439,719
G
Tubb5
tubulin, beta 5 class I
decreases expression
EXP
Buspirone results in decreased expression of TUBB5 mRNA
CTD
PMID:24136188
NCBI chr20:2,917,577...2,921,726
Ensembl chr20:2,917,539...2,921,726
G
Tufm
Tu translation elongation factor, mitochondrial
decreases expression
EXP
Buspirone results in decreased expression of TUFM mRNA
CTD
PMID:24136188
NCBI chr 1:190,504,373...190,507,980
Ensembl chr 1:190,504,373...190,508,952
G
Ube2c
ubiquitin-conjugating enzyme E2C
decreases expression
EXP
Buspirone results in decreased expression of UBE2C mRNA
CTD
PMID:24136188
NCBI chr 3:173,925,975...173,928,375
Ensembl chr 3:173,925,934...173,932,678
G
Ube2s
ubiquitin-conjugating enzyme E2S
decreases expression
EXP
Buspirone results in decreased expression of UBE2S mRNA
CTD
PMID:24136188
NCBI chr 1:78,057,659...78,061,719
Ensembl chr 1:78,057,598...78,081,628
G
Ubxn1
UBX domain protein 1
increases expression
EXP
Buspirone results in increased expression of UBXN1 mRNA
CTD
PMID:24136188
NCBI chr 1:215,194,418...215,198,343
Ensembl chr 1:215,174,216...215,198,343
G
Ugt1a6a
UDP glucuronosyltransferase family 1 member A6a
increases expression
EXP
Buspirone results in increased expression of UGT1A6 mRNA
CTD
PMID:24136188
NCBI chr 9:96,195,018...96,256,264
Ensembl chr 9:96,144,786...96,256,264
G
Ulk1
unc-51 like autophagy activating kinase 1
increases expression
EXP
Buspirone results in increased expression of ULK1 mRNA
CTD
PMID:24136188
NCBI chr12:51,511,492...51,537,746
Ensembl chr12:51,511,492...51,537,746
G
Umps
uridine monophosphate synthetase
decreases expression
EXP
Buspirone results in decreased expression of UMPS mRNA
CTD
PMID:24136188
NCBI chr11:80,311,269...80,321,678
Ensembl chr11:80,311,214...80,327,828
G
Use1
unconventional SNARE in the ER 1
increases expression
EXP
Buspirone results in increased expression of USE1 mRNA
CTD
PMID:24136188
NCBI chr16:18,069,118...18,075,816
Ensembl chr16:18,070,793...18,075,814
G
Vamp7
vesicle-associated membrane protein 7
increases expression
EXP
Buspirone results in increased expression of VAMP7 mRNA
CTD
PMID:24136188
NCBI chr12:21,842,206...21,958,556
Ensembl chr12:21,842,228...21,958,552
G
Vim
vimentin
decreases expression
EXP
Buspirone results in decreased expression of VIM mRNA
CTD
PMID:24136188
NCBI chr17:81,577,261...81,585,746
Ensembl chr17:81,568,272...81,585,746
G
Vnn1
vanin 1
increases expression
EXP
Buspirone results in increased expression of VNN1 mRNA
CTD
PMID:24136188
NCBI chr 1:23,356,324...23,366,629
Ensembl chr 1:23,356,330...23,366,629
G
Vwa8
von Willebrand factor A domain containing 8
increases expression
EXP
Buspirone results in increased expression of VWA8 mRNA
CTD
PMID:24136188
NCBI chr15:60,661,764...60,985,971
Ensembl chr15:60,661,877...60,985,971
G
Wasl
WASP like actin nucleation promoting factor
increases expression
EXP
Buspirone results in increased expression of WASL mRNA
CTD
PMID:24136188
NCBI chr 4:54,049,081...54,097,653
Ensembl chr 4:54,049,082...54,097,570
G
Wbp1l
WW domain binding protein 1-like
increases expression
EXP
Buspirone results in increased expression of WBP1L mRNA
CTD
PMID:24136188
NCBI chr 1:255,413,701...255,470,026
Ensembl chr 1:255,413,524...255,470,026
G
Wipi1
WD repeat domain, phosphoinositide interacting 1
increases expression
EXP
Buspirone results in increased expression of WIPI1 mRNA
CTD
PMID:24136188
NCBI chr10:95,042,451...95,079,679
Ensembl chr10:95,042,441...95,079,293
G
Xdh
xanthine dehydrogenase
decreases expression
EXP
Buspirone results in decreased expression of XDH mRNA
CTD
PMID:24136188
NCBI chr 6:27,282,319...27,344,022
Ensembl chr 6:27,282,057...27,344,350
G
Xpc
XPC complex subunit, DNA damage recognition and repair factor
decreases expression
EXP
Buspirone results in decreased expression of XPC mRNA
CTD
PMID:24136188
NCBI chr 4:125,550,833...125,578,084
Ensembl chr 4:125,550,833...125,578,305
G
Xpo1
exportin 1
decreases expression
EXP
Buspirone results in decreased expression of XPO1 mRNA
CTD
PMID:24136188
NCBI chr14:101,434,450...101,476,705
Ensembl chr14:101,434,517...101,476,714
G
Xylb
xylulokinase
increases expression
EXP
Buspirone results in increased expression of XYLB mRNA
CTD
PMID:24136188
NCBI chr 8:127,971,194...128,012,511
Ensembl chr 8:127,966,100...128,006,571
G
Yars1
tyrosyl-tRNA synthetase 1
decreases expression
EXP
Buspirone results in decreased expression of YARS1 mRNA
CTD
PMID:24136188
NCBI chr 5:146,820,163...146,848,377
Ensembl chr 5:146,819,358...146,848,377
G
Ybx3
Y box binding protein 3
decreases expression
EXP
Buspirone results in decreased expression of YBX3 mRNA
CTD
PMID:24136188
NCBI chr 4:166,861,180...166,884,532
Ensembl chr 4:166,861,181...166,884,691
G
Ypel5
yippee-like 5
increases expression
EXP
Buspirone results in increased expression of YPEL5 mRNA
CTD
PMID:24136188
NCBI chr 6:28,408,079...28,423,536
Ensembl chr 6:28,408,080...28,412,385
G
Ywhah
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta
decreases expression
EXP
Buspirone results in decreased expression of YWHAH mRNA
CTD
PMID:24136188
NCBI chr14:81,920,819...81,930,202
Ensembl chr14:81,920,590...81,947,930
G
Zbtb20
zinc finger and BTB domain containing 20
increases expression
EXP
Buspirone results in increased expression of ZBTB20 mRNA
CTD
PMID:24136188
NCBI chr11:70,558,010...71,297,039
Ensembl chr11:70,580,930...70,736,237
G
Zfp354a
zinc finger protein 354A
increases expression
EXP
Buspirone results in increased expression of ZFP354A mRNA
CTD
PMID:24136188
NCBI chr10:35,897,217...35,909,063
Ensembl chr10:35,897,228...35,909,510
G
Zfp446
zinc finger protein 446
increases expression
EXP
Buspirone results in increased expression of ZFP446 mRNA
CTD
PMID:24136188
NCBI chr 1:82,673,920...82,680,414
Ensembl chr 1:82,673,918...82,685,430
G
Abcb11
ATP binding cassette subfamily B member 11
decreases activity
ISO
Cisapride results in decreased activity of ABCB11 protein
CTD
PMID:23956101
NCBI chr 3:74,424,620...74,520,646
Ensembl chr 3:74,424,979...74,520,581
G
Acp5
acid phosphatase 5, tartrate resistant
multiple interactions
ISO
Cisapride inhibits the reaction [TNFSF11 protein results in increased expression of ACP5 mRNA]
CTD
PMID:31150804
NCBI chr 8:28,939,984...28,946,639
Ensembl chr 8:28,939,985...28,943,929
G
Ctsk
cathepsin K
multiple interactions
ISO
Cisapride inhibits the reaction [TNFSF11 protein results in increased expression of CTSK mRNA]
CTD
PMID:31150804
NCBI chr 2:185,747,548...185,758,512
Ensembl chr 2:185,747,165...185,765,582
G
Cyp3a2
cytochrome P450, family 3, subfamily a, polypeptide 2
multiple interactions affects metabolic processing affects chemical synthesis decreases activity
ISO
Cisapride inhibits the reaction [CYP3A4 protein results in increased oxidation of 7-benzyloxy-4-trifluoromethylcoumarin] CYP3A4 protein affects the metabolism of Cisapride CYP3A4 protein affects the chemical synthesis of Cisapride metabolite Cisapride results in decreased activity of CYP3A4 protein
CTD
PMID:11717173 PMID:15306208 PMID:19299527
NCBI chr12:14,321,771...14,343,886
Ensembl chr12:14,321,771...14,343,857
G
Dcstamp
dendrocyte expressed seven transmembrane protein
multiple interactions
ISO
Cisapride inhibits the reaction [TNFSF11 protein results in increased expression of DCSTAMP mRNA]
CTD
PMID:31150804
NCBI chr 7:72,692,364...72,706,983
Ensembl chr 7:72,671,477...72,707,009
G
Fos
Fos proto-oncogene, AP-1 transcription factor subunit
multiple interactions
ISO
Cisapride inhibits the reaction [TNFSF11 protein results in increased expression of FOS mRNA]
CTD
PMID:31150804
NCBI chr 6:110,852,188...110,855,054
Ensembl chr 6:110,852,190...110,855,598
G
Kcnh2
potassium voltage-gated channel subfamily H member 2
multiple interactions decreases activity affects localization affects binding
ISO
beta-Cyclodextrins analog inhibits the reaction [Cisapride results in decreased activity of KCNH2 protein]; Cisapride binds to and results in decreased activity of KCNH2 protein; Cisapride inhibits the reaction [KCNH2 protein results in increased transport of Thallium] Cisapride affects the localization of KCNH2 protein mutant form Cisapride binds to KCNH2 protein
CTD
PMID:9395068 PMID:10531299 PMID:11005845 PMID:11741928 PMID:12388285 PMID:15272206 PMID:15306208 PMID:15671647 PMID:15740727 PMID:17513944 PMID:18701618 PMID:19260734 PMID:19583963 PMID:21158687 PMID:24052561 PMID:24830940 PMID:27553911 PMID:28551711 PMID:30561737 More...
NCBI chr 4:11,719,357...11,751,424
Ensembl chr 4:11,692,980...11,751,421
G
Nfatc1
nuclear factor of activated T-cells 1
multiple interactions
ISO
Cisapride inhibits the reaction [TNFSF11 protein results in increased expression of NFATC1 mRNA]
CTD
PMID:31150804
NCBI chr18:76,321,386...76,430,997
Ensembl chr18:76,321,386...76,430,990
G
Scn5a
sodium voltage-gated channel alpha subunit 5
increases localization
ISO
Cisapride results in increased localization of SCN5A protein mutant form
CTD
PMID:16301357
NCBI chr 8:128,098,613...128,196,515
Ensembl chr 8:128,098,613...128,196,470
G
Slc22a2
solute carrier family 22 member 2
multiple interactions
ISO
Cisapride inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium]
CTD
PMID:21599003
NCBI chr 1:50,668,817...50,711,019
Ensembl chr 1:50,668,817...50,711,019
G
Tnfsf11
TNF superfamily member 11
multiple interactions
ISO
Cisapride inhibits the reaction [TNFSF11 protein results in increased expression of ACP5 mRNA]; Cisapride inhibits the reaction [TNFSF11 protein results in increased expression of CTSK mRNA]; Cisapride inhibits the reaction [TNFSF11 protein results in increased expression of DCSTAMP mRNA]; Cisapride inhibits the reaction [TNFSF11 protein results in increased expression of FOS mRNA]; Cisapride inhibits the reaction [TNFSF11 protein results in increased expression of NFATC1 mRNA]
CTD
PMID:31150804
NCBI chr15:60,083,008...60,114,479
Ensembl chr15:60,083,008...60,114,479
G
Abcb11
ATP binding cassette subfamily B member 11
decreases activity
ISO
Dihydroergotamine results in decreased activity of ABCB11 protein
CTD
PMID:28437613
NCBI chr 3:74,424,620...74,520,646
Ensembl chr 3:74,424,979...74,520,581
G
Abcb4
ATP binding cassette subfamily B member 4
decreases activity
ISO
Dihydroergotamine results in decreased activity of ABCB4 protein
CTD
PMID:28437613
NCBI chr 4:26,106,895...26,164,440
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
multiple interactions decreases activity increases activity
ISO EXP
Dihydroergotamine inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A1 protein] Dihydroergotamine results in decreased activity of CYP1A1 protein Dihydroergotamine results in increased activity of CYP1A1 protein
CTD
PMID:18420780 PMID:18493746 PMID:33814510
NCBI chr 8:66,991,940...66,998,014
Ensembl chr 8:66,991,970...66,998,012
G
Cyp1b1
cytochrome P450, family 1, subfamily b, polypeptide 1
decreases activity
ISO
Dihydroergotamine results in decreased activity of CYP1B1 protein
CTD
PMID:18420780
NCBI chr 6:21,093,927...21,103,091
Ensembl chr 6:21,078,146...21,103,142
G
Cyp2a3
cytochrome P450, family 2, subfamily a, polypeptide 3
decreases activity
ISO
Dihydroergotamine results in decreased activity of CYP2A4 protein
CTD
PMID:18420780
NCBI chr 1:91,299,584...91,307,650
Ensembl chr 1:91,299,561...91,307,649
G
Cyp2b3
cytochrome P450, family 2, subfamily b, polypeptide 3
decreases activity
ISO
Dihydroergotamine results in decreased activity of CYP2B10 protein
CTD
PMID:18420780
NCBI chr 1:90,780,468...90,859,852
G
Cyp2c6
cytochrome P450, family 2, subfamily C, polypeptide 6
decreases activity
ISO
Dihydroergotamine results in decreased activity of CYP2C29 protein
CTD
PMID:18420780
NCBI chr 1:247,879,058...247,916,804
Ensembl chr 1:247,879,078...247,916,798
G
Cyp2d4
cytochrome P450, family 2, subfamily d, polypeptide 4
decreases activity
ISO
Dihydroergotamine results in decreased activity of CYP2D6 protein Dihydroergotamine results in decreased activity of CYP2D22 protein
CTD
PMID:18420780
NCBI chr 7:115,762,662...115,771,832
Ensembl chr 7:115,761,696...115,771,837
G
Cyp3a2
cytochrome P450, family 3, subfamily a, polypeptide 2
decreases activity
ISO
Dihydroergotamine results in decreased activity of CYP3A4 protein
CTD
PMID:18420780
NCBI chr12:14,321,771...14,343,886
Ensembl chr12:14,321,771...14,343,857
G
Htr5b
5-hydroxytryptamine (serotonin) receptor 5B
multiple interactions
EXP
dihydroergotamine binds to protein 5-Htr5b; inhibits the reaction[5-carboxamidotryptamine binds to 5-Htr5b]
RGD
PMID:8224165
RGD:2303647
NCBI chr13:35,239,662...35,252,586
Ensembl chr13:35,239,662...35,252,586
G
Il24
interleukin 24
increases expression
ISO
Dihydroergotamine results in increased expression of IL24 mRNA
CTD
PMID:32816093
NCBI chr13:44,905,362...44,910,760
Ensembl chr13:44,905,363...44,910,760
G
Nr1i2
nuclear receptor subfamily 1, group I, member 2
increases activity
ISO
Dihydroergotamine results in increased activity of NR1I2 protein
CTD
PMID:25455453
NCBI chr11:75,965,717...76,006,733
Ensembl chr11:75,965,632...76,002,380
G
Calca
calcitonin-related polypeptide alpha
multiple interactions decreases expression
EXP
GR 127935 inhibits the reaction [eletriptan results in decreased expression of CALCA mRNA]; isamoltane inhibits the reaction [eletriptan results in decreased expression of CALCA mRNA]
CTD
PMID:14715155
NCBI chr 1:178,312,636...178,317,588
Ensembl chr 1:178,312,638...178,317,529
G
Htr1b
5-hydroxytryptamine receptor 1B
multiple interactions
EXP
eletriptan binds to and results in increased activity of HTR1B protein
CTD
PMID:11301495
NCBI chr 8:91,395,405...91,414,815
Ensembl chr 8:91,052,432...91,418,583
G
Htr1d
5-hydroxytryptamine receptor 1D
multiple interactions
EXP
eletriptan binds to and results in increased activity of HTR1D protein
CTD
PMID:11301495
NCBI chr 5:153,939,735...153,960,012
Ensembl chr 5:153,939,516...153,960,012
G
Kcnh2
potassium voltage-gated channel subfamily H member 2
decreases activity
ISO
eletriptan results in decreased activity of KCNH2 protein
CTD
PMID:28551711
NCBI chr 4:11,719,357...11,751,424
Ensembl chr 4:11,692,980...11,751,421
G
Calca
calcitonin-related polypeptide alpha
multiple interactions
EXP
Ergotamine inhibits the reaction [Nitroglycerin results in increased expression of CALCA protein]
CTD
PMID:19121572
NCBI chr 1:178,312,636...178,317,588
Ensembl chr 1:178,312,638...178,317,529
G
Casp3
caspase 3
increases activity
ISO
Ergotamine results in increased activity of CASP3 protein
CTD
PMID:21295106
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:52,395,540...52,413,732
G
Fos
Fos proto-oncogene, AP-1 transcription factor subunit
multiple interactions
EXP
Ergotamine inhibits the reaction [Nitroglycerin results in increased expression of FOS protein]
CTD
PMID:19121572
NCBI chr 6:110,852,188...110,855,054
Ensembl chr 6:110,852,190...110,855,598
G
Gstp1
glutathione S-transferase pi 1
multiple interactions
ISO
Ergotamine inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate]
CTD
PMID:23769903
NCBI chr 1:210,767,237...210,770,242
Ensembl chr 1:210,767,237...210,769,705
G
Htr2b
5-hydroxytryptamine receptor 2B
multiple interactions
ISO
Ergotamine binds to and results in increased activity of HTR2B protein
CTD
PMID:11104741
NCBI chr 9:94,184,442...94,206,851
Ensembl chr 9:94,190,109...94,204,087
G
Agmat
agmatinase
decreases expression
ISO
Fenfluramine results in decreased expression of AGMAT mRNA
CTD
PMID:22140631
NCBI chr 5:159,326,680...159,357,300
Ensembl chr 5:159,343,160...159,357,299
G
Angptl4
angiopoietin-like 4
decreases expression
ISO
Fenfluramine results in decreased expression of ANGPTL4 mRNA
CTD
PMID:22140631
NCBI chr 7:15,252,450...15,259,971
Ensembl chr 7:15,252,473...15,258,681
G
Asah1
N-acylsphingosine amidohydrolase 1
increases expression
ISO
Fenfluramine results in increased expression of ASAH1 mRNA
CTD
PMID:22140631
NCBI chr16:57,669,927...57,701,349
Ensembl chr16:57,669,750...57,718,305
G
Bmpr2
bone morphogenetic protein receptor type 2
increases response to substance
ISO
BMPR2 gene mutant form results in increased susceptibility to Fenfluramine
CTD
PMID:12358323
NCBI chr 9:68,685,942...68,801,353
Ensembl chr 9:68,685,988...68,801,350
G
C7h12orf42
similar to human chromosome 12 open reading frame 42
increases expression
ISO
Fenfluramine results in increased expression of C12ORF42 mRNA
CTD
PMID:22140631
NCBI chr 7:23,351,247...23,540,772
Ensembl chr 7:23,372,782...23,540,784
G
Ccdc62
coiled-coil domain containing 62
increases expression
ISO
Fenfluramine results in increased expression of CCDC62 mRNA
CTD
PMID:22140631
NCBI chr12:38,284,089...38,320,828
Ensembl chr12:38,284,089...38,320,965
G
Cobl
cordon-bleu WH2 repeat protein
increases expression
ISO
Fenfluramine results in increased expression of COBL mRNA
CTD
PMID:22140631
NCBI chr14:91,041,721...91,274,272
Ensembl chr14:91,041,721...91,274,257
G
Dkkl1
dickkopf like acrosomal protein 1
increases expression
ISO
Fenfluramine results in increased expression of DKKL1 mRNA
CTD
PMID:22140631
NCBI chr 1:104,830,462...104,835,711
Ensembl chr 1:104,829,478...104,835,711
G
Dock8
dedicator of cytokinesis 8
increases expression
ISO
Fenfluramine results in increased expression of DOCK8 mRNA
CTD
PMID:22140631
NCBI chr 1:232,075,468...232,268,830
Ensembl chr 1:232,075,588...232,268,833
G
Dync2h1
dynein cytoplasmic 2 heavy chain 1
increases expression
ISO
Fenfluramine results in increased expression of DYNC2H1 mRNA
CTD
PMID:22140631
NCBI chr 8:12,473,955...12,697,075
Ensembl chr 8:12,473,955...12,697,058
G
Fos
Fos proto-oncogene, AP-1 transcription factor subunit
multiple interactions increases expression
EXP
Fluoxetine inhibits the reaction [Fenfluramine results in increased expression of FOS protein]; N-chlorophenylalanine inhibits the reaction [Fenfluramine results in increased expression of FOS protein]
CTD
PMID:9452197
NCBI chr 6:110,852,188...110,855,054
Ensembl chr 6:110,852,190...110,855,598
G
Fstl5
follistatin-like 5
increases expression
ISO
Fenfluramine results in increased expression of FSTL5 mRNA
CTD
PMID:22140631
NCBI chr 2:163,156,576...163,825,140
Ensembl chr 2:163,156,576...163,825,140
G
Galc
galactosylceramidase
increases expression
ISO
Fenfluramine results in increased expression of GALC mRNA
CTD
PMID:22140631
NCBI chr 6:123,182,636...123,252,024
Ensembl chr 6:123,182,643...123,245,578
G
Gapt
Grb2-binding adaptor protein, transmembrane
increases expression
ISO
Fenfluramine results in increased expression of GAPT mRNA
CTD
PMID:22140631
NCBI chr 2:43,660,900...43,665,485
Ensembl chr 2:43,660,900...43,665,448
G
Htr2a
5-hydroxytryptamine receptor 2A
affects binding
ISO
Fenfluramine binds to HTR2A protein
CTD
PMID:10617681
NCBI chr15:56,360,647...56,428,703
Ensembl chr15:56,359,596...56,431,619
G
Htr2b
5-hydroxytryptamine receptor 2B
increases response to substance increases expression affects binding
ISO
HTR2B gene mutant form results in increased susceptibility to Fenfluramine Fenfluramine results in increased expression of HTR2B mRNA Fenfluramine binds to HTR2B protein
CTD
PMID:10617681 PMID:14659797 PMID:22140631
NCBI chr 9:94,184,442...94,206,851
Ensembl chr 9:94,190,109...94,204,087
G
Htr2c
5-hydroxytryptamine receptor 2C
affects binding
ISO
Fenfluramine binds to HTR2C protein
CTD
PMID:10617681
NCBI chr X:115,453,190...115,682,325
Ensembl chr X:115,452,842...115,682,324
G
Irf8
interferon regulatory factor 8
increases expression
ISO
Fenfluramine results in increased expression of IRF8 mRNA
CTD
PMID:22140631
NCBI chr19:65,699,284...65,721,066
Ensembl chr19:65,699,284...65,721,062
G
Itga2
integrin subunit alpha 2
increases expression
ISO
Fenfluramine results in increased expression of ITGA2 mRNA
CTD
PMID:22140631
NCBI chr 2:48,253,412...48,354,509
Ensembl chr 2:48,253,412...48,354,509
G
Klf17
KLF transcription factor 17
increases expression
ISO
Fenfluramine results in increased expression of KLF17 mRNA
CTD
PMID:22140631
NCBI chr 5:136,578,594...136,601,234
Ensembl chr 5:136,577,065...136,600,697
G
Lig4
DNA ligase 4
increases expression
ISO
Fenfluramine results in increased expression of LIG4 mRNA
CTD
PMID:22140631
NCBI chr16:86,220,345...86,228,930
Ensembl chr16:86,220,279...86,229,926
G
Morn5
MORN repeat containing 5
increases expression
ISO
Fenfluramine results in increased expression of MORN5 mRNA
CTD
PMID:22140631
NCBI chr 3:39,799,531...39,827,482
Ensembl chr 3:39,799,019...39,827,482
G
Msmo1
methylsterol monooxygenase 1
increases expression
ISO
Fenfluramine results in increased expression of MSMO1 mRNA
CTD
PMID:22140631
NCBI chr16:29,747,113...29,764,360
Ensembl chr16:29,747,137...29,764,445
G
Mucl3
mucin like 3
increases expression
ISO
Fenfluramine results in increased expression of MUCL3 mRNA
CTD
PMID:22140631
NCBI chr20:3,105,360...3,113,278
Ensembl chr20:3,105,360...3,113,278
G
Myoz3
myozenin 3
decreases expression
ISO
Fenfluramine results in decreased expression of MYOZ3 mRNA
CTD
PMID:22140631
NCBI chr18:56,296,565...56,316,582
Ensembl chr18:56,296,565...56,316,582
G
Nat8l
N-acetyltransferase 8-like
increases expression
ISO
Fenfluramine results in increased expression of NAT8L mRNA
CTD
PMID:22140631
NCBI chr14:80,980,629...80,987,264
Ensembl chr14:80,980,629...80,987,463
G
Olr1433
olfactory receptor 1433
increases expression
ISO
Fenfluramine results in increased expression of OR2W3 mRNA
CTD
PMID:22140631
NCBI chr10:43,542,833...43,546,698
G
Oxct2b
3-oxoacid CoA transferase 2B
decreases expression
ISO
Fenfluramine results in decreased expression of OXCT2 mRNA
CTD
PMID:22140631
NCBI chr 5:140,681,746...140,683,500
Ensembl chr 5:140,671,211...140,696,448
G
Pik3ap1
phosphoinositide-3-kinase adaptor protein 1
increases expression
ISO
Fenfluramine results in increased expression of PIK3AP1 mRNA
CTD
PMID:22140631
NCBI chr 1:250,040,250...250,194,364
Ensembl chr 1:250,040,250...250,154,226
G
Ppp1r12b
protein phosphatase 1, regulatory subunit 12B
increases expression
ISO
Fenfluramine results in increased expression of PPP1R12B mRNA
CTD
PMID:22140631
NCBI chr13:48,751,256...48,948,933
Ensembl chr13:48,751,477...48,948,922
G
Prl
prolactin
multiple interactions increases expression increases secretion
ISO EXP
Cocaine affects the reaction [Fenfluramine results in increased expression of PRL protein] Clonidine inhibits the reaction [Fenfluramine results in increased secretion of PRL protein]; talipexole inhibits the reaction [Fenfluramine results in increased secretion of PRL protein]
CTD
PMID:1678730 PMID:9232209 PMID:9330023 PMID:9598218 PMID:10349036
NCBI chr17:38,287,355...38,298,234
Ensembl chr17:38,288,162...38,298,217
G
Serp2
stress-associated endoplasmic reticulum protein family member 2
decreases expression
ISO
Fenfluramine results in decreased expression of SERP2 mRNA
CTD
PMID:22140631
NCBI chr15:58,289,148...58,313,224
Ensembl chr15:58,289,148...58,313,430
G
Slc16a14
solute carrier family 16, member 14
decreases expression
ISO
Fenfluramine results in decreased expression of SLC16A14 mRNA
CTD
PMID:22140631
NCBI chr 9:93,558,144...93,585,396
Ensembl chr 9:93,558,144...93,585,396
G
Slc6a15
solute carrier family 6 member 15
increases expression
ISO
Fenfluramine results in increased expression of SLC6A15 mRNA
CTD
PMID:22140631
NCBI chr 7:40,439,607...40,493,788
Ensembl chr 7:40,439,658...40,493,786
G
Smr3b
submaxillary gland androgen regulated protein 3B
increases expression
ISO
Fenfluramine results in increased expression of SMR3B mRNA
CTD
PMID:22140631
NCBI chr14:20,067,850...20,072,520
Ensembl chr14:20,067,851...20,072,527
G
Tpd52l3
TPD52 like 3
increases expression
ISO
Fenfluramine results in increased expression of TPD52L3 mRNA
CTD
PMID:22140631
NCBI chr 1:237,195,695...237,197,988
Ensembl chr 1:237,187,252...237,201,603
G
Wnt11
Wnt family member 11
decreases expression
ISO
Fenfluramine results in decreased expression of WNT11 mRNA
CTD
PMID:22140631
NCBI chr 1:162,545,660...162,565,456
Ensembl chr 1:162,545,680...162,564,660
G
Zdhhc15
zinc finger DHHC-type palmitoyltransferase 15
increases expression
ISO
Fenfluramine results in increased expression of ZDHHC15 mRNA
CTD
PMID:22140631
NCBI chr X:73,633,977...73,767,451
Ensembl chr X:73,639,819...73,767,508
G
Zfyve16
zinc finger FYVE-type containing 16
increases expression
ISO
Fenfluramine results in increased expression of ZFYVE16 mRNA
CTD
PMID:22140631
NCBI chr 2:25,448,264...25,495,180
Ensembl chr 2:25,448,829...25,483,295
G
Zscan4f
zinc finger and SCAN domain containing 4F
increases expression
ISO
Fenfluramine results in increased expression of ZSCAN4 mRNA
CTD
PMID:22140631
NCBI chr 7:14,461,674...14,464,841
G
Adra1a
adrenoceptor alpha 1A
multiple interactions
EXP
Lisuride binds to and results in decreased activity of ADRA1A protein; Lisuride promotes the reaction [Phenylephrine binds to and results in increased activity of ADRA1A protein]
CTD
PMID:16545797
NCBI chr15:45,005,648...45,111,416
Ensembl chr15:45,005,799...45,102,534
G
Htr7
5-hydroxytryptamine receptor 7
multiple interactions
ISO
[Lisuride binds to and results in decreased activity of HTR7 protein] inhibits the reaction [Colforsin results in increased abundance of Cyclic AMP]; Lisuride binds to and results in decreased activity of HTR7 protein
CTD
PMID:18996971 PMID:19509219
NCBI chr 1:243,049,064...243,173,636
Ensembl chr 1:243,049,081...243,173,230
G
Ifng
interferon gamma
increases expression
ISO
Lisuride results in increased expression of IFNG
CTD
PMID:7948314
NCBI chr 7:55,789,180...55,793,216
Ensembl chr 7:55,761,736...55,793,216
G
Prl
prolactin
multiple interactions decreases secretion
ISO EXP
Lisuride inhibits the reaction [Metoclopramide results in increased secretion of PRL protein]; Lisuride results in decreased expression of and results in decreased secretion of PRL protein Lisuride analog results in decreased secretion of PRL protein; Lisuride results in decreased secretion of PRL protein
CTD
PMID:386688 PMID:6492995
NCBI chr17:38,287,355...38,298,234
Ensembl chr17:38,288,162...38,298,217
G
Slc22a2
solute carrier family 22 member 2
multiple interactions
ISO
Lisuride inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium]
CTD
PMID:21599003
NCBI chr 1:50,668,817...50,711,019
Ensembl chr 1:50,668,817...50,711,019
G
Fos
Fos proto-oncogene, AP-1 transcription factor subunit
increases expression
EXP
Lysergic Acid Diethylamide results in increased expression of FOS mRNA
CTD
PMID:10521585
NCBI chr 6:110,852,188...110,855,054
Ensembl chr 6:110,852,190...110,855,598
G
Htr2b
5-hydroxytryptamine receptor 2B
multiple interactions affects binding
ISO
2-aminoindan analog inhibits the reaction [Lysergic Acid Diethylamide binds to HTR2B protein]; Lysergic Acid Diethylamide analog binds to and results in increased activity of HTR2B protein; N-Methyl-3,4-methylenedioxyamphetamine inhibits the reaction [Lysergic Acid Diethylamide binds to HTR2B protein]
CTD
PMID:14659797 PMID:29458138
NCBI chr 9:94,184,442...94,206,851
Ensembl chr 9:94,190,109...94,204,087
G
Htr5b
5-hydroxytryptamine (serotonin) receptor 5B
multiple interactions
EXP
lysergic acid diethylamide binds to protein 5-Htr5b; inhibits the reaction[5-carboxamidotryptamine binds to 5-Htr5b]
RGD
PMID:8224165
RGD:2303647
NCBI chr13:35,239,662...35,252,586
Ensembl chr13:35,239,662...35,252,586
G
Htr6
5-hydroxytryptamine receptor 6
affects binding
ISO
Lysergic Acid Diethylamide binds to HTR6 protein
CTD
PMID:21866910
NCBI chr 5:156,579,901...156,595,147
Ensembl chr 5:156,579,901...156,595,147
G
Taar1
trace-amine-associated receptor 1
multiple interactions increases activity
ISO
[N-methylquipazine analog results in increased activity of TAAR1 protein] which results in increased abundance of Cyclic AMP
CTD
PMID:19725810
NCBI chr 1:23,336,978...23,337,976
Ensembl chr 1:23,335,165...23,353,981
G
Htr1b
5-hydroxytryptamine receptor 1B
affects binding
ISO
naratriptan binds to HTR1B protein
CTD
PMID:9170336
NCBI chr 8:91,395,405...91,414,815
Ensembl chr 8:91,052,432...91,418,583
G
Htr1d
5-hydroxytryptamine receptor 1D
affects binding
ISO
naratriptan binds to HTR1D protein
CTD
PMID:9170336
NCBI chr 5:153,939,735...153,960,012
Ensembl chr 5:153,939,516...153,960,012
G
Htr4
5-hydroxytryptamine receptor 4
increases response to substance increases activity multiple interactions
ISO
HTR4 protein results in increased susceptibility to psilocin psilocin results in increased activity of HTR4 protein [HTR4 protein results in increased susceptibility to psilocin] which results in increased phosphorylation of PLN protein
CTD
PMID:38876450
NCBI chr18:58,036,277...58,221,327
Ensembl chr18:58,036,277...58,219,622
G
Maoa
monoamine oxidase A
multiple interactions increases metabolic processing
ISO
Disulfiram inhibits the reaction [MAOA protein results in increased metabolism of psilocin]; Raloxifene Hydrochloride inhibits the reaction [MAOA protein results in increased metabolism of psilocin]
CTD
PMID:39751877
NCBI chr X:8,615,239...8,681,372
Ensembl chr X:8,615,239...8,682,631
G
Pln
phospholamban
increases phosphorylation multiple interactions
ISO
psilocin results in increased phosphorylation of PLN protein [HTR4 protein results in increased susceptibility to psilocin] which results in increased phosphorylation of PLN protein
CTD
PMID:38876450
NCBI chr20:33,166,512...33,182,241
Ensembl chr20:33,172,494...33,182,241
G
Htr4
5-hydroxytryptamine receptor 4
multiple interactions increases activity increases response to substance
ISO
[HTR4 protein results in increased susceptibility to Psilocybin] which results in increased phosphorylation of PLN protein Psilocybin results in increased activity of HTR4 protein
CTD
PMID:38876450
NCBI chr18:58,036,277...58,221,327
Ensembl chr18:58,036,277...58,219,622
G
Pln
phospholamban
multiple interactions
ISO
[HTR4 protein results in increased susceptibility to Psilocybin] which results in increased phosphorylation of PLN protein
CTD
PMID:38876450
NCBI chr20:33,166,512...33,182,241
Ensembl chr20:33,172,494...33,182,241
G
Bdnf
brain-derived neurotrophic factor
multiple interactions
EXP
[Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin affects the expression of BDNF protein]; Sumatriptan inhibits the reaction [Capsaicin affects the expression of BDNF protein]
CTD
PMID:22150557
NCBI chr 3:116,619,633...116,670,212
Ensembl chr 3:116,619,633...116,670,657
G
Calca
calcitonin-related polypeptide alpha
multiple interactions decreases expression
ISO EXP
Sumatriptan results in decreased expression of and results in decreased secretion of CALCA protein Sumatriptan results in decreased expression of CALCA mRNA 3-(3-(dimethylamino)propyl)-4-hydroxy-N-(4-(4-pyridinyl)phenyl)benzamide inhibits the reaction [Sumatriptan results in decreased expression of CALCA mRNA]; [Sumatriptan results in increased abundance of Calcium] inhibits the reaction [MAP2K1 protein results in increased expression of CALCA mRNA]; GR 127935 inhibits the reaction [Sumatriptan results in decreased expression of CALCA mRNA]; isamoltane inhibits the reaction [Sumatriptan results in decreased expression of CALCA mRNA]; Sumatriptan inhibits the reaction [MAP2K1 protein results in increased expression of CALCA mRNA]; Sumatriptan inhibits the reaction [NGF protein results in increased expression of CALCA mRNA]
CTD
PMID:12574409 PMID:14715155 PMID:15689192
NCBI chr 1:178,312,636...178,317,588
Ensembl chr 1:178,312,638...178,317,529
G
Casp3
caspase 3
multiple interactions
EXP
Sumatriptan inhibits the reaction [Vincristine results in increased expression of CASP3 mRNA]; Sumatriptan inhibits the reaction [Vincristine results in increased expression of CASP3 protein]
CTD
PMID:29958920
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:52,395,540...52,413,732
G
Ccl2
C-C motif chemokine ligand 2
multiple interactions
EXP
[Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of CCL2 protein]; Sumatriptan affects the reaction [Capsaicin results in increased expression of CCL2 protein]
CTD
PMID:22150557
NCBI chr10:67,503,077...67,504,875
Ensembl chr10:67,503,077...67,504,875
G
Ccl20
C-C motif chemokine ligand 20
multiple interactions
EXP
[Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of CCL20 protein]; Sumatriptan inhibits the reaction [Capsaicin results in increased expression of CCL20 protein]
CTD
PMID:22150557
NCBI chr 9:91,837,139...91,839,736
Ensembl chr 9:91,836,946...91,839,736
G
Ccl22
C-C motif chemokine ligand 22
multiple interactions
EXP
[Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of CCL22 protein]; Sumatriptan inhibits the reaction [Capsaicin results in increased expression of CCL22 protein]
CTD
PMID:22150557
NCBI chr19:10,263,589...10,270,359
Ensembl chr19:10,263,589...10,270,359
G
Ccl3
C-C motif chemokine ligand 3
multiple interactions
EXP
[Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of CCL3 protein]; Sumatriptan inhibits the reaction [Capsaicin results in increased expression of CCL3 protein]
CTD
PMID:22150557
NCBI chr10:68,948,889...68,950,439
Ensembl chr10:68,948,889...68,950,439
G
Ccr4
C-C motif chemokine receptor 4
multiple interactions
EXP
[Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of CCR4 protein]; Sumatriptan inhibits the reaction [Capsaicin results in increased expression of CCR4 protein]
CTD
PMID:22150557
NCBI chr 8:123,054,505...123,060,244
Ensembl chr 8:123,054,324...123,077,642
G
Cd80
Cd80 molecule
multiple interactions
EXP
[Naproxen co-treated with Sumatriptan] affects the reaction [Capsaicin results in increased expression of CD80 protein]; Sumatriptan affects the reaction [Capsaicin results in increased expression of CD80 protein]
CTD
PMID:22150557
NCBI chr11:75,760,073...75,798,978
Ensembl chr11:75,760,147...75,797,540
G
Cilk1
ciliogenesis associated kinase 1
multiple interactions
EXP
[Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of CILK1 protein]; Sumatriptan inhibits the reaction [Capsaicin results in increased expression of CILK1 protein]
CTD
PMID:22150557
NCBI chr 8:87,868,294...87,922,995
Ensembl chr 8:87,868,156...87,922,995
G
Cntf
ciliary neurotrophic factor
multiple interactions
EXP
[Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of CNTF protein]; Sumatriptan inhibits the reaction [Capsaicin results in increased expression of CNTF protein]
CTD
PMID:22150557
NCBI chr 1:219,312,512...219,314,535
Ensembl chr 1:219,312,512...219,314,488
G
Cntfr
ciliary neurotrophic factor receptor
multiple interactions
EXP
[Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of CNTFR protein]; Sumatriptan inhibits the reaction [Capsaicin results in increased expression of CNTFR protein]
CTD
PMID:22150557
NCBI chr 5:61,619,326...61,657,359
Ensembl chr 5:61,619,326...61,645,795
G
Csf2
colony stimulating factor 2
multiple interactions
EXP
[Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of CSF2 protein]; Sumatriptan inhibits the reaction [Capsaicin results in increased expression of CSF2 protein]
CTD
PMID:22150557
NCBI chr10:38,887,692...38,889,673
Ensembl chr10:38,887,692...38,890,031
G
Ctnnb1
catenin beta 1
multiple interactions
EXP
[Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of CTNNB1 protein]; Sumatriptan inhibits the reaction [Capsaicin results in increased expression of CTNNB1 protein]
CTD
PMID:22150557
NCBI chr 8:129,517,576...129,544,661
Ensembl chr 8:129,517,545...129,544,662
G
Cx3cl1
C-X3-C motif chemokine ligand 1
multiple interactions
EXP
[Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin affects the expression of CX3CL1 protein]; Sumatriptan inhibits the reaction [Capsaicin affects the expression of CX3CL1 protein]
CTD
PMID:22150557
NCBI chr19:10,233,326...10,244,856
Ensembl chr19:10,233,329...10,242,999
G
Cxcl10
C-X-C motif chemokine ligand 10
multiple interactions
EXP
[Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of CXCL10 protein]; Sumatriptan inhibits the reaction [Capsaicin results in increased expression of CXCL10 protein]
CTD
PMID:22150557
NCBI chr14:15,989,066...15,991,263
Ensembl chr14:15,989,018...15,991,261
G
Cxcl2
C-X-C motif chemokine ligand 2
multiple interactions
EXP
[Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of CXCL2 protein]; Sumatriptan inhibits the reaction [Capsaicin results in increased expression of CXCL2 protein]
CTD
PMID:22150557
NCBI chr14:17,465,210...17,467,255
Ensembl chr14:17,465,242...17,467,255
G
Cxcr4
C-X-C motif chemokine receptor 4
multiple interactions
EXP
[Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of CXCR4 protein]; Sumatriptan inhibits the reaction [Capsaicin results in increased expression of CXCR4 protein]
CTD
PMID:22150557
NCBI chr13:42,630,383...42,634,288
Ensembl chr13:42,630,104...42,634,459
G
Errfi1
ERBB receptor feedback inhibitor 1
multiple interactions
EXP
[Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of ERRFI1 protein]; Sumatriptan inhibits the reaction [Capsaicin results in increased expression of ERRFI1 protein]
CTD
PMID:22150557
NCBI chr 5:166,606,841...166,620,124
Ensembl chr 5:166,606,834...166,620,432
G
Fadd
Fas associated via death domain
multiple interactions
EXP
[Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of FADD protein]; Sumatriptan inhibits the reaction [Capsaicin results in increased expression of FADD protein]
CTD
PMID:22150557
NCBI chr 1:209,169,245...209,175,423
Ensembl chr 1:209,169,318...209,174,976
G
Fas
Fas cell surface death receptor
multiple interactions
EXP
[Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of FAS protein]; Sumatriptan inhibits the reaction [Capsaicin results in increased expression of FAS protein]
CTD
PMID:22150557
NCBI chr 1:241,212,155...241,245,774
Ensembl chr 1:241,205,935...241,246,104
G
Faslg
Fas ligand
multiple interactions
EXP
[Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of FASLG protein]; Sumatriptan inhibits the reaction [Capsaicin results in increased expression of FASLG protein]
CTD
PMID:22150557
NCBI chr13:76,680,885...76,706,042
Ensembl chr13:76,688,243...76,695,503
G
Fgfbp1
fibroblast growth factor binding protein 1
multiple interactions
EXP
[Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin affects the expression of FGFBP1 protein]; Sumatriptan inhibits the reaction [Capsaicin affects the expression of FGFBP1 protein]
CTD
PMID:22150557
NCBI chr14:71,316,171...71,319,965
Ensembl chr14:71,317,065...71,320,309
G
Fgl1
fibrinogen-like 1
multiple interactions
EXP
[Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of FGL1 protein]; Sumatriptan inhibits the reaction [Capsaicin results in increased expression of FGL1 protein]
CTD
PMID:22150557
NCBI chr16:57,824,127...57,854,413
Ensembl chr16:57,824,200...57,854,429
G
Fos
Fos proto-oncogene, AP-1 transcription factor subunit
multiple interactions
ISO
Sumatriptan inhibits the reaction [Capsaicin results in increased expression of FOS protein]
CTD
PMID:12110114
NCBI chr 6:110,852,188...110,855,054
Ensembl chr 6:110,852,190...110,855,598
G
Fstl1
follistatin-like 1
multiple interactions
EXP
[Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of FSTL1 protein]; Sumatriptan inhibits the reaction [Capsaicin results in increased expression of FSTL1 protein]
CTD
PMID:22150557
NCBI chr11:76,400,870...76,454,053
Ensembl chr11:76,391,315...76,455,126
G
Gfra1
GDNF family receptor alpha 1
multiple interactions
EXP
[Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin affects the expression of GFRA1 protein]; Sumatriptan inhibits the reaction [Capsaicin affects the expression of GFRA1 protein]
CTD
PMID:22150557
NCBI chr 1:267,325,297...267,557,037
Ensembl chr 1:267,326,817...267,556,501
G
Gfra2
GDNF family receptor alpha 2
multiple interactions
EXP
[Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin affects the expression of GFRA2 protein]; Sumatriptan inhibits the reaction [Capsaicin affects the expression of GFRA2 protein]
CTD
PMID:22150557
NCBI chr15:52,351,499...52,443,369
Ensembl chr15:52,351,514...52,477,782
G
Gh1
growth hormone 1
multiple interactions
EXP
[Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of GH1 protein]; Sumatriptan inhibits the reaction [Capsaicin results in increased expression of GH1 protein]
CTD
PMID:22150557
NCBI chr10:91,727,883...91,729,860
Ensembl chr10:91,727,884...91,729,859
G
Ghr
growth hormone receptor
multiple interactions
EXP
[Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of GHR protein]; Sumatriptan inhibits the reaction [Capsaicin results in increased expression of GHR protein]
CTD
PMID:22150557
NCBI chr 2:54,269,066...54,532,595
Ensembl chr 2:54,270,206...54,532,331
G
Hcrt
hypocretin neuropeptide precursor
multiple interactions
EXP
[Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of HCRT protein]; Sumatriptan inhibits the reaction [Capsaicin results in increased expression of HCRT protein]
CTD
PMID:22150557
NCBI chr10:86,190,289...86,191,524
Ensembl chr10:86,189,775...86,191,524
G
Htr1b
5-hydroxytryptamine receptor 1B
multiple interactions affects binding
EXP
Sumatriptan binds to and results in increased activity of HTR1B protein Sumatriptan binds to HTR1B protein
CTD
PMID:11301495 PMID:11888550
NCBI chr 8:91,395,405...91,414,815
Ensembl chr 8:91,052,432...91,418,583
G
Htr1d
5-hydroxytryptamine receptor 1D
multiple interactions
EXP
Sumatriptan binds to and results in increased activity of HTR1D protein
CTD
PMID:11301495
NCBI chr 5:153,939,735...153,960,012
Ensembl chr 5:153,939,516...153,960,012
G
Ide
insulin degrading enzyme
multiple interactions
EXP
[Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin affects the expression of IDE protein]; Sumatriptan inhibits the reaction [Capsaicin affects the expression of IDE protein]
CTD
PMID:22150557
NCBI chr 1:244,415,495...244,516,925
Ensembl chr 1:244,416,343...244,514,526
G
Ifng
interferon gamma
multiple interactions
EXP
[Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in decreased expression of IFNG protein]; Sumatriptan inhibits the reaction [Capsaicin results in decreased expression of IFNG protein]
CTD
PMID:22150557
NCBI chr 7:55,789,180...55,793,216
Ensembl chr 7:55,761,736...55,793,216
G
Il10
interleukin 10
multiple interactions
EXP
[Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of IL10 protein]; Sumatriptan inhibits the reaction [Capsaicin results in increased expression of IL10 protein]
CTD
PMID:22150557
NCBI chr13:45,024,921...45,029,586
Ensembl chr13:45,025,087...45,029,580
G
Il13
interleukin 13
multiple interactions
EXP
[Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of IL13 protein]; Sumatriptan inhibits the reaction [Capsaicin results in increased expression of IL13 protein]
CTD
PMID:22150557
NCBI chr10:38,290,926...38,293,483
Ensembl chr10:38,290,926...38,293,483
G
Il1a
interleukin 1 alpha
multiple interactions
EXP
[Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in decreased expression of IL1A protein]; Sumatriptan inhibits the reaction [Capsaicin results in decreased expression of IL1A protein]
CTD
PMID:22150557
NCBI chr 3:136,979,804...136,990,236
Ensembl chr 3:136,979,805...136,998,013
G
Il1b
interleukin 1 beta
multiple interactions
EXP
[Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin affects the expression of IL1B protein]; Sumatriptan inhibits the reaction [Capsaicin affects the expression of IL1B protein]; Sumatriptan inhibits the reaction [Vincristine results in increased expression of IL1B mRNA]
CTD
PMID:22150557 PMID:29958920
NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:137,030,205...137,036,601
G
Il2
interleukin 2
multiple interactions
EXP
[Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of IL2 protein]; Sumatriptan inhibits the reaction [Capsaicin results in increased expression of IL2 protein]
CTD
PMID:22150557
NCBI chr 2:121,932,968...121,937,672
Ensembl chr 2:121,932,968...121,937,672
G
Il3
interleukin 3
multiple interactions
EXP
[Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin affects the expression of IL3 protein]; Sumatriptan inhibits the reaction [Capsaicin affects the expression of IL3 protein]
CTD
PMID:22150557
NCBI chr10:38,906,460...38,908,810
Ensembl chr10:38,906,460...38,908,810
G
Il4
interleukin 4
multiple interactions
EXP
[Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of IL4 protein]; Sumatriptan inhibits the reaction [Capsaicin results in increased expression of IL4 protein]
CTD
PMID:22150557
NCBI chr10:38,272,003...38,277,549
Ensembl chr10:38,272,003...38,277,549
G
Il5
interleukin 5
multiple interactions
EXP
[Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of IL5 protein]; Sumatriptan inhibits the reaction [Capsaicin results in increased expression of IL5 protein]
CTD
PMID:22150557
NCBI chr10:38,375,132...38,378,003
Ensembl chr10:38,375,132...38,378,003
G
Il6
interleukin 6
multiple interactions
EXP
[Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of IL6 protein]; Sumatriptan inhibits the reaction [Capsaicin results in increased expression of IL6 protein]
CTD
PMID:22150557
NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,889,999...5,894,610
G
Inhba
inhibin subunit beta A
multiple interactions
EXP
Sumatriptan inhibits the reaction [Capsaicin results in increased expression of INHBA protein]
CTD
PMID:22150557
NCBI chr17:53,787,159...53,810,942
Ensembl chr17:53,791,444...53,804,508
G
Ins1
insulin 1
multiple interactions
EXP
[Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of INS1 protein]; Sumatriptan inhibits the reaction [Capsaicin results in increased expression of INS1 protein]
CTD
PMID:22150557
NCBI chr 1:261,186,119...261,186,686
Ensembl chr 1:261,186,119...261,186,682
G
Lep
leptin
multiple interactions
EXP
[Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of LEP protein]; Sumatriptan inhibits the reaction [Capsaicin results in increased expression of LEP protein]
CTD
PMID:22150557
NCBI chr 4:58,626,529...58,640,663
Ensembl chr 4:58,626,523...58,640,661
G
Map2k1
mitogen activated protein kinase kinase 1
multiple interactions
EXP
[Sumatriptan results in increased abundance of Calcium] inhibits the reaction [MAP2K1 protein results in increased expression of CALCA mRNA]; Sumatriptan inhibits the reaction [MAP2K1 protein results in increased expression of CALCA mRNA]
CTD
PMID:12574409
NCBI chr 8:73,578,747...73,650,184
Ensembl chr 8:73,578,752...73,650,184
G
Mif
macrophage migration inhibitory factor
multiple interactions
EXP
[Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of MIF protein]; Sumatriptan inhibits the reaction [Capsaicin results in increased expression of MIF protein]
CTD
PMID:22150557
NCBI chr20:12,767,138...12,791,222
Ensembl chr 4:134,041,774...134,042,121 Ensembl chr20:134,041,774...134,042,121
G
Mmp13
matrix metallopeptidase 13
multiple interactions
EXP
[Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of MMP13 protein]; Sumatriptan inhibits the reaction [Capsaicin results in increased expression of MMP13 protein]
CTD
PMID:22150557
NCBI chr 8:12,782,829...12,793,108
Ensembl chr 8:12,782,813...12,793,105
G
Mmp2
matrix metallopeptidase 2
multiple interactions
EXP
[Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of MMP2 protein]; Sumatriptan inhibits the reaction [Capsaicin results in increased expression of MMP2 protein]
CTD
PMID:22150557
NCBI chr19:30,327,643...30,355,856
Ensembl chr19:30,327,643...30,355,856
G
Musk
muscle associated receptor tyrosine kinase
multiple interactions
EXP
[Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of MUSK protein]; Sumatriptan inhibits the reaction [Capsaicin results in increased expression of MUSK protein]
CTD
PMID:22150557
NCBI chr 5:77,853,560...77,967,653
Ensembl chr 5:77,853,736...77,964,338
G
Ngf
nerve growth factor
multiple interactions
EXP
[Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of NGF protein]; Sumatriptan inhibits the reaction [Capsaicin results in increased expression of NGF protein]; Sumatriptan inhibits the reaction [NGF protein results in increased expression of CALCA mRNA]
CTD
PMID:12574409 PMID:22150557
NCBI chr 2:192,589,580...192,642,971
Ensembl chr 2:192,589,582...192,643,834
G
Ngfr
nerve growth factor receptor
multiple interactions
EXP
[Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of NGFR protein]; Sumatriptan inhibits the reaction [Capsaicin results in increased expression of NGFR protein]
CTD
PMID:22150557
NCBI chr10:81,012,077...81,030,305
Ensembl chr10:81,012,089...81,030,305
G
Nos1
nitric oxide synthase 1
multiple interactions
EXP
Sumatriptan inhibits the reaction [Nitroglycerin results in increased expression of NOS1 protein]
CTD
PMID:14510930
NCBI chr12:44,276,011...44,456,371
Ensembl chr12:44,287,614...44,371,837
G
Nr0b2
nuclear receptor subfamily 0, group B, member 2
decreases expression
ISO
Sumatriptan results in decreased expression of NR0B2 mRNA
CTD
PMID:15342952
NCBI chr 5:151,063,160...151,066,475
Ensembl chr 5:151,063,160...151,066,475
G
Nrp1
neuropilin 1
multiple interactions
EXP
[Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of NRP1 protein]; Sumatriptan inhibits the reaction [Capsaicin results in increased expression of NRP1 protein]
CTD
PMID:22150557
NCBI chr19:73,256,557...73,411,705
Ensembl chr19:73,256,557...73,411,702
G
Pdgfa
platelet derived growth factor subunit A
multiple interactions
EXP
[Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of PDGFA protein]; Sumatriptan inhibits the reaction [Capsaicin results in increased expression of PDGFA protein]
CTD
PMID:22150557
NCBI chr12:20,759,366...20,780,337
Ensembl chr12:20,754,208...20,780,322
G
Plin2
perilipin 2
multiple interactions
EXP
[Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin affects the expression of PLIN2 protein]; Sumatriptan inhibits the reaction [Capsaicin affects the expression of PLIN2 protein]
CTD
PMID:22150557
NCBI chr 5:106,202,634...106,258,748
Ensembl chr 5:106,202,634...106,258,878
G
Pomc
proopiomelanocortin
decreases expression multiple interactions
ISO EXP
Sumatriptan results in decreased expression of POMC protein modified form [Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of POMC protein]; Sumatriptan inhibits the reaction [Capsaicin results in increased expression of POMC protein]
CTD
PMID:7640145 PMID:22150557
NCBI chr 6:32,659,137...32,665,175
Ensembl chr 6:32,659,346...32,665,173
G
Prkaa1
protein kinase AMP-activated catalytic subunit alpha 1
multiple interactions
EXP
[Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of PRKAA1 protein]; Sumatriptan inhibits the reaction [Capsaicin results in increased expression of PRKAA1 protein]
CTD
PMID:22150557
NCBI chr 2:55,967,766...56,003,450
Ensembl chr 2:55,967,351...56,003,450
G
Prlr
prolactin receptor
multiple interactions
EXP
[Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of PRLR protein]; Sumatriptan affects the reaction [Capsaicin results in increased expression of PRLR protein]
CTD
PMID:22150557
NCBI chr 2:60,861,391...61,051,883
Ensembl chr 2:60,861,658...61,051,882
G
Prok1
prokineticin 1
multiple interactions
EXP
[Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of PROK1 protein]; Sumatriptan inhibits the reaction [Capsaicin results in increased expression of PROK1 protein]
CTD
PMID:22150557
NCBI chr 2:197,538,747...197,547,550
Ensembl chr 2:197,537,068...197,547,550
G
Rela
RELA proto-oncogene, NF-kB subunit
multiple interactions
EXP
Sumatriptan inhibits the reaction [Vincristine results in increased phosphorylation of RELA protein]
CTD
PMID:29958920
NCBI chr 1:212,354,336...212,364,815
Ensembl chr 1:212,333,035...212,364,817
G
Retn
resistin
multiple interactions
EXP
[Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of RETN protein]; Sumatriptan inhibits the reaction [Capsaicin results in increased expression of RETN protein]
CTD
PMID:22150557
NCBI chr12:6,508,653...6,511,115
Ensembl chr12:6,508,801...6,511,116
G
Retnlb
resistin like beta
multiple interactions
EXP
[Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of RETNLB protein]; Sumatriptan inhibits the reaction [Capsaicin results in increased expression of RETNLB protein]
CTD
PMID:22150557
NCBI chr11:65,446,433...65,448,319
Ensembl chr11:65,446,434...65,448,319
G
Sele
selectin E
multiple interactions
EXP
[Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of SELE protein]; Sumatriptan inhibits the reaction [Capsaicin results in increased expression of SELE protein]
CTD
PMID:22150557
NCBI chr13:78,935,997...78,945,905
Ensembl chr13:78,936,036...78,945,903
G
Sell
selectin L
multiple interactions
EXP
[Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of SELL protein]; Sumatriptan inhibits the reaction [Capsaicin results in increased expression of SELL protein]
CTD
PMID:22150557
NCBI chr13:78,950,100...78,969,604
Ensembl chr13:78,950,015...78,969,600
G
Spp1
secreted phosphoprotein 1
multiple interactions
EXP
[Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of SPP1 protein]; Sumatriptan promotes the reaction [Capsaicin results in increased expression of SPP1 protein]
CTD
PMID:22150557
NCBI chr14:5,613,569...5,620,695
Ensembl chr14:5,613,576...5,619,820
G
Tal1
TAL bHLH transcription factor 1, erythroid differentiation factor
multiple interactions
EXP
[Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of TAL1 protein]; Sumatriptan inhibits the reaction [Capsaicin results in increased expression of TAL1 protein]
CTD
PMID:22150557
NCBI chr 5:133,823,093...133,837,737
Ensembl chr 5:133,826,003...133,837,738
G
Tek
TEK receptor tyrosine kinase
multiple interactions
EXP
[Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of TEK protein]; Sumatriptan inhibits the reaction [Capsaicin results in increased expression of TEK protein]
CTD
PMID:22150557
NCBI chr 5:114,722,815...114,849,535
Ensembl chr 5:114,723,006...114,849,991
G
Tgfb1
transforming growth factor, beta 1
multiple interactions
EXP
[Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of TGFB1 protein]; Sumatriptan inhibits the reaction [Capsaicin results in increased expression of TGFB1 protein]
CTD
PMID:22150557
NCBI chr 1:90,324,312...90,340,627
Ensembl chr 1:90,324,046...90,340,899
G
Tgfb2
transforming growth factor, beta 2
multiple interactions
EXP
[Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of TGFB2 protein]; Sumatriptan inhibits the reaction [Capsaicin results in increased expression of TGFB2 protein]
CTD
PMID:22150557
NCBI chr13:100,691,540...100,793,227
Ensembl chr13:100,692,953...100,792,856
G
Tgfb3
transforming growth factor, beta 3
multiple interactions
EXP
[Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of TGFB3 protein]; Sumatriptan inhibits the reaction [Capsaicin results in increased expression of TGFB3 protein]
CTD
PMID:22150557
NCBI chr 6:111,435,170...111,457,646
Ensembl chr 6:111,435,170...111,456,946
G
Timp1
TIMP metallopeptidase inhibitor 1
multiple interactions
EXP
[Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of TIMP1 protein]; Sumatriptan inhibits the reaction [Capsaicin results in increased expression of TIMP1 protein]
CTD
PMID:22150557
NCBI chr X:3,766,509...3,772,578
Ensembl chr X:3,766,510...3,771,135
G
Timp2
TIMP metallopeptidase inhibitor 2
multiple interactions
EXP
[Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of TIMP2 protein]; Sumatriptan inhibits the reaction [Capsaicin results in increased expression of TIMP2 protein]
CTD
PMID:22150557
NCBI chr10:104,041,604...104,089,214
Ensembl chr10:104,041,604...104,089,214
G
Timp3
TIMP metallopeptidase inhibitor 3
multiple interactions
EXP
[Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of TIMP3 protein]; Sumatriptan inhibits the reaction [Capsaicin results in increased expression of TIMP3 protein]
CTD
PMID:22150557
NCBI chr 7:19,408,539...19,459,558
Ensembl chr 7:19,409,631...19,459,547
G
Tlr4
toll-like receptor 4
multiple interactions
EXP
[Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of TLR4 protein]; Sumatriptan inhibits the reaction [Capsaicin results in increased expression of TLR4 protein]
CTD
PMID:22150557
NCBI chr 5:85,161,247...85,174,882
Ensembl chr 5:85,161,192...85,175,007
G
Tnf
tumor necrosis factor
multiple interactions
EXP
[Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of TNF protein]; Sumatriptan inhibits the reaction [Capsaicin results in increased expression of TNF protein]; Sumatriptan inhibits the reaction [Vincristine results in increased expression of TNF mRNA]
CTD
PMID:22150557 PMID:29958920
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,626,532...3,629,303
G
Tnfrsf19
TNF receptor superfamily member 19
multiple interactions
EXP
[Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin affects the expression of TNFRSF19 protein]; Sumatriptan inhibits the reaction [Capsaicin affects the expression of TNFRSF19 protein]
CTD
PMID:22150557
NCBI chr15:39,268,305...39,334,566
Ensembl chr15:39,268,305...39,356,438
G
Tnfsf10
TNF superfamily member 10
multiple interactions
EXP
[Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of TNFSF10 protein]; Sumatriptan inhibits the reaction [Capsaicin results in increased expression of TNFSF10 protein]
CTD
PMID:22150557
NCBI chr 2:112,136,550...112,155,903
G
Vcam1
vascular cell adhesion molecule 1
multiple interactions
EXP
[Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of VCAM1 protein]; Sumatriptan inhibits the reaction [Capsaicin results in increased expression of VCAM1 protein]
CTD
PMID:22150557
NCBI chr 2:206,723,050...206,742,783
Ensembl chr 2:206,723,044...206,742,801
G
Vegfa
vascular endothelial growth factor A
multiple interactions
EXP
[Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of VEGFA protein]; Sumatriptan affects the reaction [Capsaicin results in increased expression of VEGFA protein]
CTD
PMID:22150557
NCBI chr 9:22,452,854...22,468,194
Ensembl chr 9:22,439,392...22,468,194
G
Zfp866
zinc finger protein 866
multiple interactions
EXP
[Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of CXCL5 protein]; Sumatriptan inhibits the reaction [Capsaicin results in increased expression of CXCL5 protein]
CTD
PMID:22150557
NCBI chr16:19,687,869...19,710,407
Ensembl chr16:19,702,297...19,709,330
G
Cyp1a2
cytochrome P450, family 1, subfamily a, polypeptide 2
decreases activity
ISO
tegaserod results in decreased activity of CYP1A2 protein
CTD
PMID:11560869
NCBI chr 8:66,971,261...66,978,149
Ensembl chr 8:66,971,261...66,978,149
G
Cyp2d4
cytochrome P450, family 2, subfamily d, polypeptide 4
increases metabolic processing decreases activity multiple interactions
ISO
CYP2D6 protein results in increased metabolism of tegaserod tegaserod results in decreased activity of CYP2D6 protein Quinidine inhibits the reaction [CYP2D6 protein results in increased metabolism of tegaserod]
CTD
PMID:11560869
NCBI chr 7:115,762,662...115,771,832
Ensembl chr 7:115,761,696...115,771,837
G
Esr1
estrogen receptor 1
multiple interactions
ISO
tegaserod binds to and results in decreased activity of ESR1 protein
CTD
PMID:25752796
NCBI chr 1:43,511,685...43,904,454
Ensembl chr 1:43,644,392...43,900,354
G
Htr4
5-hydroxytryptamine receptor 4
multiple interactions
ISO
tegaserod binds to and results in increased activity of HTR4 protein
CTD
PMID:15238200 PMID:15961989
NCBI chr18:58,036,277...58,221,327
Ensembl chr18:58,036,277...58,219,622
G
Pgr
progesterone receptor
multiple interactions
ISO
tegaserod binds to and results in decreased activity of PGR protein
CTD
PMID:25752796
NCBI chr 8:14,354,398...14,413,271
Ensembl chr 8:14,354,398...14,413,271
G
Thra
thyroid hormone receptor alpha
multiple interactions
ISO
tegaserod binds to and results in decreased activity of THRA protein
CTD
PMID:25752796
NCBI chr10:84,198,141...84,225,659
Ensembl chr10:84,197,011...84,225,657
G
Apoe
apolipoprotein E
affects response to substance
ISO
APOE protein affects the susceptibility to Varenicline
CTD
PMID:28202387
NCBI chr 1:88,481,889...88,485,816
Ensembl chr 1:88,481,385...88,485,855
G
Cd36
CD36 molecule
multiple interactions increases expression
ISO
methyllycaconitine inhibits the reaction [Varenicline results in increased expression of CD36 mRNA]; methyllycaconitine inhibits the reaction [Varenicline results in increased expression of CD36 protein] Varenicline results in increased expression of CD36 mRNA; Varenicline results in increased expression of CD36 protein
CTD
PMID:28202387
NCBI chr 4:18,209,088...18,302,142
G
Cdh5
cadherin 5
decreases expression multiple interactions
ISO
Varenicline results in decreased expression of CDH5 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Varenicline results in decreased expression of CDH5]; methyllycaconitine inhibits the reaction [Varenicline results in decreased expression of CDH5]; pyrazolanthrone inhibits the reaction [Varenicline results in decreased expression of CDH5]; SB 203580 inhibits the reaction [Varenicline results in decreased expression of CDH5]
CTD
PMID:28842382
NCBI chr19:821,875...860,931
Ensembl chr19:822,464...860,822
G
Chrna3
cholinergic receptor nicotinic alpha 3 subunit
multiple interactions
EXP
Varenicline binds to and results in increased activity of [CHRNA3 protein binds to CHRNB2 protein]; Varenicline binds to and results in increased activity of [CHRNA3 protein binds to CHRNB4 protein]
CTD
PMID:16766716
NCBI chr 8:64,297,755...64,311,251
Ensembl chr 8:64,297,755...64,311,412
G
Chrna4
cholinergic receptor nicotinic alpha 4 subunit
multiple interactions
ISO EXP
Varenicline binds to and results in increased activity of [CHRNA4 protein binds to CHRNB2 protein] Varenicline binds to and results in decreased activity of [CHRNA4 protein binds to CHRNB2 protein] varenicline binds to Chrna4 protein; varenicline inhibits [alpha-conotoxin MII binds to Chrna4 protein] in rat brain striatal sections
CTD RGD
PMID:16766716 PMID:20100906 PMID:20207347 PMID:20331614 PMID:20373480 PMID:20388087 PMID:22550286 More...
RGD:8549526
NCBI chr 3:188,506,802...188,535,558
Ensembl chr 3:188,501,209...188,535,105
G
Chrna6
cholinergic receptor nicotinic alpha 6 subunit
multiple interactions affects binding
EXP
Varenicline binds to and results in increased activity of CHRNA6 protein Varenicline inhibits the reaction [alpha-Conotoxin MII binds to Chrna6]; Varenicline inhibits the reaction [epibatidine binds to Chrna6]. Varenicline binds to Chrna6 protein
CTD RGD
PMID:16766716 PMID:22550286 PMID:22550286
RGD:8549526 , RGD:8549526
NCBI chr16:71,400,615...71,407,315
Ensembl chr16:71,400,615...71,407,315
G
Chrna7
cholinergic receptor nicotinic alpha 7 subunit
multiple interactions
EXP
Varenicline binds to and results in increased activity of [CHRNA7 protein binds to CHRNA7 protein]
CTD
PMID:16766716
NCBI chr 1:126,123,425...126,249,181
Ensembl chr 1:126,123,425...126,446,858
G
Chrnb2
cholinergic receptor nicotinic beta 2 subunit
multiple interactions
ISO EXP
Varenicline binds to and results in decreased activity of [CHRNA4 protein binds to CHRNB2 protein] Varenicline binds to and results in increased activity of [CHRNA4 protein binds to CHRNB2 protein] Varenicline binds to and results in increased activity of [CHRNA3 protein binds to CHRNB2 protein]; Varenicline binds to and results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]
CTD
PMID:16766716 PMID:20100906 PMID:20207347 PMID:20331614 PMID:20373480 PMID:20388087 More...
NCBI chr 2:177,479,091...177,487,306
Ensembl chr 2:177,479,091...177,491,326
G
Chrnb4
cholinergic receptor nicotinic beta 4 subunit
multiple interactions
EXP
Varenicline binds to and results in increased activity of [CHRNA3 protein binds to CHRNB4 protein]
CTD
PMID:16766716
NCBI chr 8:64,312,644...64,333,319
Ensembl chr 8:64,313,669...64,333,248
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
decreases activity
ISO
Varenicline results in decreased activity of CYP1A1 protein
CTD
PMID:33814510
NCBI chr 8:66,991,940...66,998,014
Ensembl chr 8:66,991,970...66,998,012
G
Cyp1b1
cytochrome P450, family 1, subfamily b, polypeptide 1
decreases activity
ISO
Varenicline results in decreased activity of CYP1B1 protein
CTD
PMID:33814510
NCBI chr 6:21,093,927...21,103,091
Ensembl chr 6:21,078,146...21,103,142
G
Mapk1
mitogen activated protein kinase 1
increases phosphorylation multiple interactions decreases activity
ISO
Varenicline results in increased phosphorylation of MAPK1 protein methyllycaconitine inhibits the reaction [Varenicline results in increased phosphorylation of MAPK1 protein] Varenicline results in decreased activity of MAPK1 protein
CTD
PMID:28202387 PMID:28842382
NCBI chr11:97,462,025...97,529,193
Ensembl chr11:97,462,025...97,527,825
G
Mapk3
mitogen activated protein kinase 3
increases phosphorylation decreases activity multiple interactions
ISO
Varenicline results in increased phosphorylation of MAPK3 protein Varenicline results in decreased activity of MAPK3 protein methyllycaconitine inhibits the reaction [Varenicline results in increased phosphorylation of MAPK3 protein]
CTD
PMID:28202387 PMID:28842382
NCBI chr 1:190,797,189...190,803,411
Ensembl chr 1:190,797,185...190,803,411
G
Olr1
oxidized low density lipoprotein receptor 1
increases expression multiple interactions
ISO
Varenicline results in increased expression of OLR1 mRNA; Varenicline results in increased expression of OLR1 protein methyllycaconitine inhibits the reaction [Varenicline results in increased expression of OLR1 mRNA]; methyllycaconitine inhibits the reaction [Varenicline results in increased expression of OLR1 protein]
CTD
PMID:28202387
NCBI chr 4:164,612,460...164,635,082
Ensembl chr 4:164,612,463...164,634,598
G
Pon1
paraoxonase 1
decreases activity
ISO
Varenicline results in decreased activity of PON1 protein
CTD
PMID:31581362
NCBI chr 4:34,261,312...34,292,327
Ensembl chr 4:34,261,289...34,287,924
G
Rela
RELA proto-oncogene, NF-kB subunit
increases phosphorylation multiple interactions
ISO
Varenicline results in increased phosphorylation of RELA protein methyllycaconitine inhibits the reaction [Varenicline results in increased phosphorylation of RELA protein]
CTD
PMID:28202387
NCBI chr 1:212,354,336...212,364,815
Ensembl chr 1:212,333,035...212,364,817
G
Slc22a2
solute carrier family 22 member 2
affects response to substance
ISO
SLC22A2 gene SNP affects the susceptibility to Varenicline
CTD
PMID:25143296
NCBI chr 1:50,668,817...50,711,019
Ensembl chr 1:50,668,817...50,711,019
G
Ache
acetylcholinesterase
increases activity
EXP
Vortioxetine results in increased activity of ACHE protein
CTD
PMID:39557222
NCBI chr12:25,042,882...25,050,608
Ensembl chr12:25,043,461...25,050,410
G
Adrb1
adrenoceptor beta 1
affects binding
ISO
vortioxetine binds to ADRB1 protein
CTD
PMID:21486038
NCBI chr 1:265,777,103...265,780,114
Ensembl chr 1:265,766,079...265,849,237
G
Bax
BCL2 associated X, apoptosis regulator
increases expression
EXP
Vortioxetine results in increased expression of BAX mRNA
CTD
PMID:39557222
NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:105,076,473...105,086,429
G
Bcl2
BCL2, apoptosis regulator
decreases expression
EXP
Vortioxetine results in decreased expression of BCL2 mRNA
CTD
PMID:39557222
NCBI chr13:23,204,464...23,366,900
Ensembl chr13:23,204,464...23,366,900
G
Bdnf
brain-derived neurotrophic factor
decreases expression
EXP
Vortioxetine results in decreased expression of BDNF mRNA
CTD
PMID:39557222
NCBI chr 3:116,619,633...116,670,212
Ensembl chr 3:116,619,633...116,670,657
G
Cdh1
cadherin 1
decreases expression
ISO
Vortioxetine results in decreased expression of CDH1 protein
CTD
PMID:38043629
NCBI chr19:51,402,178...51,471,572
Ensembl chr19:51,402,034...51,471,565
G
Htr1a
5-hydroxytryptamine receptor 1A
multiple interactions
ISO
vortioxetine binds to and results in increased activity of HTR1A protein
CTD
PMID:21486038
NCBI chr 2:38,427,169...38,431,733
Ensembl chr 2:38,427,083...38,540,760
G
Htr1b
5-hydroxytryptamine receptor 1B
multiple interactions
ISO
vortioxetine binds to and affects the activity of HTR1B protein
CTD
PMID:21486038
NCBI chr 8:91,395,405...91,414,815
Ensembl chr 8:91,052,432...91,418,583
G
Htr3a
5-hydroxytryptamine receptor 3A
multiple interactions
ISO EXP
Ondansetron affects the reaction [vortioxetine binds to and affects the activity of HTR3A protein]; vortioxetine binds to and affects the activity of HTR3A protein vortioxetine binds to and results in decreased activity of HTR3A protein
CTD
PMID:21486038
NCBI chr 8:58,138,514...58,150,960
Ensembl chr 8:58,138,226...58,150,884
G
Htr7
5-hydroxytryptamine receptor 7
multiple interactions
ISO
vortioxetine binds to and results in decreased activity of HTR7 protein
CTD
PMID:21486038
NCBI chr 1:243,049,064...243,173,636
Ensembl chr 1:243,049,081...243,173,230
G
Slc6a4
solute carrier family 6 member 4
multiple interactions decreases expression
ISO EXP
vortioxetine binds to and results in decreased activity of SLC6A4 protein Vortioxetine results in decreased expression of SLC6A4 protein
CTD
PMID:21486038 PMID:38043629
NCBI chr10:62,322,688...62,357,060
Ensembl chr10:62,324,254...62,357,056
G
Tjp1
tight junction protein 1
decreases expression
ISO
Vortioxetine results in decreased expression of TJP1 protein
CTD
PMID:38043629
NCBI chr 1:128,260,330...128,505,018
Ensembl chr 1:128,260,330...128,505,158
G
Ache
acetylcholinesterase
multiple interactions
EXP
xaliproden inhibits the reaction [Vincristine results in decreased expression of ACHE protein]
CTD
PMID:8413926
NCBI chr12:25,042,882...25,050,608
Ensembl chr12:25,043,461...25,050,410
G
Kcnh2
potassium voltage-gated channel subfamily H member 2
decreases activity
ISO
xaliproden results in decreased activity of KCNH2 protein
CTD
PMID:28551711
NCBI chr 4:11,719,357...11,751,424
Ensembl chr 4:11,692,980...11,751,421
G
Chrm1
cholinergic receptor, muscarinic 1
increases response to substance multiple interactions
ISO EXP
CHRM1 gene results in increased susceptibility to xanomeline; CHRM1 results in increased susceptibility to xanomeline xanomeline binds to and results in increased activity of [CHRM1 protein binds to CHRM4 protein]
CTD
PMID:19111716 PMID:19996296 PMID:21211109
NCBI chr 1:214,996,180...215,012,136
Ensembl chr 1:214,995,872...215,020,602
G
Chrm4
cholinergic receptor, muscarinic 4
affects binding multiple interactions increases response to substance
ISO EXP
xanomeline binds to CHRM4 protein xanomeline binds to and results in increased activity of [CHRM1 protein binds to CHRM4 protein] [WIN 62577 co-treated with Quinuclidinyl Benzilate] inhibits the reaction [xanomeline binds to CHRM4 protein] CHRM4 gene results in increased susceptibility to xanomeline; CHRM4 results in increased susceptibility to xanomeline
CTD
PMID:16709648 PMID:19111716 PMID:19996296 PMID:21211109
NCBI chr 3:98,349,080...98,356,821
Ensembl chr 3:98,348,650...98,358,771
G
Egr1
early growth response 1
increases expression
EXP
xanomeline results in increased expression of EGR1 mRNA
CTD
PMID:11313039
NCBI chr18:26,737,078...26,740,877
Ensembl chr18:26,736,838...26,740,843
G
Fos
Fos proto-oncogene, AP-1 transcription factor subunit
increases expression
EXP
xanomeline results in increased expression of FOS mRNA
CTD
PMID:11313039
NCBI chr 6:110,852,188...110,855,054
Ensembl chr 6:110,852,190...110,855,598
G
Htr4
5-hydroxytryptamine receptor 4
increases activity
EXP
zacopride results in increased activity of HTR4 protein
CTD
PMID:8577400
NCBI chr18:58,036,277...58,221,327
Ensembl chr18:58,036,277...58,219,622
G
Bad
BCL2-associated agonist of cell death
multiple interactions
EXP
zolmitriptan inhibits the reaction [Diethylnitrosamine results in decreased expression of BAD mRNA]; zolmitriptan inhibits the reaction [Diethylnitrosamine results in decreased expression of BAD protein]
CTD
PMID:31129132
NCBI chr 1:213,562,719...213,572,034
Ensembl chr 1:213,562,187...213,572,034
G
Bax
BCL2 associated X, apoptosis regulator
multiple interactions
EXP
zolmitriptan inhibits the reaction [Diethylnitrosamine results in decreased expression of BAX mRNA]; zolmitriptan inhibits the reaction [Diethylnitrosamine results in decreased expression of BAX protein]
CTD
PMID:31129132
NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:105,076,473...105,086,429
G
Bcl2
BCL2, apoptosis regulator
multiple interactions
EXP
zolmitriptan inhibits the reaction [Diethylnitrosamine results in increased expression of BCL2 mRNA]; zolmitriptan inhibits the reaction [Diethylnitrosamine results in increased expression of BCL2 protein]
CTD
PMID:31129132
NCBI chr13:23,204,464...23,366,900
Ensembl chr13:23,204,464...23,366,900
G
Bcl2l1
Bcl2-like 1
multiple interactions
EXP
zolmitriptan inhibits the reaction [Diethylnitrosamine results in increased expression of BCL2L1 mRNA]; zolmitriptan inhibits the reaction [Diethylnitrosamine results in increased expression of BCL2L1 protein]
CTD
PMID:31129132
NCBI chr 3:161,713,777...161,764,844
Ensembl chr 3:161,745,540...161,764,907 Ensembl chr 1:161,745,540...161,764,907
G
Casp3
caspase 3
multiple interactions
EXP
zolmitriptan inhibits the reaction [Diethylnitrosamine results in decreased expression of CASP3 mRNA]; zolmitriptan inhibits the reaction [Diethylnitrosamine results in decreased expression of CASP3 protein]
CTD
PMID:31129132
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:52,395,540...52,413,732
G
Casp9
caspase 9
multiple interactions
EXP
zolmitriptan inhibits the reaction [Diethylnitrosamine results in decreased expression of CASP9 mRNA]; zolmitriptan inhibits the reaction [Diethylnitrosamine results in decreased expression of CASP9 protein]
CTD
PMID:31129132
Ensembl chr 5:159,391,188...159,409,648
G
Cyp1a2
cytochrome P450, family 1, subfamily a, polypeptide 2
decreases activity
ISO
zolmitriptan results in decreased activity of CYP1A2 protein
CTD
PMID:18816299
NCBI chr 8:66,971,261...66,978,149
Ensembl chr 8:66,971,261...66,978,149
G
Gpt
glutamic--pyruvic transaminase
multiple interactions
EXP
zolmitriptan inhibits the reaction [Diethylnitrosamine results in increased expression of GPT protein]
CTD
PMID:31129132
NCBI chr 7:110,295,599...110,300,134
Ensembl chr 7:110,296,206...110,300,160
G
Nos2
nitric oxide synthase 2
multiple interactions
EXP
zolmitriptan inhibits the reaction [Diethylnitrosamine results in increased expression of NOS2 mRNA]
CTD
PMID:31129132
NCBI chr10:64,313,335...64,349,221
Ensembl chr10:64,313,335...64,401,880
G
Nos3
nitric oxide synthase 3
multiple interactions
EXP
zolmitriptan inhibits the reaction [Diethylnitrosamine results in decreased expression of NOS3 mRNA]
CTD
PMID:31129132
NCBI chr 4:11,686,088...11,706,604
Ensembl chr 4:11,686,268...11,706,664
G
Snca
synuclein alpha
multiple interactions
EXP
Dextromethorphan promotes the reaction [zolmitriptan inhibits the reaction [Reserpine results in increased expression of SNCA protein]]; Glutamic Acid inhibits the reaction [zolmitriptan inhibits the reaction [Reserpine results in increased expression of SNCA protein]]; zolmitriptan inhibits the reaction [Reserpine results in increased expression of SNCA protein]
CTD
PMID:38229316
NCBI chr 4:91,026,474...91,127,444
Ensembl chr 4:91,026,474...91,126,315
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all